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ABSTRACT 
 
 
RELIABILITY OF 
 
URINARY BLADDER PRESSURE MEASUREMENT 
 
IN CRITICAL CARE 
 
 
 
 
 
By 
 
Melanie Horbal Shuster, PhD, RN 
 
Dissertation supervised by:  L. Kathleen Sekula, PhD, APRN-BC, Associate Professor of 
Nursing 
Background of the study:  Intra abdominal pressure (IAP) theoretically may be a 
predictor of enteral nutrition tolerance (EN).  Urinary bladder pressure (UBP) is the gold 
standard for estimating IAP.  Current recommendations for UBP measurement (UBPM) 
calls for the instillation of normal sterile saline (NSS) into the bladder while the patient is 
supine with a zero degree (0°) head of bed elevation (HOBE).  How different instill 
volumes (IVs) and body positions influence UBPM were unknown, and the intra- and 
inter-observer reliability had not been adequately investigated.   
Specific aims:  1) Systematically evaluate the relative contribution of bladder IV and 
subject’s position upon UBPM.  2)  Determine inter- and intra- observer reliability of 
UBPM.  3)  Identify other factors that may influence IAP and UBPM:  age, gender, Body 
Mass Index (BMI), net fluid balance (NFB), positive airway pressure, use of paralytic 
agents, EN and length of stay (LOS).  Method:  Prospective randomized study of 120 
 v 
 
 
critically-ill adults who had UBPMs taken in four different positions and before and after 
three different IVs.  All UBPMs except 20 were obtained by the principle investigator 
(PI).  To determine inter-and intra-observer reliability the PI and a nurse co-investigator 
obtained 20 UBPMs each in 10 subjects.   
Results:  Two way ANOVA showed a significant volume (p<0.053), position (p<0.007) 
and volume-position interaction (p<0.004).  200 ml IVs gave higher UBP estimates and 
variability, 0 ml IV gave lower UBP estimates, high variability and occasional negative 
values.  The supine-0° HOBE yielded lower values.  No statistically significant 
difference in UBP was observed among the three positions that were with a 30° HOBE 
when measured with a 25 ml IV.  Intra-and inter-observer reliability was high.  BMI, 
NFB, LOS, and EN use were found to be predictors of UBP.    
Significance to nursing:  The findings of this study impacts critical care (CC) nurses’ 
bedside practice by contributing data to develop an evidenced based UBPM procedure.  It 
also allows for further investigation of the relationship between increased IAP and the 
gastrointestinal tract in critical illness and will facilitate the exploration of the 
relationship between increased IAP and EN tolerance. 
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Chapter 1  
 
 
Introduction  
 
Background of the Study 
Critically ill patients, like all humans, require nutrition to survive.  Often, 
critically ill patients cannot eat secondary to endotracheal intubation, dysphagia, or an 
altered level of consciousness.  Invasive nutritional support therefore must be provided to 
these individuals either via the parenteral or enteral route.  Recent evidence supports 
preferential use of the enteral over the parenteral route to minimize the complications and 
poor outcomes that have been observed with parenteral nutrition (Heyland, Dhaliwal, 
Drover, Gramlich, & Dodek, 2003).  However, the provision of enteral nutrition (EN) to 
critically ill patients is not without challenges (Guenter & Silkroski, 2001).  The greatest 
difficulties are related to the initiation, advancement, and maintenance of EN  (Bernard et 
al., 2004), which is under the purview of the bedside critical care nurse (CCN) who 
executes the prescribed EN orders while continuously monitoring the patients’ response 
(Pinilla, Samphire, Arnold, Liu, & Thiessen, 2001). 
Enteral nutrition administration is often limited by critically ill patients’ 
intolerance.   Intolerance is defined by Bernard and colleagues (2004) as side effects, 
adverse reactions, and complications that occur during the administration of EN.  
Intolerances include physical signs and symptoms such as nausea, vomiting, or bloating; 
metabolic derangements including hyperglycemia and altered electrolytes; and functional 
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or motility problems (ileus) which, individually or collectively, impedes the attainment of 
nutritional goals.  Enteral nutrition intolerance is partially related to altered and/or 
compromised intestinal function.  Currently there is no objective tool or reliable method 
to assess intestinal function in critically ill patients.  Such a tool or method could be used 
to predict which patient will or will not tolerate EN, and would be most useful for nurses.  
A potential objective predictor of EN tolerance is intra-abdominal pressure (IAP). 
Intra-abdominal pressure is the steady state pressure within the abdominal cavity.  
Intra-abdominal pressure varies between individuals, with position and activity.  In 
normal human subjects in the supine position, IAP is zero or slightly positive (Tzelepis, 
Nasiff, McCool, & Hammond, 1996).  The IAP normally increases during inspiration 
(diaphragmatic contraction) and decreases during expiration (relaxation) (Drye, 1948; 
Tzelepis et al., 1996).  In hospitalized patients in the supine position, IAP ranges from 0 
to 12.5 mmHg with a mean of 6.5  3.3 mmHg (Sanchez et al., 2001).  Intra-abdominal 
pressure increases when the volume (blood, air, water, etc.) inside the abdominal cavity 
increases or when abdominal wall compliance is reduced or inhibited (binders).  A 
measured IAP value > 12 mmHg is considered intra-abdominal hypertension (IAH) 
(Malbrain, De Laet, & Cheatham, 2007).  This commonly occurs with abdominal trauma 
or surgery or with aggressive fluid resuscitation secondary to shock states.   
Intra-abdominal pressure may be a good prognostic indicator of EN tolerance, 
because gastrointestinal (GI) physiology is very sensitive to increased IAP.  Intestinal, 
gastric and hepatic blood flows are reduced when IAP is > 10 mmHg causing intestinal 
hypoxemia, ischemia, and edema (Bongard, Pianim, Dubecz, & Klein, 1995; Caldwell & 
Ricotta, 1987; Diebel, Dulchavsky, & Wilson, 1992; Ivatury et al., 1998).  As IAP 
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increases, intestinal perfusion decreases creating a cycle of cellular hypoxia, 
inflammation and edema that continues unabated until perfusion is restored or intestinal 
cellular death occurs.  Intestinal ischemia and edema disrupts many of the protective 
intestinal barrier functions and may allow migration of bacteria from the intestinal lumen 
to the lymphatic system (Alverdy, Laughlin, & Wu, 2003; Diebel, Dulchavsky, & Brown, 
1997; Gargiulo, Simon, Leon, & Machiedo, 1998; Steinberg, 2003), a process known as 
translocation.  Bacteria also incite the production of pro-inflammatory cytokines further 
perpetuating this destructive cycle (Oda, Ivatury, Blocher, Malhotra, & Sugerman, 2002; 
Rezende-Neto et al., 2002).  In the critical care unit (CCU), IAH and bacterial 
translocation have been implicated as an etiology of bacteremia, systemic inflammatory 
response syndrome (SIRS), and the development of the multiple organ failure syndrome 
(MOFS) (Balogh, McKinley, Cox et al., 2003; Moore, 1999) 
Increased IAP also affects organ systems other than the GI tract.  The 
cardiovascular system is affected by a decreased venous return leading to a decreased 
cardiac output (Kashtan, Green, Parsons, & Holcroft, 1981; Ridings, Bloomfield, 
Blocher, & Sugerman, 1995).  The pulmonary system is affected because increased IAP 
elevates the diaphragm, which in turn reduces thoracic volume and lung compliance and 
increases intra-pleural pressure (Cullen, Coyle, Teplick, & Long, 1989).  The renal 
system is affected due to compression of the renal veins and collecting systems (Harman, 
Kron, McLachlan, Freedlender, & Nolan, 1982).  Finally, IAH can result in increased 
intra-thoracic pressure, which in turn may cause obstruction of cerebral venous blood 
flow leading to increased intra-cranial pressure and brain injury (Bloomfield, Ridings, 
Blocher, Marmarou, & Sugerman, 1997; Ertel, Oberholzer, Platz, Stocker, & Trentz, 
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2000).  The development of organ dysfunction in one or more systems in association with 
IAH is known as abdominal compartment syndrome (ACS).  Therefore, it stands to 
reasons that EN intolerance will occur with ACS.  The treatment of ACS is abdominal 
decompression and is accomplished most effectively with surgery and less effectively 
with nasogastric suction or drainage tubes (De Keulenaer et al., 2003) and muscle 
relaxants (De Waele, Benoit, Hoste, & Colardyn, 2003).  Effective decompression will 
decrease IAP and in turn permit EN tolerance.   
Presently there is no reliable or accurate way to determine IAP by physical 
examination, but it can be measured by direct or indirect techniques.  Because the 
abdomen is considered to be a relatively non-compressible cavity and primarily fluid in 
character, IAP can be measured directly by percutaneously inserting a catheter into any 
part of the abdomen or indirectly by inserting catheters into any hollow structure within 
the abdomen such as the inferior vena cava, uterus, or portal vein.  The most commonly 
used indirect measurement techniques to assess IAP in the CCU are gastric, rectal, and 
urinary bladder catheters.  Among these, the urinary bladder pressure (UBP) is the most 
widely used and is considered to be, by experts in the field, the gold standard for 
estimating IAP (Malbrain et al., 2006). 
Many clinicians survey critically ill patients for IAH by measuring UBP.  When 
ACS develops there is a need for emergent intervention, i.e. laparotomy or drainage of 
intra-abdominal fluid collections.  However, there is no consensus as to the absolute 
value of UBP which indicates a need for intervention. Furthermore, the measurement of 
UBP is not standardized and may lead to under or over estimations.  Underestimation of 
UBP may delay abdominal decompression in some individuals, while over estimation of 
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UBP may promote surgical intervention in some individuals when it is not warranted.  
Therefore, accurate and reliable UBP measurements as estimated by the bedside CCN is 
of crucial importance from the nursing, medical, and surgical standpoints, and to assess 
the usefulness of UBP as a predictor of enteral nutrition tolerance.   
Urinary bladder pressure measurement in critically ill patients is a nursing 
responsibility, however the technical accuracy and reliability of UBP measurements 
taken by the bedside CCN is currently unknown.  This is not surprising since the same 
can be said of cardio-pulmonary pressure monitoring (CPPM).  Compared with bedside 
CPPM, bedside UBP monitoring (UBPM) is considered to be in its infancy with regards 
to experience, interpretation, and interventions based on the data.  Research has shown 
that when monitoring equipment is properly assembled and calibrated, valid cardio-
pulmonary pressure (CPP) measurements can be obtained (Ahrens, 1997; Gardner, 1996; 
Woods & Mansfield, 1976) 
Therefore, variability in CPP measurements is not attributed to equipment 
problems but to differences in nurses’ knowledge and skills.  The nursing skills required 
for CPP measurements are proper positioning of patients, selecting the appropriate 
reference point, preparing the monitoring equipment, leveling and zeroing the transducer, 
assurance of waveform transmission, interpretation of the waveforms (Ahrens, Penick, & 
Tucker, 1995; Quaal, 1993) and recording the data.  Unfortunately, little is known about 
the technical accuracy and reliability of CPP values obtained by nurses.  The little that is 
known indicates CCNs’ knowledge of CPPM is fragmented and inadequate (Ahrens, 
1997, 1999).  
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Cardio-pulmonary pressure monitoring was introduced into clinical practice in the 
1970’s as a way to monitor patients with acute cardiac disease (Swan et al., 1970).  Since 
then, CPPM has grown and guides therapy of critically ill non-cardiac patients as well.  
Cardio-pulmonary pressure is a measurement and monitoring technique usually 
performed or supervised by bedside CCNs and the information obtained is used by 
critical care practitioners to guide patient therapy.  Nurses have been monitoring CPP for 
over 30 years.  Despite the wisdom and experience gained over this period, the nursing 
knowledge and practice of CPPM is regrettably poor.  In particular, the technical 
accuracy and reliability of CPPM is not known.  The main reason for this situation is the 
absence of nursing research that validates and guides the practice of CPPM.  Therefore, 
the validity and reliability of CPPM by CCNs, and its value to critical care practitioners 
as a tool for directing patient care is questionable.   
Although many physicians believe that the information provided by CPPM is 
useful in guiding therapy and improving patient outcomes (Trottier & Taylor, 1997) 
others do not.  Connors et al. (1983) reported that CPPM was associated with high 
mortality rates and high utilization of resources.  Based on this data, in an accompanying 
editorial, Dalen and Bone (1996) called for a moratorium on the use of CPPM until more 
data were available from clinical trials.   
As with CPPM, UBPM will be performed at the bedside by CCNs and data 
obtained will be used by critical care practitioners to guide patient care and for the 
potential monitoring of EN tolerance.  Inaccurate and or unreliable UBP measurements 
will lead to improper patient care.  Therefore, it is important that the technical accuracy 
and reliability of the UBP measurement procedure and monitoring technique be 
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established before it becomes widely used.  Failure to perform the proper nursing studies 
now will promote tradition based nursing practice and not evidenced based practice. 
Three major variables that can impact UBP measurement are bladder instill 
volume, patient position, and the nursing procedure for measurement.  Bladder instill 
volume is the volume of normal sterile saline (NSS) injected into the urinary bladder 
prior to obtaining a pressure reading.  It is assumed that the bladder needs to be distended 
to accurately transmit IAP (Kron, Harman, & Nolan, 1984; Malbrain, 1999) but UBP has 
been measured using no instill volume or as much as 250 milliliters (ml).  Currently, it is 
not known how a small or large instill volume affects UBP.  
Current guidelines recommend that UBP be measured in the supine position only 
(Gallagher, 2005; Lameier & NeCamp, 1990).  Because patients in CCU are rarely 
positioned flat and supine, this implies that patients will need to be re-positioned before 
UBP is measured several times per day.  This will disrupt patient’s sleep and increase 
nurse’s workload.  Furthermore, patients who are enterally fed will need to have the EN 
stopped for the UBP measurement decreasing the amount of EN provided to the patient. 
Therefore, it is important to determine if UBP needs to be measured in the supine 
position only, or if it can be as effectively measured when the patient is in a more 
comfortable or required position, i.e. 30 degree head of bed elevation (30º HOBE).  
Further studies are needed to determine the affect of patient’s position upon UBP and to 
decide if patients truly need to be flat and supine to have IAP measured accurately. 
In the CCU, UBP may be measured once, several times per day, or continuously.  
The current literature most commonly reports UBP as a maximal or mean UBP, which is 
the average of four measurements usually measured every six hours during a 24-hour 
 8 
 
 
period.  Few data regarding the intra-observer reliability of a single measurement or for 
repeated UBP measurements exists.  Preliminary studies indicate that the coefficient of 
variation of UBP is 4% to 66% (Malbrain, 2004; Malbrain et al., 2004; Malbrain, 1999).  
The apparent large variation in UBP may be due to true diurnal variation of IAP, to inter-
observer variability, to intra-observer variability, or to other technical issues of the UBP 
measurement technique such as leveling, zeroing, patient position, etc.  Although nursing 
procedures for UBP have been established and recommended for clinical use, these 
procedures have been written, recommended, and advocated without scientific evidence 
(Balogh & Moore, 2005a).    
In summary, EN intolerance occurs in critically ill patients.  Presently, there is no 
reliable objective method to evaluate GI physiology and its relationship to EN intolerance 
or the potential for developing EN intolerance.  Intra-abdominal pressure may be a tool to 
assess GI physiology and EN tolerance.  Intra-abdominal pressure can easily be measured 
at the bedside indirectly using UBP, and CCNs are charged with the responsibility of 
UBP measurement.  Because UBP data is used by clinicians to guide patient care, it is 
important to assure that UBP measurements are accurate and reliable.  Unfortunately, the 
technical accuracy and reliability of UBP measurements taken by bedside CCNs are 
unknown.  In addition, there is not a consensus regarding the effect of bladder instill 
volume and patient’s position upon UBP measurement.  Therefore, before UBP 
measurement becomes widespread and used as an index to assess EN tolerance, it is 
important that nursing research be conducted to determine the role of bladder instill 
volume and patient position upon the reliability of UBP measurements taken by CCNs at 
the bedside.  This study will provide the necessary data required to develop an evidenced 
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based procedure and protocol for CCNs to measure UBP at the bedside of critically ill 
patients.  Establishing evidence based practice of bedside UBPM is necessary to avoid 
the controversies and problems that have occurred with CPPM, and evade the errors in 
the interpretation of the data that have been witnessed with bedside hemodynamic 
monitoring. 
 
Purpose of the Study 
The purpose of this study is to critically evaluate the process of UBPM in a 
naturalistic critical care setting.  The specific aims are to: 
1. Systematically evaluate the relative contribution of bladder instill volume 
upon UBP measurement. 
2. Systematically evaluate the relative contribution of subject’s position upon 
UBP measurement. 
3. Determine the inter-observer reliability of UBP measurement. 
4. Determine the intra-observer reliability of UBP measurement. 
5. Identify other factors that may influence IAP and UBP measurement:  age, 
gender, Body Mass Index (BMI), fluid balance, respiratory or ventilatory 
status, and paralytic agents. 
6. Develop evidence-based recommendations for UBP measurement by 
bedside CCNs. 
 
Research Questions 
1. Does the amount of bladder instill volume effect UBP measurement? 
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2. Does subject’s body position effect UBP measurement? 
3. What is the inter-observer reliability of UBP measurement? 
4. What is the intra-observer reliability of UBP measurement? 
5. What other factors influence UBP measurement? 
6. What are the elements of an evidenced based protocol necessary for CCNs 
to reliably perform bedside UBP measurement? 
 
Definition of Terms 
Instill volume is the amount of NSS instilled into the urinary bladder prior to 
obtaining a bladder pressure measurement.  This volume is assumed to be necessary to 
distend the bladder to assure that a bladder pressure can be transduced to a bedside 
monitor and measured and is reflecting the IAP. 
Critical care unit (CCU) is a geographic location within the hospital where 
critically ill adult patients are admitted for aggressive and intensive medical and nursing 
care.  The term critical care unit is used as the preferred term reflecting the concept of 
acuity.  However, it also includes intensive care unit (ICU) as these are designations of 
specific units.  Adults patients admitted to any of the six critical care units:  trauma, 
surgical ICU, medical ICU, coronary care, and two neuro ICUs were screened for 
possible inclusion into the study. 
Intra-abdominal pressure (IAP) is the steady state pressure within the abdominal 
cavity at any given time and in healthy individuals is zero when supine, but in critically 
ill patients can range from zero to 50 mmHg. 
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Position refers to one of four positions subjects assumed for bladder pressure 
measurement.  Positions will vary by supine or back lying and lateral or side lying and by 
the degree of HOBE, zero or 30°.   
 Supine-0° HOBE position:  subject supine with 0° HOBE and a pillow 
under the head.   
 Supine-30° HOBE position:  subject supine with 30° HOBE and a pillow 
under the head.   
 Right lateral-30° HOBE position:  subject right side lying with a 30° 
HOBE and a pillow under the head and a second pillow placed between 
the legs.  The right lateral position will also be maintained with a 45° 
wedged positioning pillow.   
 Left lateral-30° HOBE position:  subject left side lying with a 30°HOBE 
and a pillow under the head and a second pillow placed between the legs.  
The left lateral position will also be maintained with a 45° wedged 
positioning pillow. 
Reliability has been defined by Dolter (1989) as consistency, stability, and 
repeatability of results.  Acknowledging this definition and for the purpose of this study, 
reliability is further defined as the ability to reproduce and record the same or a very 
similar UBP measurements at two different times by one or more observers (within a 30 
minute period) using the same procedure.   
Urinary bladder pressure (UBP) is an indirect method of measuring IAP. 
Validity for the purpose of the study refers to the ability of a UBP measurement to 
accurately measure IAP. 
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Assumptions 
1. The abdominal cavity is a closed system that behaves according to 
Pascal’s law. 
2. Urinary bladder pressure is a valid method of measuring IAP. 
3. Urinary bladder pressure measurement is an indirect measure of IAP. 
4. Urinary bladder pressure measurement is an important clinical sign to be 
monitored in critically ill patients. 
5. Measurement of UBP by hydrostatic methods is reliable. 
6. Bedside monitoring equipment when properly calibrated and assembled 
accurately measures pressures. 
7. Urinary bladder pressure measurement is an important nursing 
responsibility.  
Limitations 
1. Subjects were selected from multiple critical care units but only one 
clinical site was used. 
2. A limited and selected number of bladder instill volumes were studied     
(0 ml, 25 ml, 50 ml, 200 ml). 
3. A limited and selected variety of body positions were studied.  Two 
positions were supine with zero and 30° HOBE, and two were side lying 
positions, right and left lateral, both with 30° HOBE.  
4. This study did not include an independent measure of IAP to validate the 
indirect measurement of UBP in critically ill patients. 
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Strengths 
1. The same observer completed multiple (480) UBP measurements. 
2. A variety of subjects in varied clinical settings were measured by the same 
observer. 
3. More subject positions and bladder instill volumes were studied by one 
observer than any other study to date. 
4. Uniquely designed and highly powered human study of UBP measurement 
in a critical care setting. 
 
Weaknesses 
1. Only one clinical site for the study was used. 
2. A limited population by age, gender, BMI, ethnicity, positive airway 
pressure, paralytic agents, and diagnosis was studied. 
3. No changes in outcomes were measured. 
4. Reliability was only determined between two nurses. 
 
Significance of the Study 
The intention of the study was to evaluate the important factors necessary to 
standardize the critical care nursing procedure for bedside UBP measurement.  The 
findings of this study will have immediate impact upon CCN’s bedside practice by 
contributing the data necessary to develop an evidenced based UBP measurement 
procedure that may be evaluated as a tool for enteral feeding tolerance.   
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The study also has broader implications for critical care nursing and medicine as 
it relates to the phenomenon of increased IAP and GI pathophysiology.  In particular, it 
will allow for further investigation of the relationship between increased IAP and the 
physiological response of the GI tract in critical illness, as well as the investigation of the 
relationship between increased IAP and the function of other organ systems in critical 
illness.  Specifically, the results of this study will facilitate the exploration of the 
relationship between increased IAP and EN tolerance.   
Finally, the results of the study will have greater clinical implications.  Once the 
technique of UBP measurement is standardized, UBP can be measured more frequently.  
More frequent measurement will be helpful in establishing circadian variances and 
differences that may be related to various critical care states.  This will lead to prompt 
recognition and diagnosis of ACS and perhaps will lead to earlier treatment and 
interventions preventing patient compromise.   
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Chapter 2  
 
Review of the Literature  
 
Introduction 
The purpose of this literature review is two fold.  First, to discuss the basic 
pressure concepts upon which IAP and UBP measurements are based, and second to 
review studies of UBP validity and reliability measurements. 
Intra-abdominal pressure can be measured like a variety of other bodily pressures, 
because pressures are generated within the human body secondary to fluid filled cavities 
being contained within semi rigid structures.  Physical properties and flow dynamics 
influence these pressures.  The literature review will evaluate the concepts of pressure 
measurement including:  principles of hydrostatic pressure, intra-abdominal pressure 
physiology, clinical significance of increased IAP, factors affecting IAP measurement 
and interpretation, techniques of IAP measurement, and UBP measurement as an 
indicator of IAP.    
Pressures that are generated in fluid filled cavities can be quantified or measured 
when compressed or cannulated, i.e. blood pressure measured with a cuff and manometer 
or an arterial line.  Nurses frequently are responsible for measuring various patient 
pressures, using direct and indirect techniques, interpreting the measurements, and often 
initiating or altering therapy and treatments based on these observations by employing 
algorithms or by consulting with other practitioners.  Urinary bladder pressure as an 
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indirect measure of IAP is one of the more recent cavity pressures to be measured at the 
patient’s bedside, and the literature review will examine animal and human studies of 
validity and reliability of IAP and UBP measurements.  The concepts of pressure 
measurement and the relevant research studies together form the foundation upon which 
the research questions and study design addressing nursing and UBP measurement rests.  
The unifying theoretical model upon which the study is based is depicted in Figure 1. 
The study investigated the left side of the model which is the role of nursing in the 
accuracy and reliability of UBP measurement.  However, it is important to acknowledge 
the right side of the model, which represents the physiological and clinical relevance of 
the study.  At the center of the model is tolerance to EN which was the research 
hypothesis that prompted the current study.  It is hoped that the research findings 
generated from this study will later be used to investigate if UBPM is a reliable predictor 
of EN tolerance. 
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Figure 1. Theoretical model for reliability of bedside urinary bladder pressure 
measurement and enteral nutrition in critical care. 
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Although a nursing theory is not directly tested in the current study, the critical 
thinking theory of Benner (1982; 1996) as applied to nursing by Martin (1995) represents 
a theoretical framework for the rationale and nursing importance of the study.  Critical 
thinking is the cerebral process employed by nurses in clinical decision making.  
According to this theory, nurses’ critical thinking ascends from a low to a high level over 
time as a nurse becomes more knowledgeable and experienced (Figure 2).  Benner (1987; 
1992) describes five levels of nursing competence based on knowledge and years of 
experience:  novice, new beginner, competent, proficient, and expert.   
The novice is a student or new graduate and is transitioning from student to 
professional nurse.  This is often facilitated in the orientation phase of an initial 
professional nursing position.  Knowledge and experience are gained through mentoring 
and preceptoring relationships.  Novice nurses use objective data to make clinical 
decisions with the assistance of others.  The advanced beginner is a nurse with less than 
two years of experience whose practice is guided by policies and procedures and is 
focused on tasks, but uses a theoretical knowledge base.  Nurses transitioning to the 
competent level integrate theoretical knowledge and experience and have mastered 
technical skills and have practiced nursing for two to three years.  After three to five 
years of experience proficiency is attained.  At this level nurses have in-depth knowledge 
and have a more global approach to patients and families and are able to respond to 
unplanned events.  Finally, as an expert nurse with greater than five years of experience, 
care is delivered with confidence to patients and families both independently and 
collaboratively and is based upon a deep and wide knowledge foundation (Benner, 1982; 
Benner et al., 1992; Haag-Heitman & Kramer, 1998). 
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Figure 2.  Critical thinking theory as applied to nursing. 
Note. Adapted from The Theory of Critical Thinking of Nursing, by C. Martin, (2002).  .  
 
Applying the critical thinking theory of Benner (1982) to the decisions regarding 
the administration of EN in critically ill patients is two fold.  First, it could be 
hypothesized that when comparing novice nurses to expert nurses, the expert nurse would 
be better able to use subjective and objective data of GI tract function and would make 
more appropriate decisions regarding initiation, advancement, and maintenance of EN, as 
well as suspending and terminating EN.  Second, it could be hypothesized that expert 
nurses would also be more adept at recognizing subjective and objective signs of normal 
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GI tract function or dysfunction more readily and accurately when compared to novice 
nurses, therefore expert nurses would be better able to decide when to initiate, advance, 
maintain, suspend or terminate EN.   
Furthermore, it is hoped that Benner’s theory of critical thinking in nursing as 
applied to UBP would be able to demonstrate that novice nurses lack tolerance for 
patients who experience alterations in GI tract functions with EN and prematurely 
terminate feeding as compared to expert nurses.  Continuing with this thought process 
and when considering the elements upon which EN administration decisions are made by 
bedside nurses, it would be expected that as nurses gain knowledge and experience with 
EN better decisions would be made in regards to successful administration of EN.  
Therefore, because an objective tool of assessing GI tract function or EN does not 
currently exist, it would be expected that patients cared for by expert nurses would 
achieve higher success in EN administration because such a nurse will rely more on 
experience (Figure 3).  In contrast, patients cared for by novice nurses would be at a 
disadvantage due to lack of experience.  Finally, the lack of an objective tool for GI tract 
function and assessment decreases the level of clinical decisions made by all levels of 
nurses and an objective reliable tool would be most helpful for all levels of practicing 
nurses. 
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Figure 3. Theory of critical thinking of nursing as applied to enteral nutrition. 
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Using the results from this study, further nursing research could be conducted to 
explore the relationships between nurse’s skills of assessment of GI tract function and 
critical decision making skills in reference to initiating, advancing, maintaining, 
suspending, or terminating EN.  If UBP is proved to be a reliable objective tool and an 
indicator of EN tolerance, then UBPM can be used by nurses at all levels of Benner’s 
classification to help with the clinical decisions regarding administration of EN.  It is 
predicted that such a tool will be useful for nurses at all levels, but it would be of greater 
importance to the novice and less-than-expert nurse since it would empower them with 
knowledge and a skill that can be readily acquired and is not dependent upon years of 
experience (Figure 4). 
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Figure 4. Hypothesized effect of urinary bladder pressure upon theory of critical thinking 
of nursing as related to enteral nutrition administration. 
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Concepts of Pressure 
Hydrostatic Pressure Measurement 
Urinary bladder pressure measurements like hemodynamic pressure 
measurements are based on hydrostatic pressure principles.  To obtain pressure 
measurements, typically a fluid-filled catheter is placed into the chamber of interest (i.e. 
right or left atrium, or urinary bladder).  The hydrostatic fluid pressure within the 
chamber is transmitted thru an opening in the catheter to a pressure transducer-amplifier- 
monitor system located at the patient’s bedside.  The transducer converts the pressure 
signals into an electrical signal that is amplified and recorded by the monitor (Ahrens, 
1999).   
To accomplish accurate bedside monitoring several concepts must be understood 
and incorporated into nursing procedures.  First, physiologic pressures including CPP and 
IAP are measured against atmospheric pressure.  Thus, the contribution of atmospheric 
pressure must be subtracted from the measured pressure.  This is accomplished by 
opening the transducer to air.  This procedure is known as zeroing and in effect makes the 
hydrostatic pressure at the opening of the catheter used for measuring equal to zero.   In 
other words, the position of the catheter’s measuring port in relation to the transducer will 
determine the relative hydrostatic fluid pressure within the chamber.  To accurately 
measure the pressure in the cavity, hollow organ, or blood vessels it is important that the 
catheter used for measuring be at the same level as the transducer, and this procedure is 
referred to as positioning or leveling.  Failure to level the transducer to the catheter’s 
measuring orifice will result in erroneous measurements, either greater than or less than 
the true value.   Erroneously lower pressure results when the transducer is higher than the 
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catheter opening, and erroneously higher pressure results when the transducer is lower 
than the catheter opening. 
The second essential concept with regards to leveling is patient position. For 
optimal results, pressure measurements need to be taken when patients are in a 
standardized position.  Very often, it is not possible to know exactly where the measuring 
orifice of the catheter is internally and an external landmark is used.  For UBP 
measurement the transducer is most commonly leveled at the symphysis pubis.   This is 
convenient because the symphysis pubis is an easily identifiable anatomic landmark and a 
reference point for the lower aspect of the bladder.  Recently others have suggested using 
the mid-axillary line at the iliac crest as the zero reference point (Malbrain et al., 2007).      
The accepted convention for CPPM is to level and zero the transducer at the 
phlebostatic axis (Winsor & Burch, 1945), which is an external marker for the right 
atrium (RA).  When patients are in a flat supine (0° HOBE) position the phlebostatic axis 
is the point marked by the intersection of two planes: one vertical and one horizontal.  
The vertical plane is at the fourth intercostal space and the horizontal plane is the 
midpoint between the bed inferiorly and the sternum superiorly (Winsor & Burch, 1945).  
However, other markers have been proposed.  Cuortois and colleagues (1995) recently 
suggested that for intra-cardiac measurements the transducer should be leveled at the 
uppermost blood level in the chamber for which the pressure is to be measured.  This site 
can be measured for each patient by echocardiography or can be estimated if a large 
database is obtained.   
It is important to emphasize that the reference point for leveling the transducer is 
specific to the position of the chamber of interest.  It is not appropriate to use the 
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phlebostatic axis for hemodynamic measurements when patients are supine with the head 
of bed (HOB) elevated (HOBE) or when the patient is in a lateral position, because the 
position of the right atrium may change.  The phlebostatic axis was designed to be used 
for patients in the 0° HOBE position.  Other reference points must be used when patients 
are in other positions besides a 0° HOBE position.  Reference points that have been used 
for these purposes have been described by others.  Paolella and colleagues (1988) used 
computerized tomography (CT) to determine the position of the RA. Kee and colleagues 
(1993) as well have used echocardiography to determine external anatomic references of 
the RA.  
Intra-Abdominal Pressure Physiology 
Intra-abdominal pressure is defined as the steady state pressure within the 
abdominal cavity, and has two major physiological roles.  One is as a regulator of normal 
respiration and the other is the stability of the spinal column (Overholt, 1931; Salkin, 
1934).  The anatomic boundaries of the abdominal cavity are the movable diaphragm and 
the shifting costal arch superiorly, the rigid pelvis and the lumbar skeleton inferiorly and 
posteriorly, respectively, and the muscles that surround the abdominal cavity.  The 
important muscles that provide shape and support to the abdominal cavity are the rectus 
abdominis, anteriorly; the external and internal oblique abdominal muscles and the 
transverses abdominis, laterally; and the muscles of the pelvic floor, inferiorly (Hall-
Craggs, 1995; Snell, 1995).  Because the abdominal cavity contains rigid components 
(i.e., spine and hip) it usually maintains its shape in various positions.  Increases in IAP 
with changes in position and weight lifting are greatly due to gravitational effects of the 
organs and to contractions of the abdominal cavity muscles (De Troyer, 1983) 
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The abdominal cavity contains solid organs (liver, pancreas, spleen) and hollow 
organs such as the gastrointestinal (GI) tract (stomach, small bowel and colon), uterus (in 
women), blood vessels (e.g. portal vein, inferior vena cava) and the urinary bladder.  
Normally, nothing else is contained within this space except for a small amount of 
peritoneal fluid that moistens and lubricates the surfaces.  Because of these attributes the 
abdominal cavity is often considered to be a closed system containing a relatively non-
compressible material and therefore should follow Pascal’s law (Bradley & Bradley, 
1947).  Pascal’s law states that an increase in pressure exerted at any point of a confined 
fluid will result in an equal increase in pressure at every other point within the container 
(Daugherty & Franzini, 1977).  If this principle holds true for the abdomen, catheters 
placed at different points in the abdomen should register similar pressures reflective of 
IAP and should be sensitive to changes in patient’s position.   
Experimental support for these assumptions comes from the studies of Mead et al. 
(1990) and confirmed by Tzelepis and colleagues (1996) in healthy human subjects.   
These investigators measured IAP at different levels within the abdomen by placing 
catheters at various sites in the GI tract.  Their results showed that changes in IAP 
induced by changes in position or breathing were of the same magnitude if measured in 
the upper or the lower part of the abdomen.  The pressures in the lower part of the 
abdomen were five to 10 percent lower than the pressure in the upper part of the abdomen 
due to partial compression caused by air in the lower colon.  
The physiological factors that normally determine IAP are the up and down 
movement of the diaphragm, tension or relaxation of the abdominal and pelvic muscles, 
the weight of the organs, and the degree of shearing decompression between the organs 
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(Loring, Yoshino, Kimball, & Barnas, 1994).  In healthy individuals lying supine, IAP is 
zero or slightly negative (sub-atmospheric) or positive and normally increases with 
inspiration and decreases during expiration (Tzelepis et al., 1996).  Activities of daily 
living increase IAP.  Sitting or standing increases IAP by 5-10 mmHg (Twardowski et 
al., 1986).  Walking and running increases IAP to 22-38 mmHg and jumping produces an 
increase to approximately 89 mmHg (Grillner, Nilsson, & Thorstensson, 1978; 
Twardowski et al., 1986).  Intra-abdominal pressure also increases with abdominal 
compression, cough, the valsalva maneuver, and by lifting heavy objects (Twardowski et 
al., 1986).  Obesity (Sanchez et al., 2001; Sugerman, Windsor, Bessos, & Wolfe, 1997) 
and pregnancy result in higher IAP (Soderberg, 1971). 
Clinical significance 
Intra-abdominal pressure ranges from zero to 12.5 mmHg with a mean of 6.5  
3.3 mmHg (Sanchez et al., 2001) in hospitalized patients in the supine position.  Intra-
abdominal pressure increases when the volume (blood, air, water, etc) inside the 
abdominal cavity increases.  Intra-abdominal pressure > 12 mmHg is considered intra-
abdominal hypertension (IAH) (Malbrain et al., 2004) and is a well-recognized 
complication of certain types of surgeries (e.g. after reduction of large diaphragmatic 
hernias or closure of the abdomen under excessive tension) and trauma when intra-
abdominal bleeding from splenic, hepatic and mesenteric injuries are common (Eddy, 
Key, & Morris, 1994; Malbrain et al., 2004; Morken & West, 2001).  Intra-abdominal 
hypertension may also occur with medical illnesses such as hypovolemic shock and 
massive fluid resuscitation, peritoneal dialysis, ileus, ascites, and acute pancreatitis. 
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Organ dysfunction in one or more systems in association with IAH is known as 
abdominal compartment syndrome (ACS).  Abdominal compartment syndrome clinically 
presents as oliguria, decreased cardiac output, and rising peak airways pressures (Moore, 
Hargest, Martin, & Delicata, 2004).  The exact incidence of ACS is unknown since, 1) 
IAP is not measured routinely in CCU (Mayberry et al., 1999; Ravishankar & Hunter, 
2005) , 2) the methods of measuring IAP are not standardized, and 3) the heterogeneity of 
patients.  The reported incidence of ACS ranges from 0.1% to 33% of postoperative and 
trauma patients (Eddy, Nunn, & Morris, 1997; Hong et al., 2002; Meldrum et al., 1997; 
Sugrue et al., 1995).  Currently, there is no agreement on the absolute value of IAP that 
leads to ACS.  Some patients may exhibits signs of organ dysfunctions with IAP of 10-12 
mmHg while others will not develop clinical signs of organ failure until IAP rises to 15-
18 mmHg.  However, IAP > 20 mmHg should be considered clinically significant in 
every patient.   
The treatment of ACS is abdominal decompression.  Decompression can be 
accomplished by laparotomy or by draining intra-abdominal collections utilizing invasive 
radiologic guided procedures and techniques.  Less commonly used methods of 
decompression are placement of nasogastric tubes for suction (De Keulenaer et al., 2003) 
and muscle relaxants (De Waele et al., 2003).  Currently a consensus among researchers 
and clinicians on the best time to intervene in ACS is lacking.  Ivatury and Sugerman 
(2000) have suggested intervention when IAP is > 25 mmHg as this may permit an 
opportunity to reverse some of the damage caused by IAH.  In contrast, others have 
suggested waiting until clear signs of organ dysfunction are observed, such as increased 
airway pressure (Eddy et al., 1997) or oliguria (Meldrum et al., 1997) before intervening. 
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In trauma patients with ACS, early abdominal decompression is associated with 
improvement in organ functions.  Unfortunately, only a small percentage of those who 
undergo decompression survive, and sadly even though 80% of patients who initially 
were treated with decompression responded, most did not survive.  Survival rate after 
surgical decompression ranges from 17 to 75% (Sugrue et al., 2001).  It appears that after 
an initial and often dramatic response to decompression, many patients eventually 
developed MOFS and died.  These results suggest that once formed, ACS triggers a 
systemic inflammatory response that progresses to MOFS regardless of interventions 
(Oda et al., 2002).   
Compared to trauma patients, less is known about the incidence, significance, and 
treatment of ACS in other types of surgical and medical patients.  However, it is likely 
that general surgical and medical patients also suffer from potentially lethal 
pathophysiological decompensation associated with ACS as witnessed in trauma patients.  
Therefore, all critically ill patients could benefit from accurate and reliable monitoring of 
IAP provided the data obtained is accurate, reliable, and reproducible, and trends of IAP 
can be established. 
The clinical data summarized underscores the need for routine monitoring of IAP 
in critically ill patients, both surgical and medical.  Monitoring IAP is necessary to 
recognize IAH and to prevent and treat ACS in hope of reducing MOFS and death.  
Therefore, it is necessary to develop research based standardized protocols for use in the 
clinical setting to recognize early IAH and predict ACS.  Several authors have called for 
greater awareness of IAP, and for more training in the measurement of IAP, and for the 
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early recognition and treatment of ACS in CCU (Balogh & Moore, 2005b; Malbrain, 
2002; Malbrain, 2004; Malbrain et al., 2004; Sugrue, 2002) 
Techniques of Intra-Abdominal Pressure Measurement 
Physical examination cannot be used as a reliable or accurate method to determine 
IAP nor can it be used to predict the development of IAH and ACS.  Kirpatrick and 
associates (2000) assessed the utility of a clinical abdominal examination in detecting 
IAP and IAH in patients admitted to a university affiliated trauma center.  The specificity 
and sensitivity of a clinical abdominal examination in detecting clinically significant IAP 
(> 10 mmHg) was 40% and 94% respectively and of detecting very high IAP (> 15 
mmHg) was 56% and 87%, respectively (Kirkpatrick et al., 2000).  In a similar study, 
Sugrue et al. (2002) found that the specificity and sensitivity of a clinical examination in 
detecting IAH, defined as IAP > 18 mmHg, was 60.9% and 80.5% respectively.  The 
positive predicted value was 45.2%, and the negative predicted value was 88.6%. These 
authors concluded that clinical examination is not an accurate method to assess IAP, nor 
is it an accurate tool to predict IAH, and further stated that IAP needs to be measured in 
the clinical setting.  Other investigators have reached the same conclusion (Platell, Hall, 
Clarke, & Lawrence-Brown, 1990). 
Direct or indirect measurement techniques can be used to measure IAP.  The 
abdomen is considered to be a relatively non-compressible cavity and primarily fluid in 
character, therefore, IAP can be measured directly by percutaneously inserting a catheter 
into any part of the abdomen or indirectly by inserting catheters into any cavity within the 
abdomen such as the inferior vena cava (IVC), uterus, portal vein (PV), etc.  Accurate 
IAP measurements have been taken using IVC, uterine, gastric, rectal and bladder 
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catheters (Gudmundsson, Viste, Gislason, & Svanes, 2002; Malbrain, 2004).  However, 
obtaining access to the IVC, PV, or uterus is rather invasive and requires expertise not 
readily available in CCU.  Similarly, placing an intra-peritoneal catheter for the sole 
purpose of measuring IAP is impractical and has the potential to add unnecessary risk to 
critically ill patients.  Therefore, indirect measurement techniques are most commonly 
used to assess IAP in the CCU.  Of the available techniques, UBP is used most widely.  
Furthermore, UBP is considered by experts in the field to be the gold standard for 
estimating IAP (Malbrain, 2004).   
The UBP technique was first described by Kron et al. (1984) and their technique 
involves using a patient’s existing urinary drainage catheter.  For each measurement the 
catheter is disconnected from the collecting system and then 50 to 100 ml of a NSS is 
instilled into the bladder.  The catheter is then clamped at a position distal to the sampling 
port and a 16-gauge needle, which is attached to primed pressure tubing and a transducer, 
is inserted into the sampling port.  The transducer is leveled and zeroed at the symphysis 
pubis.  The bladder pressure is then taken at end-expiration from the monitor or from a 
paper recording.  The needle is then withdrawn and reinserted for each bladder pressure 
measurement that follows (Kron et al., 1984). 
The technique of Kron et al. (1984) has been utilized extensively in clinical 
practice.  The main problems with this technique are the repeated violation of the sterile 
system for each intermittent measurement, increased risk of urinary tract infections 
(UTI), time consuming, increased risk to nurses for needle stick injuries, and exposure to 
blood and body fluids.  An additional clinical concern is with the advent of needleless 
systems and avoidance of needles, a needleless connection to measure UBP may not be 
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as accurate as a 16 gauge needle.  However, there is no data examining the use of a 
needleless system in UBPM. 
Kron and colleagues’ (1984) original technique has been modified by Iberti et al. 
(1989), Cheatham and Safcsak (1998), and Malbrain et al. (2004).  The main contribution 
of Iberti and colleagues (1989) was to convert Kron and colleagues’ method from an 
open to a closed system by directly attaching a liter of NSS to the urinary catheter to 
make the instill volume easier to administer.  Otherwise all the disadvantages of the 
original Kron and colleagues’ technique also apply to Iberti’s methods.  For instance, 
Iberti’s method still required insertion of a needle into the sampling port of the urinary 
drainage system with the risk to patients for infection and the risk to nurses for needle 
stick injuries and exposure to bodily fluids (Iberti et al., 1989). 
Cheatman and Safcsak (1998) modified the method of Iberti et al. (1989) by 
attaching the urinary catheter to two three-way stopcocks connected in series.  The first 
stopcock is attached to a liter of NSS, and the second stopcock is attached to a 60 ml 
syringe that facilitated the instillation of saline into the bladder.  A plastic catheter then is 
inserted into the urinary drainage sampling port and left in place.  This closed system 
allowed repeated UBP measurements over time without exposing the patient to infection 
from intermittent violation of the sterile system.  However, eventually the connector port 
leaked causing problems, and again increasing the risk of urinary tract infection.   
Malbrain (2004) modified Cheatman and Safcsak’s (1998) technique by attaching 
a third stopcock in a series and eliminating the need to insert a needle into the sampling 
port, because the third stopcock was attached to the transducer. The system is primed 
with NSS and then the series of stopcocks are opened to air and the transducer is zeroed 
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and leveled at the symphysis pubis. This relatively closed system allowed repeated 
measurements over days.  In addition, it had the advantages of shortening UBP 
measurement times and reducing the risks to patients and nurses as described above. 
Commercially available systems for obtaining IAP measurement using UBP are 
the latest innovation.  The AbViser™ (Wolfe-Tory Medical, Inc. Salt Lake City, UT) is 
one of two systems available and the FoleyManometer LV™ (Holtech Medical.  
Charlottenlund, Denmark) is the other.  The AbViser™ is a two-way valve that is 
sterilely placed directly between the urinary catheter and the collection system.  When the 
AbViser™ is in the open position saline can be instilled into the bladder or the bladder 
can be drained, and when the valve is in the closed position UBP can be measured.  The 
AbViser™ offers the same advantages as the Malbrain (2004) technique with three three-
way stopcocks in tandem, but in addition facilitates repeated measurements with ease, 
decreased time, and decreased risk of infection. 
Urinary bladder pressure measurement techniques as described by Kron et al. 
(1984) and modified by others are based on hydrostatic pressure principles.  Therefore, 
all UBP measurements are prone to problems inherent in such a system.  In particular, 
accuracy will depend on the nurse’s abilities to precisely perform the procedural 
techniques for assembling, priming, zeroing, and leveling the transducer and maintaining 
the monitoring equipment as well as positioning the patient appropriately.  Because UBPs 
are frequently measured in patients who are also undergoing hemodynamic 
measurements, it is important that the dedicated transducer used for UBP measurement is 
leveled at the symphysis pubis and not leveled with the other transducers used for CPP 
measurements, where those transducers are zeroed and leveled at the phlebostatic axis.  
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In addition, it is important to re-level the transducer with changes in patient’s position.  
Malposition of the transducer following a change in the patient’s position may over- or 
under-estimate the UBP and IAP.  It is also important to recognize and correct for over- 
and under-damping of the UBP waveform.  Dampening can be caused by the presence of 
air-bubbles in the pressure tubing or by a tube that is too long or too compliant (De 
Waele, Billiet, Hoste, & Colardyn, 2004).  However, a square wave test can be performed 
to insure integrity and accuracy of the monitoring system and assess for dampening 
(Kleinman, Powell, Kumar, & Gardner, 1992; Quaal, 1993). 
Nursing and Urinary Bladder Pressure Measurement 
Measurement of UBP in critically ill patients is a nursing responsibility.  Data 
obtained by nurses is used by nurses and other clinicians to guide therapy.  For this 
measurement to become a ubiquitous guide for clinicians as a determinate of therapy, it is 
essential that it is reliable.  This is very important because, underestimation of UBP may 
delay abdominal decompression, while overestimation of UBP may promote surgical 
intervention when it is not warranted.  Therefore, accurate and reliable UBP 
measurements obtained by nurses are of critical importance from the nursing, medical, 
and surgical standpoints.  However, the technical accuracy and reliability of UBP 
measured by nurses is unknown.  A review of the literature showed only one research 
study that assessed the technical accuracy, inter-observer, and intra-observer reliability of 
UBP measurement (Kimball, Mone, Wolfe, Baraghoshi, & Alder, 2007).  This is not 
surprising because the same is true of CPPM which has been used for > 30 years.   
Bedside UBPM is considered to be in its infancy with regards to experience, 
interpretation, and interventions based upon observed data when compared with bedside 
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CPPM.  However, CPPM and UBPM share many similarities, and a review of the CPPM 
literature is relevant for this study to understand how a new bedside procedure was 
introduced, evaluated, accepted, and deemed essential by nurses and physicians and 
adopted as a standard of care by the critical care community.  This knowledge is 
necessary to avoid the difficulties and errors that have been noted with hemodynamic 
pressure monitoring preceding UBP measurement. 
There are many similarities between CPPM and UBPM.  First, CPPM and UBPM 
will provide information to clinicians that are otherwise unobtainable by history and 
physical examination alone (Connors et al., 1983; Eisenberg, Jaffe, & Schuster, 1984; 
Kirkpatrick et al., 2000; Sugrue et al., 2002).  Second, both are based on hydrostatic 
pressure principles and use similar equipment (transducers, amplifiers, and monitors).  
Moreover, proper measurement of CPP and UBP demand that the nurse level and zero 
the transducer properly for accurate measurement.  Third, both require the insertion of a 
fluid-filled catheter for measurement (arterial, pulmonary artery, urinary bladder) to 
transmit the pressure waveform with fidelity.  Fourth, CPPM and UBPM are performed 
at the bedside by CCNs and the data obtained is readily used by intensive care 
practitioners to monitor patient’s response to treatment and to guide interventions.  
Therefore, as with other diagnostic modalities, the clinical utility of CPPM and UBPM 
depends greatly on the proper collection and interpretation of the data.   
Research has shown that when monitoring equipment is properly assembled and 
calibrated, valid CPP measurements can be obtained (Ahrens, 1999; Gardner, 1996; 
Woods & Osguthorpe, 1993).  Therefore, variability in CPP measurements is not due to 
equipment problems but to differences in nurses’ knowledge and skills.  The nursing 
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skills required for CPP measurements are proper positioning of patients, selecting the 
appropriate reference point, preparing the monitoring equipment, leveling and zeroing the 
transducer, assurance of waveform transmission, interpretation of the waveforms 
(Ahrens, 1999; Quaal, 1993) and recording the data.  Unfortunately, little is known about 
the technical accuracy and reliability of CPP values obtained by nurses.  The little that is 
known indicates CCNs’ knowledge of CPPM is fragmented and inadequate (Ahrens, 
1997, 1999).  Research has shown that nurses do not understand the process of zeroing 
and leveling and may perform these procedures in situations when it is not necessary 
(Ahrens et al., 1995).  Research has also shown that nurses do not have a clear 
understanding of the square wave test (AACN, 1993; Quaal, 1995; Woods & Osguthorpe, 
1993), an important measure, because over- and under-damping will result in under- and 
over-estimation of pressures, respectively.  Additionally, research has shown that nurses 
have difficulty interpreting waveforms and determining the correct value as displayed on 
the bedside monitor particularly when there is respiratory artifact (Al-Kharrat, Zarich, 
Amoateng-Adjepong, & Manthous, 1999). 
Review of the CPPM literature is also helpful to predict the usefulness of UBPM 
in patient care.  In the 1970s CPPM was introduced into clinical practice as a way to 
monitor patients with acute cardiac disease (Swan et al., 1970).  Since then, CPPM has 
grown and now guides therapy of critically ill non-cardiac patients.  Many physicians 
believe that the information provided by CPPM is useful in guiding therapy and 
improving patients’ outcomes (Trottier & Taylor, 1997).  However, despite its wide 
acceptance and use by the nursing and medical communities, there is no consensus as to 
whether CPPM improves patient outcomes.   
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In 1996, Connors et al. (1996) reported that CPPM was associated with high 
mortality and high utilization of resources.  Based on this data, in an accompanying 
editorial, Dalen and Bone (1996) called for a moratorium on the use of CPPM until more 
data were available from clinical trials.  As a response, several medical and nursing 
societies formed the Pulmonary Artery Consensus Conference Organization (PACO) to 
review the available data regarding the use of CPPM (Taylor, Calvin, & Matuschak, 
1997).  This review process confirmed that there was no evidence that CPPM improves 
outcomes (Rackow, 1997).  In addition, it became evident that CPPM lacked 
standardization and data used by clinicians to make decisions was often flawed.  The 
review also revealed that physicians’ and nurses’ knowledge of CPPM and interpretation 
of the data was poor.  Based on this information, PACO made two major 
recommendations regarding CPPM:  First, PACO did not support a moratorium and 
recommended to continue with CPPM, and second called for better training of physicians 
and nurses in the technical aspects of CPPM and the interpretation of data gathered 
(Taylor, 1997; Taylor et al., 1997; Trottier & Taylor, 1997).   
One possible way to explain the lack of evidence that CPPM improved outcome is 
that nurses’ techniques are variable and sometimes leads to erroneous results and by 
consequence erroneous clinical recommendations.  Currently, no consensus regarding 
many important aspects of CPPM exists.   One area of controversy is the selection of the 
correct anatomic landmark for placement, leveling, and zeroing of the transducer to 
insure accurate CPP values.  For CPPM, the most widely used reference point for 
leveling the transducer is the fourth inter-costal space at the midpoint of the anterior-
posterior diameter.  This location is known as the phlebostatic axis and is intended to be 
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an external reference point for the RA (Winsor & Burch, 1945).  However, recent 
imaging studies using computed tomography (Paolella et al., 1988) and echocardiography 
(Courtois et al., 1995; Kee et al., 1993) have cast doubts about the validity of this 
landmark for CPPM.  Incorrect leveling of the transducer in reference to the RA will 
cause either over- or under-estimation of RA pressure. 
Another area of practice that lacks consensus regarding procedures for CPPM is 
the influence and importance of patient positioning upon pressures.  Most commonly, 
CPPM is performed with patients supine.  However, in CCUs most patients rest with the 
HOB elevated to some degree and in the right or left lateral position, as well as supine.  
The nursing standard is to reposition patients unable to reposition themselves every two 
hours to prevent integument compromise (Baas, 2003; Perry & Potter, 1998; Reilly, 
2001; Rodgers, 2001; Vollman & Aulbach, 1998).  Therefore, nurses find patients in a 
variety of positions just before CPP measurement.  Having to change a patient’s position 
to obtain CPP will disturb patients sleep, rest, and comfort, which is against the primary 
goals of nursing.  Patients who are able to reposition themselves would be forced to 
assume a position for measuring and then remain in a non-mobile steady state so a 
pressure measurement could be taken.  Lastly, changing patient positions excessively 
increases nurses’ workload and increases the risk of dislodging medical devices often 
used in critically ill patients.  Obviously obtaining an accurate measurement in any 
position at anytime would be desirable for both nurses and patients. 
At least a dozen nursing studies have investigated the effect of patient positioning 
and CPP measurements (Cason & Lambert, 1990; Chulay & Miller, 1984; Cline & 
Gurka, 1991; Clochesy, Hinshaw, & Otto, 1984; Dobbin, Wallace, Ahlberg, & Chulay, 
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1992; Groom, Frisch, & Elliott, 1990; Keating, Bolyard, Eichler, & Reed, 1986; 
Kennedy, Bryant, & Crawford, 1984; Laulive, 1982; Wilson, Bermingham-Mitchell, 
Wells, & Zachary, 1996; Woods, Grose, & Laurent-Bopp, 1982; Woods & Mansfield, 
1976) .  In most of these studies, various CPP measurements obtained in the supine-flat 
(0° HOB elevation) position were compared with measurements taken when patients 
were in the supine position with various degrees of HOB elevation (HOBE), the right 
lateral, and left lateral positions.  Unfortunately, most nursing studies that investigated 
the importance of position in CPP measurement were underpowered, and suffered from 
major design flaws that make the results difficult to accept and use in clinical practice.  
The major design flaws identified in these studies were: 1) failure to validate the 
reference point, 2) failure to re-level the transducer with position changes; 3) failure to 
provide information about inter-observer and intra-observer reliability; and 4) failure to 
document the validity and reliability of the equilibrium period after each position change.  
The preponderance of the evidence suggests that pulmonary artery pressures (PAP) and 
other values do not greatly differ when subjects are supine–flat or supine with HOBE of 
20-45 , but that lateral positioning does produce variables results.  However, because of 
these serious research methodological problems, it is difficult to affirm with any degree 
of certainty whether one particular position is preferred over another for accuracy and 
reliability of CPPM.  Currently, critical care nursing textbooks recommend CPPM be 
measured with patients in the spine position with the HOB elevated zero to 60° (Daily & 
Schroeder, 1981; Whalen & Kelleher, 1998) .  Usually lateral positioning is not 
recommended (Cason & Lambert, 1993).   
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The lack of definitive nursing research in regards to CPPM (i.e. well designed and 
fully powered studies) has created a great deal of confusion among nurses regarding 
proper patient positioning for CPPM.  Grap, Pettrey, and Thornby (1997) assessed CPPM 
practices of 1000 members of the American Association of Critical Nurses (AACN) 
using a mailed questionnaire that both assessed knowledge with a quiz and questions 
regarding actual practice.  The investigators found that nurses’ knowledge regarding 
pulmonary artery pressure (PAP) measurement was reflected in practice.  Respondents’ 
knowledge of flat (supine-0° HOBE) positioning to measure PAP was 26.5% and 24.1% 
of the respondents reported always keeping the bed flat when measuring PAP.  Tested 
knowledge found that 57.3% or nurses knew that the HOB should be < 45° and 55.9% of 
nurses reported elevating the HOB 30° or less in practice.  Finally, 84.3% of nurses tested 
knew that the patient should be supine for measurement and 80.7% reported that patients 
are supine for measurements.  Only 13.3% of nurses reported placing patients in lateral 
and other positions for PAP measurements.  Although the results of this study 
demonstrates nurses knowledge guides nursing practice, it also suggest that there is great 
variability among nurses regarding the practice of CPPM which may greatly affect the 
pressure measurements obtained by nurses and may directly affect patient therapy.   
In summary, CPP is a measurement and monitoring technique usually performed 
or supervised by bedside CCNs and the information obtained is used by critical care 
practitioners to guide patient therapy.  Nurses have been monitoring CPP for over 30 
years.  Despite the wisdom and experience gained over this period, the nursing 
knowledge and practice of CPPM is regrettably poor.  In particular, the technical 
accuracy and reliability of CPPM is not known.  The main reason for this situation is the 
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absence of nursing research that validates and guides the practice of CPPM.  Therefore, 
the validity and reliability of CPPM by CCNs and its value to critical care practitioners as 
a tool for directing patient care is questionable.  Additional well-designed and fully 
powered nursing studies are needed to validate CPPM practice.  Unfortunately, because 
CPPM is so widely accepted and frequently used at the bedside as a critical care nursing 
technique, it is highly unlikely that a study to establish reliability will ever be performed.  
Urinary bladder pressure monitoring, as an indirect measure of IAP, is the new 
frontier of CCU monitoring.  As with CPPM, UBPM will be performed at the bedside by 
CCNs and data obtained will be used by critical care practitioners to guide patient care.  
Inaccurate and or unreliable UBP estimations will lead to improper patient care.  
Therefore, it is important that technical accuracy and reliability of the UBP measurement 
technique and monitoring be established before it becomes widely used.  Failure to 
perform the proper nursing studies now will only lead to the repeated errors that have 
been committed with CPPM.  
Validity of Urinary Bladder Pressure Measurement 
The UBP technique has been validated in both animal and human studies by 
comparing direct IAP measurements with UBP measurements. 
 
Animal studies. 
Iberti and colleagues (1987) measured IAP in dogs directly by placing an intra-
abdominal catheter surgically into the peritoneal space, and indirectly by placing a 
urinary bladder catheter.  These investigators found that IAP ranged from 10  5 mmHg 
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to 70  10 mmHg for the bladder catheter and those pressures accurately reflected IAP 
measured with the peritoneal catheter (Iberti et al., 1987).  In an investigation of validity 
of indirect methods of IAP measurement in rabbits, IAP was gradually increased by 
inflation of an air-filled balloon (Lacey et al., 1987).  These investigators found that only 
indirect IAP measured with the urinary bladder and inferior vena cava catheters had good 
statistical correlation with direct IAP measurement (Lacey et al., 1987).  Intra-abdominal 
pressure measured using catheters placed in the stomach, rectum, superior vena cava, 
femoral and brachial artery were all poorly correlated with direct IAP measurements 
(Lacey et al., 1987).  Ridings et al. (1995) measured IAP by a direct method and by UBP 
in a swine model.  Intra-abdominal pressure was measured at baseline and after IAP was 
increased from 10 to 35 mmHg.  The IAP measured directly was highly correlated with 
UBP (0.98, p<0.001).  Gudmundsson et al. (2002) placed intra-peritoneal and bladder 
catheters in pigs and either progressively increased or decreased IAP in a stepwise 
fashion from 10 to 40 mmHg by instilling or withdrawing Ringer’s solution into or from 
the abdomen.  These investigators demonstrated that the IAP measured indirectly by the 
bladder pressure catheter paralleled increases or decreases in relation to IAP as measured 
directly via the intra-peritoneal catheter.   
 
Human studies. 
Iberti and colleagues (1989) compared IAP measured directly via surgically 
placed intra-peritoneal catheters and IAP measured indirectly with a urinary bladder 
catheter in sixteen postoperative patients.  Measurement of IAP was done in three 
positions: supine, supine with gentle manual compression, and supine with the HOBE at 
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a 45  angle.  The researchers found that the IAP measured by the bladder and the 
peritoneal catheters resulted in nearly identical values regardless of the position.  The 
correlation between the two methods of IAP measurement was 0.91 (p< 0.001) 
independent of patients’ position.   
Further validation of the urinary bladder catheter method as an accurate reflection 
of IAP in humans has been performed during laparoscopy.  Researchers compared 
indirect IAP measured with a urinary bladder catheter with direct IAP measured with the 
CO2 insufflator used for laparoscopic surgery in 40 patients before elective laparoscopic 
cholecystectomy (Yol, Kartal, Tavli, & Tatkan, 1998).  The IAP’s were measured before 
and after the IAP was raised to five, 10 and 15 mmHg by CO2 insufflation.  The results of 
the study are shown in Table 1. 
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Table 1.  
Comparison of Direct and Indirect Measurements of Intra-Abdominal Pressure. 
(Yol et al., 1998) 
 
Insufflator Pressure  
Direct Measurement 
Urinary Bladder Pressure  
Indirect Measurement 
(mean  SD) 
mmHg cm H2O cm H2O 
0 0 2.5  1.4 
5 6.8 7.3  1.5 
10 13.6 12.9  1.6 
15 20.4 19.7 1.5 
 
There was very good correlation between IAP measured directly with the 
insufflator and indirectly by the urinary bladder catheter (r = 0.973, p < 0.0001).  Further 
validation of the bladder technique was offered by Fusco et al. (2001).  Like Yol et al. 
(1998), Fusco et al. (2001) compared insufflator pressures with bladder pressures in 37 
patients prior to undergoing various laparoscopic surgeries.  Each patient had UBP 
measured when IAP was set from zero to 25 mmHg by CO2 insufflation and bladder 
instill volumes ranged from zero to 200 ml.  Evaluating all bladder volumes together, 
bladder pressure correlated well with the insufflator pressure (R
2
= .68).   
Other investigators have validated the bladder technique in humans by comparing 
direct to other indirect methods of IAP measurement.  Collee and colleagues (1993) and 
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Sugrue et al. (1994) also found good correlations between IAP measured with gastric and 
bladder catheters.   
The validity of UBP measurement also has been recently investigated in neonates 
in CCUs.  Davis, and colleagues (2005) measured IAP in 20 neonates (median age 10 
days) who required peritoneal dialysis due to renal failure that developed after cardiac 
surgery.  Intra-abdominal pressure was measured directly through the peritoneal dialysis 
catheter that was placed for dialysis and indirectly by urinary and gastric catheters.  
Urinary bladder pressure was measured after the bladder had drained and after instilling 
one, three, or five ml/kg of sterile normal saline solution (NSS) into the bladder.  An 
instill volume of one ml/kg demonstrated close agreement between IAP measured by 
UBP and IAP measured directly by the peritoneal catheter.  The UBP tended to give 
values that were between 0.07 and 1.23 mmHg higher than the IAP measured by the 
peritoneal catheter with limits of agreement between 3.08 mmHg higher and 1.79 mmHg 
lower than the peritoneal catheter.  In summary, both animal and human studies have 
validated UBP as an accurate reflection of IAP.   
Reliability of urinary bladder pressure measurement 
Although UBP offers a valid estimate of IAP, the reliability of bedside UBP 
measurements taken by CCNs is unknown.  Most studies reporting IAPs only show a one 
time value (usually the maximum) obtained over several hours of monitoring (O'Mara, 
Slater, Goldfarb, & Caushaj, 2005) and do not report whether these values were obtained 
by one or more observers.  The first report of bladder pressure variability is one study 
designed to assess the prevalence of IAH in critically ill patients (Malbrain et al., 2004).  
This was a one-day study where bladder pressures were measured in patients admitted to 
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13 CCUs in seven European countries.  The bladder pressure was measured four times 
(12:00, 18:00, 24:00 and 6:00 hours) in 24 hours using the Cheatman and Safcsak (1998) 
modification of the Kron technique (1984).  The study included 97 surgical and medical 
patients.  All measurements were taken by the same standardized protocol with subjects 
in the supine position with 50 ml of sterile NSS instilled into the bladder before the 
measurements were taken.  It is presumed that nurses took most if not all of the 
measurements, but no information was provided to evaluate nurses’ knowledge, level of 
training and expertise using the UBP technique.  The average UBP detected in this study 
was 9.7  4.7 mmHg.  The average difference between the maximal and minimal four 
daily UBPs was 5  3.7 mmHg.  When the measurements taken every six hours in each 
patient were considered, the average coefficient of variation was 0.25  0.13 or 25%  
13%.  However, when the data from individual centers were compared the coefficient of 
variation ranged from 4% to 66% among the centers (Malbrain et al., 2004).  Since it is 
not known if there is a diurnal variation in IAP, it is not possible to determine from this 
data whether this variability reflects normal daily fluctuations, patient related changes, or 
differences in measurements techniques between the same or different observers.   
An extensive review of the literature revealed only one laboratory and one clinical 
study that assessed reliability of UBPM (Wolfe & Kimball, 2005a).  Wolfe and Kimball 
(2005b) built a laboratory model of the abdomen by using a 210 liter container with a 
urinary catheter exiting from its base.  The proximal end of the urinary catheter tip was 
sealed with a 100 ml bag to simulate the urinary bladder and it was placed at the base of 
the container, and the other end was connected to an AbViser
™
 kit which in turn was 
connected to a transducer and a monitor.  The transducer was leveled at the level at the 
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simulated urinary bladder at the bottom of the container.  A column of fluid was placed 
within the container to simulate IAP of 5, 10, 15, 20, 25, 30, and 40 mmHg.  Eleven (11) 
observers then took five measurements each for each of the seven simulated IAPs.  The 
differences between the measured and the actual values were small the standard deviation 
of the means were 0 to 0.49.  The differences between the measured and actual values 
were ± 1 mmHg.  This study only assessed variability of the monitoring system but did 
not address more important questions as variability introduced by subjects or by nurses’ 
techniques.   
Kimball and associates (2007) estimated inter-reliability and intra-reliability of 
UBP in subjects admitted to a CCU and at risk for IAH.  One nurse measured UBP twice 
and a second nurse measured it a third time in 18 subjects.  The differences between the 
two measurements taken by the first nurse were used to estimate intra-observer reliability 
and the difference in the measurement between the first and second nurse was used to 
estimate inter-observer reliability.   
Overall, 89 nurses performed 212 sets of UBPM in 18 subjects.  Urinary bladder 
pressure was measured between 1-39 times per subjects.  All subjects were measured in 
the supine position and with 50 ml bladder instill volume. The UBP values ranged from 
4-25 mmHg with average of 12.23 ± 4.68 mmHg.  The Pearson correlation for the intra- 
and inter-observer paired comparisons was 0.93 and 0.95, respectively.  For the intra-
observer reliability the mean difference between the measurements was 0.570 mmHg (CI 
0.306-0.834; limits of agreement -2.98 and 4.078 mmHg).  For the inter-observer 
reliability the mean difference between the measurements was 0 mmHg (CI -0.254 to 
0.245; limit of agreement -3.069 to 3.069 mmHg).  Kimball and associates (2007) found 
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that fluctuations of 4 mmHg (32% Coefficient of Variation) were very common between 
and within nurses and 10.5% of subjects had paired measurement fluctuations of > 2 
mmHg.  This variability may be of clinical significance since it may affect the definition 
of IAH and may also affect clinical decisions.  The study of Kimball and associates 
(2007) was the first study to demonstrate low variability and therefore high reliability of 
UBP measurements in the CCU setting. 
It stands to reason that specific knowledge and skills would be required to 
perform UBP, but the knowledge and skills of nurses related to UBP measurement has 
not been systematically studied.  This is not surprising since the same can be said about 
the assessment of knowledge and skills of nurses regarding hemodynamic measurements 
even though this technique has been widely accepted and used for over 30 years 
(Rackow, 1997).  For instance, little is known about inter- and intra-observer reliability of 
hemodynamic measurements taken by nurses (Ahrens, 1999; Rackow, 1997).  Whatever 
is known suggests that nurses’ knowledge and skills of hemodynamic measurements are 
poor (Ahrens, 1997; Al-Kharrat et al., 1999; Iberti et al., 1994).   
Iberti et al. (1994) used a questionnaire to assess the level of understanding 
regarding the use of pulmonary artery catheters and hemodynamic measurements.  
Critical care nurses registered to attend a hemodynamic monitoring workshop sponsored 
by the AACN were surveyed (N=236) using questions in seven categories related to 
hemodynamic monitoring: complications, waveforms, patient management, insertion 
techniques, positioning, physiology, and calculations.  The mean test score was 16.5  
5.7 or 48.5 %.  Nurses correctly answered 63% of questions related to complications, 
52.2 % of questions regarding waveforms, 50.5% of questions about patient management, 
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and 49.9% of questions dealing with insertion technique, 47.2 % of questions specific to 
positioning, 40.9% of questions addressing physiology, and 38.6% of questions 
concerning calculations.  In a separate analysis of the data, it was found that test scores 
were significantly associated with years of experience in critical care, job title, being a 
certified critical care registered nurse, being responsible for repositioning and 
manipulating catheters, area of expertise, frequency of use of catheters, and self-assessed 
adequacy of knowledge.  The same questionnaire was administered by Burns and Shively 
(1996) to another 168 critical care nurses with similar results.  The mean test score for the 
37 item questionnaire was 56.8%.  Although not a consolation, it should be pointed out 
that nurses are not alone in this area.  Other researchers reported low scores related to 
knowledge regarding hemodynamic measurements among critical care physicians as well 
(Iberti et al., 1990; Trottier & Taylor, 1997). 
Other studies have shown that many nurses lack the basic skills related to zeroing 
and leveling of transducers and very often perform these procedures when not needed 
(Ahrens et al., 1995) and do not understand and know how to perform a square wave test 
(Quaal, 1995).  A more recent study also indicated that CCNs have difficulty interpreting 
waveforms and calculating data obtained from pulmonary artery catheters (Al-Kharrat et 
al., 1999).  A significant finding of Al-Kharrat’s study (1999) was that upon re-
interpretation of the data by critical care physicians, 30% of the pulmonary artery 
occlusion pressure values obtained by CCNs could have led to different therapeutic 
decisions (either failure to treat or inappropriate treatment).  These observations question 
the inter-observer reliability of pressure measurements.   
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In summary, there is limited data addressing the intra- observer and inter-
reliability of CCNs’ ability to obtain UBPs (Kimball et al., 2007).  Existing data indicates 
that the knowledge and the technical accuracy of CPPM, using skills similar to those 
required to obtain UBP, performed by CCNs are poor.  Because, nurses use the same 
skills when measuring UBP as when measuring CPP, examining the existing data 
investigating nurses’ knowledge of invasive monitoring is pertinent.  Considering what is 
known about UBP measurement in combination with what is known regarding the 
reliability for other CPP, large variability, poor reliability, and questionable 
reproducibility of UBP measurement is to be expected.  This creates a clinical problem 
since UBP, like CPPM, is one of the tools often used by critical care practitioners and 
surgeons to direct therapy.  Over and/or underestimation of UBP may in some instances 
produce over utilization of resources while in other instances patients may be deprived of 
needed therapy that may reduce the risks of MOFS and death.  In either situation patients 
may be at risk of receiving unwarranted treatment. 
However, before definitive studies to determine reliability of UBP measurements 
can be performed, it is important that the measurement technique be standardized.  
Current protocols recommended for UBP measurement are not based on solid scientific 
research evidence.  Two variables that may affect UBP measurement are bladder instill 
volume and patient position, both require further investigation.   
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Influencing Factors of Urinary Bladder Pressure Measurement 
Instill volume. 
Sterile NSS is commonly instilled into the bladder before UBP measurement.  
The literature regarding the need for and the optimal amount of a sterile solution for 
instillation into the bladder prior to bladder pressure measurement is inconclusive.  It is 
believed that instilling sterile NSS or water into the bladder improves pressure 
transmission and wave recognition.  However, this could result in over-estimation of 
UBP and IAP if the instilled volume independently causes distention of the bladder.  
Researchers have claimed that with instill volumes of less that 100 ml the bladder acts as 
passive reservoir (Kron et al., 1984).  However, a study to validate this statement was not 
provided.  Animal and human bladder pressure studies have used instill volumes ranging 
from zero to 250 ml (Iberti et al., 1989; Obeid et al., 1995).  Iberti et al. (1989) in their 
initial studies of dogs showed that accurate IAP measurements can be obtained with 
instill volumes ranging from zero to 100 ml.  Iberti et al. (1989) also showed accurate 
IAP could be obtained with a 250 ml instill volume.  Although some studies show that 
bladder pressure can be measured with a wide range of instill volumes, none can be used 
to support the use of one volume over another. 
Gudmundsson et al. (2002) demonstrated that accurate IAP measurements can be 
obtained by measuring UBP with an instill volume of 0 ml in pigs.  Using the same pig 
model these investigators later investigated the bladder instill volume required to increase 
bladder pressure by 2 mmHg.  Intra-abdominal pressure was gradually increased by 
instilling Ringer’s Lactate into the pig’s abdomen until the desired pressure was 
achieved.  To achieve an increase in bladder pressure by 2 mmHg when IAP was set at   
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< 8 mmHg an average of 131  113 ml (range 30 to 300 ml) of NSS was required to be 
instilled into the urinary bladder.  However, when the IAP was set at 20 mmHg a much 
lower average of 39  23 ml (range 10 to 80 ml) was needed to be instilled into the 
urinary bladder to increase bladder pressure by 2 mmHg.  Data is shown in Table 2.   
Moreover, for every paired data set, smaller volumes were needed when IAP pressure 
was set at 20 mmHg as compared to when pressure was set at < 8 mmHg.  This data 
suggests that even instill volumes < 50 ml can influence IAP.   However, caution should 
be exercised when extrapolating this data to humans, because of the anatomical 
differences between humans and pigs.  Specifically the urinary bladder in pigs is located 
intra-peritoneally but in humans is located in the pelvis, and not within the peritoneal 
space. 
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Table 2. 
Effect of Bladder Instill Volumes on Intra-Abdominal Pressures. 
Gudmundsson et al. (2002). 
Animal # 
IAP < 8 mmHg  
ml of NSS instilled to increase 
UBP 2 mmHg 
IAP = 20 mmHg  
ml of NSS instilled to increase 
UBP 2 mmHg 
1 150 15 
2 300 80 
3 300 60 
4 30 10 
5 40 30 
6 80 50 
7 120 40 
8 30 40 
Mean  
SD 
131  113 39  23 
 
Fusco et al. (2001) assessed the effects of bladder instill volumes on the accuracy 
of IAP measured using the bladder technique in humans with instill volumes that ranged 
from zero to 200 ml.  In this study, IAP was increased by direct CO2 insufflation prior to 
elective laparoscopic surgery.  A good correlation between UBP and IAP measured with 
the insufflation needle was found.  In addition, correlations between direct insufflation 
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and indirect UBP measured with instill volumes ranging from zero to 200 ml did not 
differ significantly from each other.  When data from all volumes and pressures were 
considered the UBP was 3.8  0.29 mmHg higher than direct insufflation pressure 
readings.  A urinary bladder instill volume of 0 ml demonstrated the lowest bias differing 
from the insufflation pressure by -0.79  0.73 mmHg and an instill volume of 200 ml 
demonstrated the higher bias differing from the insufflation pressure by –5.2  0.60 
mmHg.  However, when only the data set obtained when the insufflation pressure was set 
at 25 mmHg (i.e. high IAP), instill volumes of 50 ml demonstrated a lower bias compared 
to 0 ml instill volume (1.5 vs. 2.0 mmHg).   
Davis et al. (2005) investigated the effect of bladder instill volumes on the 
accuracy of IAP measurement in 20 children (median age 10 days) admitted to a surgical 
CCU.  Urinary bladder pressure was measured after the bladder was drained and after 
instilling one, three, or five ml/kg of sterile saline into the bladder.  The results were 
compared to IAP measured directly via a peritoneal catheter.  Intra-abdominal pressure 
was most accurately estimated by UBP when one ml/kg of sterile saline was instilled into 
the bladder.  Increasing the instill volume from one to three, or five led to a greater 
overestimation of IAP compared to the direct measurement.  Decreasing the instill 
volume from one to 0 ml/kg led to more variability and wider limits of agreement.  If 
these results can be applied to typical critically ill adults who weigh 50 to 100 kg, it could 
be predicted that instill volumes of 50 to 100 ml would lead to accurate UBP 
measurements. 
De Waele et al. (2006) measured UBP in 20 subjects at risk of IAH admitted to a 
surgical CCU.  Urinary bladder pressure was measured 10 times within a short period.  
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The first measurement was taken one minute after instilling 10 ml of sterile saline into 
the bladder.  Subsequently, UBP measurements were taken after each 10 ml increment 
increase up to 100 ml.  Measurements were taken after a one minute equilibration period 
elapsed following each instillation.  An “oscillation test” was done after each instillation 
to evaluate whether the system was sensitive enough to detect the measurement.  This test 
requires gently tapping the abdomen just above the symphysis pubis and observing the 
response in the monitoring system.  The minimal instill volume required to detect a 
positive oscillation test was 10 ml.  An instill volume of 10 ml gave the lower estimation 
of UBP and instill volumes of 50 and 100 ml were 17 and 33% higher than the UBP 
measured with an instill volume of 10 ml.  These results suggest that small instill 
volumes (< 50 ml) may be desirable when measuring UBP.   However, it is interesting to 
note that 50 ml has been accepted as a usual or traditional volume for UBP measurement, 
and the current volume recommended by the World Society of Abdominal Compartment 
Syndrome (WSACS) is 25 ml or less.  Unfortunately, the study if De Waele et al.  (2006) 
had serious design flaws and involved a limited number of subjects; therefore using this 
work to make deductions is questionable.  For example, the authors used a custom 
designed IAP monitoring set based on the technique of Cheatham et al. (1998) but did not 
clearly specify patient’s positions or the technique for leveling and zeroing the 
transducer.  All of these factors may greatly affect the results.  In addition, 0 ml was not 
tested and the consecutive and cumulative effect of saline instillation upon the UBP 
steady sate is unknown.   
Malbrain and Deeren (2006) investigated the effect of different volumes in UBP 
in 12 subjects admitted to a CCU.  All subjects were sedated, ventilated and supine at the 
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time of the UBP measurement.  The pressure transducers were zeroed at the symphysis 
pubis.  Urinary bladder pressure was measured before any volume (0 ml) was instilled, 
then 25 ml NSS was added to the bladder consecutively up to a net bladder volume of 
300 ml.  Following each additional 25 ml bladder instill volume a UBPM was taken up to 
the total and final volume of 300 ml.  One subject had a UBP of 0 mmHg with 0 ml 
bladder instill volume.  Urinary bladder pressure was lowest with a 0 ml bladder instill 
volume and gradually increased with each 25 ml instill volume increment.  The mean 
values of UBP for the 0 ml, 25 ml, 50 ml and 200 ml cumulative bladder instill volume 
were 6.2 ± 6 mmHg, 6.9 ± 7.5 mmHg, 8 ± 8 mmHg and 14.4 ± 13 mmHg, respectively. 
Chiumello and associates (2007) also investigated the effect of instill volume on 
UBP measurements in 13 subjects admitted to a CCU.  Initial UBP measurement was 
taken with a 50 ml NSS instill volume and then subsequently after each 25 ml addition of 
NSS to a maximum of 200 ml.  All subjects were in the supine-0º HOBE position and the 
transducer was zeroed at the symphysis pubis for all measurements.  After each saline 
addition, UBP was measured at five to 10 seconds and again after five minutes.  The 
bladder catheter was closed during the five minute waiting period and drainage was 
inhibited.  There was no difference in UBP when 50 ml and 100 ml of NSS were instilled 
into the bladder but there was a significant difference in UBP measurement between the 
50 ml and the 150 ml and 200 ml of NSS instill volumes.  In addition, with the 150 ml 
and 200 ml NSS instillation, the five minute UBP measurements were lower than the 
UBP measurements recorded at the five to 10 seconds interval after the instillation.  This 
indicates that the bladder takes longer to reach a stable condition when large volumes are 
instilled into the bladder. 
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In summary, both animal and human data have shown that reliable estimates of 
IAP can be obtained with 0 ml instill volumes and higher UBPs are obtained with higher 
instill volumes (Chiumello et al., 2007; Davis et al., 2005; De Waele et al., 2006; Fusco 
et al., 2001; Gudmundsson et al., 2002; Malbrain & Deeren, 2006).  Two of these studies 
were performed in settings other than CCU and one was done in neonates.  Three of these 
studies reflect the complex clinical situation of a modern CCU, where most patients are 
receiving mechanical ventilation, intravenous fluids, and enteral nutrition, all which can 
impact upon IAP (Chiumello et al., 2007; Davis et al., 2005; Malbrain & Deeren, 2006).  
Therefore, it is likely that most critically ill patients in the CCU have an undetermined 
amount of urine contained within the bladder at any given time and instilling an 
additional fixed volume into the urinary bladder may falsely elevate bladder pressure, 
suggesting increased IAP erroneously.  If Gudmundsson’s (2002) data from pigs can be 
applied to humans, it would be difficult to predict which patient would or would not be 
affected by different instill volumes.   
Finally, the studies of De Waele et al. (2006), Chiumello et al. (2007), and 
Malbrain and Deeren (2006) use a repeated measures design where instill volumes were 
successively increased using a fixed amount until a final target volume was reached.  
This design is flawed because the bladder was not emptied between measurements and is 
biased against higher instill volumes.  In addition, the time that elapsed between 
consecutive measurements in these studies was usually one minute.  A recent study by 
Kimball et al. (2007) suggests that a time interval less than eight minutes is associated 
with high variability.  Therefore, the experimental design used by Chiumello et al. 
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(2007), De Waele et al. (2006), and Malbrain and Deeren  (2006) does not assess the 
effect of instill volume on UBP but rather measures urinary bladder compliance.  
Positioning. 
In healthy human volunteers, changing from the supine to other positions results 
in increases in IAP.  Moving from a supine to a sitting and/or standing position increases 
IAP (Twardowski et al., 1986).  Moving from the supine to the left lateral position 
increases IAP by 68% and moving from the supine to the right lateral position decreases 
IAP by 30% (Hebbard, Reid, Sun, Horowitz, & Dent, 1995).  The changes in IAP 
secondary to position have been attributed to the gravitational effects of the organs and to 
contraction of abdominal muscles (Grillner et al., 1978; Hemborg, Moritz, & Lowing, 
1985).  De Troyer (1983) measured abdominal muscle activity as subjects moved serially 
from the 45º head down position, to supine, to 45º head up, to standing positions.  He 
demonstrated that in the supine position the abdominal muscles were silent, but that 
abdominal muscle contraction occurs when subjects are gradually moved from the head 
down to the standing position.  
Compared with healthy individuals, much less is known about the effect of 
position changes upon IAP measurements in hospitalized patients.  Currently, UBP in 
hospitalized patients is nearly exclusively performed in the supine and flat (0° HOBE) 
position.  However, there are no physiological or clinical reasons to suggest that this is 
the best position to measure bladder pressure.  Indeed, there is no evidence that suggests 
that this position is superior to other positions regarding accuracy, variability, reliability, 
or reproducibility of the value.   
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The main advantages of using the 0° HOBE position for UBP measurement are: 
1) standardization, 2) simple identification of an anatomic leveling point, and 3) nurses 
familiarity with position for performing hemodynamic measurements.  However, it 
should be pointed out that the 0° HOBE position is not commonly used in the CCU.  
Presently, due to increased risk for aspiration pneumonia, patients in CCUs are rarely 
maintained in a 0° HOBE position for extended periods.  Exceptions are situations where 
the preferred position with the HOB elevated is contraindicated for medical reasons, i.e. 
hemodynamic or neurological or spinal instability, difficulty with oxygenation, or an 
open chest or abdomen.   
Therefore, changing a patient’s position from some degree of HOBE to 0° HOBE 
for the sole purpose of UBP measurement disturbs patient’s rest and sleep; increases the 
risk of equipment dislodgment, and increases nurse’s work load.  In addition, it is a 
common practice in the CCU to discontinue enteral nutrition (EN) when the patient is 
placed in the 0° HOBE position in an attempt to reduce the risk of aspiration pneumonia.  
Unfortunately this practice reduces the time patients receive EN contributing to weight 
loss and malnutrition in critically ill patients.   
The current standard of care regarding the recommended position for CCU 
patients to prevent complications related to EN is supine with a 30º HOBE (Heyland et 
al., 2003).  In addition, to prevent decubitus ulcer formation and improve patients 
comfort, CCNs are taught to rotate patient’s position from back lying to side lying every 
two hours.  Common rotation or positioning schedules are supine with a 30º HOBE, then 
rotate to the right or left lateral side lying position with a 30º HOBE, and then again to 
the supine position with a 30º HOBE, followed by left or right side lying position with a 
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30º HOBE, and so forth on a two hour schedule over a 24 hour period.  Since it would be 
convenient to measure UBP without repositioning and causing patients discomfort, it is 
of interest to know if these commonly used positions affect UBP. 
In the standing position, the urinary bladder is located in the inferior-dependent 
segment of the abdominal cavity within the pelvis and in the supine position the bladder 
is less dependent.  Regardless of the position, the urinary bladder is always in contact 
with the abdominal cavity and capable of detecting and transmitting IAP.  Increased IAP 
in critically ill patients is not due to the weight of the abdominal organs compressing the 
urinary bladder but rather due to an increase in abdominal volume (fluids or air) or to 
reduction in abdominal wall compliance. 
Few research studies have directly assessed the effect of body position on UBP 
measurement in hospitalized patients.  Iberti et al. (1989) measured UBP in 16 
postoperative subjects in three positions: supine, supine with compression, and supine 
with 45  HOBE.  All subjects had both an intra-peritoneal and a urinary drainage catheter 
that allowed the simultaneous measurement of IAP both directly and indirectly by UBP 
technique, respectively.  An average of 250 ml of sterile NSS was instilled into the 
bladder before pressure measurements were taken and the transducer was leveled at the 
symphysis pubis.   
The results showed a good correlation between the IAP measured directly via the 
intra-peritoneal catheters and those measured indirectly by urinary bladder catheters in all 
three positions.  Unfortunately, Iberti et al. (1989) did not report individual bladder 
pressure values with each position, and the difference between the supine and supine with 
a 45  HOBE cannot be determined.  In addition, bladder pressure was measured with a 
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large instill volume and the research report offered no assurance that the transducers were 
re-leveled with position changes. 
The effect of abdominal compression on IAP was briefly assessed by Iberti et al. 
(1989).  Data from an individual subject demonstrated acute UBP increases with 
abdominal compression, but the magnitude of the increase cannot be determined.  
Increases in IAP with compression are to be expected based on the assumption that the 
abdominal cavity is relatively non-compressible and follows Pascal’s law.  Coughing has 
also been observed to increase IAP (Drye, 1948) which further provides evidence 
supporting Pascal’s law.  Increases in IAP have also been found by investigators who 
have measured bladder pressures in patients in the prone position (Hering et al., 2002; 
Hering et al., 2001; Pelosi et al., 1998).  Prone positioning is used in critically ill patients 
with acute lung injury when oxygenation (PaO2) remains unacceptably low despite 
ventilation with high positive end-expiratory pressure (PEEP) and high-inspired fraction 
of oxygen (FiO2).  Although prone positioning improves oxygenation, these studies have 
shown that prone positioning restricts abdominal movement leading to increased IAP 
(Hering et al., 2002; Hering et al., 2001).   
Obeid et al. (1995) measured changes in IAP in the supine, Trendelenburg and 
reverse-Trendelenburg positions in patients undergoing laparoscopic cholecystectomy.  
When IAP was increased from 10 to 16 mmHg by insufflating C02, UBP measured in the 
supine position accurately reflected the 6 mmHg increase (5.7  9.8mmHg) in IAP.  
However, in the Trendelenburg and reverse-Trendelenburg (anti-Trendelenburg) 
positions UBP reflected smaller changes in IAP (2.1  7.5 and 3.4  6.2 mmHg), 
respectively.   
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Malbrain (2003) measured UBP in 10 critically ill subjects in four positions: 
supine, Trendelenburg, anti-Trendelenburg, and upright.  This study was only reported as 
an abstract and minimal details about the experimental design are available.  All 10 
subjects were receiving mechanical ventilation.  The results of the study showed that the 
upright and anti-Trendelenburg positions tended to give higher UBP values and the 
Trendelenburg position gave lower UBP values as compared to the supine position as 
displayed in Table 3.  The strength of this data is that it was obtained with subjects 
typically seen in a CCU.  However, this report suffers serious flaws making the 
usefulness of this information questionable.  One problem is that the sample size was 
small.  Although Malbrain et al.  (2003) reported 79 paired observations, he only studied 
10 subjects, therefore each subject was measured an average of 7.9  4 times.  
Additionally, no information is provided explaining the rationale for subject positions, 
and it is unclear if the positioning was dictated by a research protocol or a clinical 
situation. 
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Table 3 
Effect of Subject Position on Urinary Bladder Pressure 
From Malbrain et al. (2003) 
 
 
 
 
 
 
 
 
Without specific information, it is impossible to know if the differences in 
measured UBP as presented were related to position or to other clinical variables.  
Second, the choice of positions studied by Malbrain et al. (2003) warrants an explanation.  
Except for the upright position, which is used occasionally in patients with pulmonary 
edema, the others positions are rarely used in the CCU. The Trendelenburg position (head 
down at 45  and legs and feet over the edge of the table) is more commonly used during 
abdominal operations to push the abdominal organs toward the chest (Martin, 1995; 
Ostrow, 1997).  Because of the gravitational forces produced by organ shift and the 
changes in abdominal muscle tone produced by the volume changes, decreases in IAP 
and by extension UBP, will be expected when changing from a supine to a Trendelenburg 
position.  Finally, Malbrain et al. (2003) does not state his reference point for zeroing and 
Position IAP (mmHg) 
Supine 8.8  3.9 
Trendelenburg 4.3  3.8 
Anti-Trendelenburg 13.3  4.8 
Upright 17.1  6.1 
Total 10.9  6.8 
P (ANOVA) <0.0001 
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leveling the transducers nor does he mention if the transducer was re-leveled with 
changes in position. 
Vasquez et al. (2007) measured UBP in 45 subjects admitted to an CCU due to 
trauma.  In each subject, UBP was measured in five different supine positions that varied 
in the degree of HOBE.  The positions investigated were supine-0º HOBE, supine-15º 
HOBE, supine-30º HOBE, supine-45º HOBE and supine-30º HOBE plus 15º of reverse 
Trendelenburg tilt.  Each subject served as their own control and was assigned to three 
counterbalanced sequences of the five positions (of a possible 120 such sequences).  Each 
subject was measured in each of the five positions three times to calculate a mean UBP 
for the position.  After a minimum interval of one minute following repositioning, UBP 
measurements were obtained using a 50 ml bladder instill volume.  The position of the 
pressure transducer was not reported and it was not changed with position changes.  All 
measurements were taken within four hours to reduce the potential confounding factors 
introduced by changes in the subject’s clinical status with time.  A statistically 
significance effect of HOBE upon UBP was found.  Post hoc analysis using the least 
significant difference test showed that all possible paired comparisons were significant 
from each other.  
McBeth et al. (2007) measured UBP in the supine position with five different 
HOBE positions in 37 subjects admitted to a CCU who were at risk of developing IAH.  
All subjects were intubated and ventilated.  Continuous UBP monitoring was performed 
using the Balogh technique (Balogh, Jones, D'Amours, Parr, & Sugrue, 2004).  
Continuous UBP monitoring differs from the intermittent UBP measurement technique of 
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Kron et al. (1984) that has been used in previous research studies and the study by 
Vasquez et al. (2007) discussed above.   
Continuous UBP monitoring requires placement of a 3-way urinary bladder 
catheter.  The third port which is traditionally used for continuous bladder irrigation is 
connected to an in-line pressure transducer and the monitoring system.  The bladder was 
irrigated continuously with NSS at 4 ml/hr.  The pressure transducer was positioned at 
the mid-axillary line at the iliac crest when the subjects were in the supine-0º position.  
Using this technique, UBP was measured in the supine-0º HOBE, supine-10º HOBE, 
supine-20º HOBE, supine-30º HOBE and supine-45º HOBE.  The order of the position 
was not specified but the pressure transducer was not repositioned after each position 
change.  The investigators also took intermittent measurements of UBP, using a 50 ml 
instill volume to validate the continuous and intermittent technique of UBP 
measurements but the data of the intermittent UBPM was not reported.  The mean of the 
supine-0º HOBE estimated from a graph was 13.5 mmHg.  Elevating the HOB to 10º, 
20º, 30º, and 45º mmHg increased the UBP by 1.2 mmHg, 2.9 mmHg, 5.0 mmHg and 7.4 
mmHg, respectively. 
In summary, research studies have investigated the effects of select body positions 
on UBP measurements.  Current research supports the fact that prone positioning 
increases UBP by compression of the abdominal wall (Hering et al., 2002).  A 
preliminary study suggests that UBP decreases during Trendelenburg, and increases 
during anti-Trendelenburg and upright positions, but these positions are not relevant to 
CCU patients and flaws in the experimental design cast doubts regarding the validity of 
the findings.  Except for the studies in the prone position, all studies suffered from small 
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sample size and did not address or identify the position of the transducer in relation to 
changes in patient positions nor were it stated if the transducer was re-leveled with 
position change.  Prior to the initiation of this study no published studies assessed the 
effects of commonly used patient positions in critical care: supine with 30  HOBE and 
right or left lateral position with 30  HOBE.  Recent studies have shown higher UBPs 
when subjects were measured in positions other than the supine-0º HOBE (McBeth et al., 
2007; Vasquez et al., 2007).  Up to now no study has assessed the effect of the right 
lateral and left lateral positions on UBP measurements. 
 
Conclusion 
The abdominal compartment is a closed system and its contents are considered to 
be mostly liquid and non-compressible.  The pressure within the abdominal cavity 
depends on the gravitational weight of the organs, shearing forces and deformity, and on 
the actions of the muscles of the diaphragm, abdominal wall, and pelvic floor.  Normally, 
IAP increases with natural movements and when individuals move from supine to the 
upright positions.  Intra-abdominal pressure is physiologically important due to its role in 
the regulation of normal respiration and in the maintenance of the lumbar spine stability. 
Intra-abdominal pressure can be estimated accurately by UBP.  Several protocols 
exist for the measurement of UBP but none is evidence-based.  There are questions 
regarding the effect of instill volume and subject’s position that are required for UBP 
measurement.  In addition, there is an urgent need to assess the inter- and intra-observer 
reliability of the UBP technique before it can be endorsed as a reliable monitoring 
technique and becomes widely used in critical care.  
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For these reasons, a nursing protocol for measuring UBP, as a reliable method for 
indirect IAP measurement, must be established.  Furthermore, the protocol must be based 
on scientific evidence.  Because there is a paucity of nursing literature regarding the 
reliability of UBP measurement, research efforts need to be directed towards establishing 
inter-observer and intra-observer reliability.  Furthermore, prior to the development of a 
nursing protocol, research must be undertaken to establish the influence of position on 
UBP, as well as the instillation volumes influence on UBP.  It is imperative that the 
nursing protocol and procedure be based on nursing research and scientific evidence prior 
to its widespread use in the clinical setting.  Only after an evidenced based nursing 
procedure is established can UBP be tested as an objective measure of EN tolerance.   
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Chapter 3  
 
 
Methodology 
 
Design 
This was a randomized prospective observational study.  The study design is 
depicted in Figure 5.  Subjects were recruited from the adult critical care patient 
population of a large metropolitan hospital as identified by a health care professional 
(HCP), primarily nurses or physicians, who had an established direct professional 
relationship with the patient.  The HCP involved with the patient and providing direct 
care introduced the study to the patient, next of kin, or surrogate decision maker and 
notified the principal investigator (PI).  The PI explained the study in detail and answered 
any questions asked by the subject or surrogate decision maker before any review if the 
medical record was undertaken.  After the purpose and methods of the study were 
explained to the patient, next of kin, or surrogate decision maker, consent to participate 
was requested.  Physician co-investigators obtained the informed consent (Appendix D).  
After informed consent was obtained consenting subject’s medical records were screened 
according to the Screening, Enrollment, and Randomization Log (SERL) (Appendix A) 
for eligibility.  If study criteria were met the subjects were enrolled and a study 
identification number and was assigned to a randomization group.  The randomization 
scheme was prepared by the statistician and delivered to the PI in sealed envelopes.  The 
envelopes were only opened after the subject signed the informed consent.  The study 
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identification number was used throughout the study and was the only identifier for the 
duration of the study. Demographic and clinical data were obtained from the medical 
record and entered on to a Data Collection Form (Appendix B) which was used to enter 
the study data into a computerized database. 
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Recruitment
 Preliminary consent   Legend:
    V = Instill volume
    P = Body  position
   0  S =    supine
 30  S =  30°  supine
 30  RL = 3 ight lateral
 30  LL = 
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Explain study
Inter-observer reliability
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Made by Nurse B
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110 sets 220  measurements 
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Intra-observer reliability 
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V:  0 ml 
25 ml
P: 30° S
V:  0 ml
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P:  30°S
First Set of Measurements
V:  0 ml
200 ml
P: 0° S
V: 0 ml     
25 ml
P: 30°LL
V: 0 ml  
25 ml
P: 30°RL
V:0 ml   
25 ml
P: 0° S
V:  0 ml 
50 ml
P: 30°LL
V:  0 ml 
50 ml
P: 30°RL
V:  0 ml  
50 ml
P: 30° S
V:  0 ml 
50 ml
P: 0° S
V: 0 ml 
200 ml
P: 30°RL
V: 0 ml 
200 ml
P: 30° S
Obtain informed consent
UBP measurement
Obtain  demographic data
V:  0 ml 
25 ml
P: 30° S
V: 0 ml 
200 ml
P: 30°LL
Second Set  of Measurements
 
Figure 5. Study design. 
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All subjects had two sets of urinary bladder pressure (UBP) measurements taken.  
Each set had two UBP measurements taken for a total of four measurements per subject.  
The first set of UBP measurements was taken with subjects supine-30º HOBE with 0 ml 
instill volume followed quickly by another UBP measurement with a 25 ml instill 
volume.  Subjects were then randomly assigned to one of twelve groups (Table 4).  The 
second set of UBP measurements were taken in the randomized position using a 0 ml 
instill volume quickly followed by another UBP measurement with the instill volume as 
determined by randomization.  The instill volume and position combinations were 
selected from one of three instill volumes and one of four positions.  All UBP 
measurements (480) were taken by the PI.   
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Table 4  
Study Groups for Bladder Instill Volume and Subject Position 
P
o
si
ti
o
n
 
Head of Bed 
Elevation 
(HOBE) 
0  30  30  30  
Trunk 
Supine 
(S) 
Supine   
(S) 
Right Lateral 
(RL) 
Left Lateral 
(LL) 
Leg Flat Flat Right Lateral Left Lateral 
B
la
d
d
er
 I
n
st
il
l 
V
o
lu
m
e 
200 ml 
 
S-0  200 
Group 9 
 
 
S-30  200 
Group 10 
 
 
RL-30  200 
Group 11 
 
 
LL-30  200 
Group 12 
 
50 ml 
 
S-0  50 
Group 5 
 
S-30  50 
Group 6 
RL-30  50 
Group 7 
LL-30  50 
Group 8 
25 ml 
 
S-0  25 
Group 1 
 
S-30  25 
Group 2 
RL-30  25 
Group 3 
LL-30  25 
Group 4 
  
The 10 subjects randomized to the supine-30° HOBE with a 25 ml instill volume 
had a third set of UBP measurements taken within 30 minutes of the first measurement.  
The third and final set of UBP measurements for this group was taken by the nurse co-
investigator.  Comparison between the second and the third set of UBP measurements 
(the second set done by the PI and the third set done by the nurse co-investigator) allowed 
assessment of inter-observer reliability of UBP measurements. 
Each set of UBP measurements were taken within two to five minutes and 
measurements were obtained within 30 minutes or less.  Each subject had the UBP 
measurements obtained on the same day and UBP measurements were not be repeated 
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again in the same subject regardless of how long they stay in the critical care unit (CCU).  
Once all measurements were obtained, the PI or nurse co-investigator positioned the 
subject in the most appropriate or comfortable position based on their medical condition 
and wishes. 
Urinary bladder pressure was measured in all subjects following the protocol 
described in Table 5.   
Table 5.  
Protocol for Bedside Urinary Bladder Pressure Measurement 
Step Nurse Action 
1. PI Assure bedside monitor with electrocardiographic, respiratory, 
and pressure monitoring capabilities is available and functional 
2. PI Gather materials and equipment 
   Sterile Gloves   
   AbViser™ kit 
   500 ml NSS 
   Transducer 
   Laser level 
   Positioning wedged pillow 
   Hemostat 
   Clean gloves 
   Isopropyl alcohol wipes 
3. PI Note subjects: Heart rate, respiratory rate and rhythm, blood 
pressure and mean arterial pressure, before positioning 
4. PI Position the subject supine with a 30° HOBE 
5. PI Open AbViser™ kit  
6. PI Spike the NSS bag and prime tubing and transducer 
7. PI Connect the transducer to the amplifier-monitor and select the 
lowest pressure scale 
8. PI After cleansing the connection site and using sterile technique, 
connect the AbViser™ valve to the subject’s urinary catheter  
9. PI Place the catheter between the subject’s legs and place the 
collection bag toward the foot of the bed and suspend the 
collection bag either to the right or to the left side preventing any 
increase in elevation of the collecting system or compression of 
the catheter or collecting system. 
10. PI Level the transducer with the symphysis pubis 
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Table 5 (Continued) 
Step Nurse Action 
11. PI Zero the transducer by opening the stopcock to air and selecting  
  the zero option on the monitor 
12. PI Assess the responsiveness of the monitoring system  
   Perform a manual square wave test 
   Close the stopcock to the subject  
   Inject saline against the transducer 
   Observe a square wave on the monitor.   
13. PI Assess the conductivity of the fluid filled column  
   Squeeze the urinary drainage catheter proximal to the 
connection of the AbViser™ 
   Observe a pressure inflection on the bedside monitor 
14. PI Determine if steady state is present 
   Compare vital signs (VS) prior to positioning with VS 
after positioning  
   Confirm difference is less than 10 percent 
15. PI With no urine in the collection tubing clamp the urinary collection 
tubing with a hemostat distal to but as close as possible to the 
AbViser™ for the first UBP measurement 
16. PI Empty the urimeter and record on the output record 
17. PI Record the first UBP measurement of the first set from the 
monitor at the end of expiration: zero instill volume with 30º 
HOBE.   
18. PI Unclamp the urinary drainage catheter distal to the AbViser™ 
valve by releasing the hemostat and allow the bladder to drain for 
30 to 60 seconds noting the amount of urine that drains into the 
urimeter and record on the output record 
19. PI Determine if steady state is present 
   Compare vital signs (VS) prior to positioning with VS 
after positioning  
   Confirm difference is less than 10 percent 
20. PI Inject 25 ml of NSS into the bladder with the syringe 
21. PI Record the second UBP measurement of the first set from the 
monitor at the end of expiration:  25 ml instill volume with 30° 
HOBE 
22. PI The AbViser™ valve will automatically open to permit drainage 
noting the amount of urine and NSS that drains into the urimeter 
is ≥ 25 ml 
23. PI Document the instill volume on the intake record and the drainage 
on the output record  
24. PI Note subjects: Heart rate, respiratory rate and rhythm, blood 
pressure and mean arterial pressure, before positioning 
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Table 5 (Continued) 
Step Nurse Action 
25. PI Position the subject according to randomization group and assure 
the catheter is between the subject’s legs and place the collection 
bag toward the foot of the bed and suspend the collection bag 
either to the right or to the left side preventing any increase in 
elevation of the collecting system or compression of the catheter 
or collecting system. 
26. PI Re-level the transducer with the symphysis pubis 
27. PI Re-zero the transducer 
28. PI Note subjects: Heart rate, respiratory rate and rhythm, blood 
pressure and mean arterial pressure after positioning 
29. PI Determine if steady state is present 
   Compare vital signs (VS) prior to positioning with VS 
after positioning  
   Observed difference is less than 10 percent 
30. PI With no urine in the collection tubing clamp the urinary collection 
tubing with a hemostat distal to but as close as possible to the 
AbViser™ for the first UBP measurement 
31. PI Record the first UBP measurement of the second set from the 
monitor at the end of expiration: zero instill volume in the 
randomized position 
32. PI Unclamp the urinary drainage catheter distal to the AbViser™ 
valve by releasing the hemostat and allow the bladder to drain for 
30 to 60 seconds noting the amount of urine that drains into the 
urimeter 
33. PI Document the instill volume on the intake record and the drainage 
on the output record 
34. PI Determine if steady state is present 
   Compare vital signs (VS) prior to positioning with VS 
after positioning  
   Confirm difference is less than 10 percent 
35. PI Inject the randomized instill volume (25, 50, 200 ml) of NSS into 
the bladder with the syringe 
36. PI Record the first UBP measurement of the second set from the 
monitor at the end of expiration:  randomized instill volume with 
randomized position 
37. PI The AbViser™ valve will automatically open to permit drainage 
noting the amount of urine and NSS that drains into the urimeter 
is ≥ the randomized instill volume 
38. PI Document the instill volume on the intake record and the drainage 
on the output record 
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Table 5 (Continued) 
Step Nurse Action 
39. Nurse co-
investigator 
For subjects randomized to the 30° HOBE in the supine position, 
the nurse co-investigator will make a third set of UBP 
measurements 
40. Nurse co-
investigator 
After verifying the subject’s position the nurse co-investigator 
will place the catheter between the subject’s legs and place the 
collection bag toward the foot of the bed and suspend the 
collection bag either to the right or to the left side preventing any 
increase in elevation of the collecting system or compression of 
the catheter or collecting system and will empty the urimeter 
41. Nurse co-
investigator 
Re-level the transducer with the symphysis pubis 
42. Nurse co-
investigator 
Re-zero the transducer 
43. Nurse co-
investigator 
Assess the responsiveness of the monitoring system  
   Perform a manual square wave test 
   Close the stopcock to the subject  
   Inject saline against the transducer 
   Observe a square wave on the monitor.   
44. Nurse co-
investigator 
Assess the conductivity of the fluid filled column  
   Squeeze the urinary drainage catheter proximal to the 
connection of the AbViser™ 
   Observe a pressure inflection on the bedside monitor 
45. Nurse co-
investigator 
Determine if steady state is present 
   Compare vital signs (VS) prior to positioning with VS 
after positioning  
   Observed difference is less than 10 percent 
46. Nurse co-
investigator 
Clamp the urinary drainage catheter distal to the AbViser™ 
47. Nurse co-
investigator 
Record the first UBP measurement of the third set of UBP 
measurements from the monitor at end expiration:  zero instill 
volume with 30° HOBE 
48. Nurse co-
investigator 
Unclamp the urinary drainage catheter distal to the AbViser™ 
valve and allow the bladder to drain for 30 to 60 seconds noting 
the amount of urine that drains into the urimeter 
49. Nurse co-
investigator 
Inject 25 ml of NSS into the bladder with the syringe 
50. 
 
Nurse co-
investigator 
Record the second UBP measurement of the third set of UBP 
measurements from the monitor at end expiration:  25 ml instill 
volume with 30° HOBE 
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Table 5 (Continued) 
Step Nurse Action 
51. Nurse co-
investigator 
 Document the 25 ml instill volume on the intake record   
52. Nurse co-
investigator 
The AbViser™ valve will automatically open to permit drainage 
noting the amount of urine and NSS in the urimeter  is ≥ 25 ml 
and record in the output record 
53. PI or nurse 
co-
investigator 
Disconnect the NS administration set with pressure tubing and the 
transducer and from the AbViser™ valve 
54. 
 
PI or nurse 
co-
investigator 
Cap the end of the AbViser™ valve administration tubing and 
tape to the collection tubing which is to remain in place until the 
urinary catheter is removed 
55. PI or nurse 
co-
investigator 
Reposition the subject into a comfortable position as determined 
by the subject’s or nurse’s preference 
 
Setting 
Six adult critical care units, 80 beds, of a large, metropolitan tertiary-care and 
teaching hospital, total 778 beds, located in southwestern Pennsylvania. 
 
Sample 
Subjects were selected regardless of gender, race, ethnicity, diagnosis, or hospital 
treatment.  Subjects were included in the study if: a) age > 18 years, b) signed informed 
consent was obtained from the subject, his/hers surrogate or power of attorney for health 
care, c) there was a clinical need for a urinary drainage catheter as determined by the 
primary care or attending physician or the critical care team, d) admitted to an CCU, and 
e) not pregnant.  
Subjects were excluded if: a) informed consent was not obtained, b) not in a 
critical care unit, c) did not have a urinary drainage catheter in place, d) unable to assume 
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body positions as required for study, e) neurogenic bladder, f) bladder tumor, g) bladder 
perforation, and h) hematuria. 
There were no clinical, physiological, or ethical reasons to exclude pregnant 
women or patients < 18 years of age but they were excluded since they are not admitted 
to the adult CCUs of the clinical site. Others subjects with bladder abnormalities were 
excluded because the bladder pressure measurement would either not be physically 
possible or the pressure measurements obtained would be unreliable. 
 
Procedure for Urinary Bladder Pressure Measurement 
  The procedure for UBP measurement is depicted in Table 5.  Bladder pressure 
was measured using the method of Kron et al. (1984) as modified by Cheatham et al. 
(1998) and Malbrain et al. (2004) except the AbViser™ was used instead of stopcocks.  
The AbViser™ is a medical device approved by the Food and Drug Administration 
(FDA) for intermittent UBP measurement.  The AbViser™ is a two way valve that was 
sterilely attached to the subject’s existent urinary bladder drainage catheter and in the 
open position the free flow of urine is permitted and when saline is injected across the 
value occlusion occurs and the saline that was injected into the bladder remains there 
until a UBP measurement can be taken.  The AbViser™ kit contains the AbViser™ 
valve; a 20 ml syringe with sterile sleeve and a double check valve; tubing and spike for 
the sterile saline bag connection; infusion and pressure tubing; transducer and extra pole 
mounting tubing; zeroing stopcock and dead end caps; tape to secure the urinary catheter 
to the AbViser™ valve; S hook to hang the syringe at the bedside; sterile drape; and 
instructions for use.  The AbViser™ kit was used for its approved and intended use. 
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To answer research questions number one and two:  the effect of subject position 
and instill volumes on UBP, all subjects had two sets of UBP measurements taken within 
30 minutes.  A set of measurements consisted of two UBP measurements.  One UBP 
measurement in the supine 30º HOBE position with a 0 ml instill volume and another 
with a 25 ml instill volume.  The second set of UBP measurements were obtained in one 
of the 12 combinations of body position and instill volume described in Table 4.  All 
UBP measurements were taken by the PI.  The preparation of the equipment and the 
positioning of the patient took approximately 15-30 minutes, and the actual UBP 
measurements were taken within approximately two to five minutes of each other and 
both sets were taken within 30 minutes.  
To answer research questions three and four the 10 subjects randomized to the 
supine-30º HOBE position with a 25 ml instill volume group had a third set of UBP 
measurements taken within 30 minutes of the first set of UBP measurements.  The third 
and final set of UBP measurements were obtained by the nurse co-investigator.  This 
group of subjects was used to assess inter-observer reliability.   
Urinary bladder pressure measurements were obtained using the protocol for 
bedside UBP measurement as outlined in Table 5.  The only difference between the first 
two UBP measurement sets were that the AbViser™ valve was not re-placed and the 
assembly of the AbViser™ (Table 5 steps five to eight) was not be repeated.  This was 
done to maintain a closed system and to reduce the risk of infections in these subjects.  
Prior to departure from the bedside and after the third set of UBP measurements taken by 
the nurse coo-investigator, the pressure transducer was misaligned from the symphysis 
pubis.  The nurse co-investigator prior to obtaining the final UBP measurement, 1) 
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performed a manual square wave test to assure that the dynamic properties of the system 
were maintained, 2) confirmed the conduction of pressure from the catheter to the 
monitor, and 3) confirmed and/or re-positioned the subject into the appropriate position.  
The transducer was than leveled and zeroed again.   
The urinary drainage catheter was clamped with a hemostat distal to the 
AbViser™.  A measurement with zero volume was taken, and then using the pre-attached 
syringe instillation of 25 ml of NSS into the bladder was completed.  The UBP was 
measured from the monitor at end expiration.  Once the UBP was obtained, the 
AbViser™ valve automatically opened to permit drainage of the bladder and remained in 
place until the urinary drainage catheter was removed.  The subject was returned to the 
most appropriate position based on his/her clinical condition and plan of care dictated by 
the bedside nurse.  Finally, documentation of the bladder instill volume used in the UBP 
measurement was recorded on the intake and output record. 
The medical record was reviewed to extract selective demographic and clinical 
information to determine what other subject or clinical factors may have influenced UBP.  
Subject data included age, gender, and height and weight for BMI determination.  
Relevant clinical data included, intake and output records to determine net fluid balance, 
and ventilatory and respiratory status for presence of positive airway pressure, and use of 
paralytic agents as these variables have been reported by others to influence IAP.  This 
data was used to answer research question number five. 
Justification of Body Positions 
The selection of subject’s positions was based on research necessity, clinical 
relevance, and interest.  The supine-0° HOBE position was chosen because it is the 
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position most commonly recommended by experts for measurement of UBP (Gallagher, 
2005; Lameier & NeCamp, 1990; Malbrain, 2004) .  However, patients in CCUs are 
rarely positioned supine-0° HOBE unless there is a clinical indication, such as artificially 
closed abdomen or chest, ventilatory difficulties, or clinical instability.  The supine-0° 
HOBE position is believed to predispose patients to aspiration pneumonias. 
The other positions selected represent positions most commonly assumed by 
patients in CCU.  Nursing textbooks recommend that patients be repositioned every two 
hours to prevent decubitus ulcer formation caused by pressure points (Baas, 2003; 
Rodgers, 2001).  Most commonly, nurses rotate patients following a turning schedule 
from supine to lateral positions, back to supine and then to the opposite lateral position 
(Baas, 2003).  This rotation is repeated several times a day.  Because most patients in 
CCUs are receiving enteral nutrition, it is recommended that the HOB be maintained at a 
minimum of 30º at all times to reduce the risk of tube feeding formula refluxing and 
causing aspiration pneumonia (Heyland et al., 2003).  Therefore, the supine position with 
30º HOBE was chosen, because it is one of the most common positions assumed by 
patients in today’s CCU, and it is of interest to know if this modest degree of HOBE 
affects UBP measurement.  The right and left lateral positions were chosen because they 
represent two of the most common alternative positions assumed by patients.  Both right 
and left lateral positions were chosen because at least theoretically they could have a 
different effect on UBP.  For instance, it can be argued that the pressure on the bladder 
exerted by the liver and stomach will be higher in the left lateral position.  However, this 
will be against Pascal’s law and the basic assumptions upon which the UBP technique is 
based.  When patients are positioned in the right or left lateral position nurses commonly 
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support their back with pillows (Baas, 2003), to simulate this position, a 45º wedged 
positioning pillow to support the patient’s back will be used to standardize the side lying 
position.  
Other positions that have been previously studied regarding the effect on UBP 
were not chosen because they are not relevant in CCU setting.  The Trendelenburg and 
anti-Trendelenburg are positions of interest during surgery (Obeid et al., 1995).  
However, these positions are used in CCU only when patients are unstable and therefore 
not of major clinical relevance for study (Ostrow, 1997).  Head of bed elevations of 45º-
90º positions are used in stable CCU patients who are at low risk for IAH, and UBP is 
rarely needed in these populations.  The prone position only can be done in patients with 
normal IAP, because prone positioning is known to increase IAP.   
 
Description of Body Positions 
The body positions were standardized as follows: 
 Supine-0° HOBE position    (Groups 1-5-9) 
Subjects were positioned on their back with head, back, legs and arms resting in 
one plane.  The head of the bed was at zero degrees elevation.  Legs were positioned 
together and arms rested comfortably on the bed at the subject’s sides.  The back of the 
head was supported with one pillow. 
Supine-30º HOBE position    (Groups 2-6-10) 
Subjects were positioned on their backs with arms at their sides and their head and 
back were elevated at 30º as determined by the bed angle protractor.  The legs were 
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positioned flat in another plane at zero degrees.  The head of the subject was supported 
with one pillow. 
Right lateral-30º HOBE position   (Groups 3-7-11) 
Subjects were positioned on their right side.  The head of the bed was elevated at 
30º as determined by the bed protractor.  The left leg was positioned on top of the right 
leg and a pillow was placed between the legs.  The back of the subject was resting against 
a 45º wedged positioning pillow.  A pillow was placed under the right side of the face.  
Left Lateral-30° HOBE position   (Groups 4-8-12) 
Subjects were positioned on their left side.  The head of the bed was elevated at 
30º as determined by the bed protractor.  The right leg was positioned on top of the left 
leg and a pillow was placed between the legs.  The back of the subject was resting against 
a 45º wedged positioning pillow.  A pillow was placed under the left side of the face. 
 
Justification of Bladder Instill Volume 
Selected bladder instill volumes were chosen from a critical review of previous 
studies of UBP measurement.  Based on the current research questions relevant to the 
UBP measurement technique and the recommendations of the World Society of 
Abdominal Compartment Syndrome (WSACS) (Malbrain et al., 2007) several volumes 
were chosen.  In the original description of the technique to measure UBP Kron et al. 
(1984) recommended instillation of 50 to 100 ml of saline to distend the bladder before 
measurement.  Therefore, 50 ml was chosen to represent this range.  Two hundred 
milliliters as an instill volume was chosen because this volume has the potential to be 
large enough to distend the bladder and increase bladder pressure independently of IAP.  
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The WSACS currently recommends a maximum instillation volume of 25 ml (Malbrain 
et al., 2007).  Finally, no instill volume (0 ml) was chosen because animal and human 
studies have shown that a zero instill volume produces the lower measurement bias and 
the lowest risk of raising UBP independently of IAP (Fusco et al., 2001).  In addition, a 0 
ml instill volume would be the most convenient for nurses.  Also it is of clinical interest 
to know if 0 ml would produce reliable results in the clinical setting.  
 
Procedure for Data Collection 
Only select and necessary data was extracted from the subject’s medical record 
which included date of birth; usual and critical care unit (CCU) admission weight; height; 
gender; race; reason for hospital admission and reason for critical care unit admission; 
other medical and surgical diagnoses; intake and output records to determine the net fluid 
balance; amount of EN administered; respiratory and ventilatory status with the level of 
positive airway pressure used; blood pressure, heart rate, and respiratory rate to determine 
steady state; and use and dose of paralyzing agents.  All data was recorded on the Data 
Collection Form (Appendix B).  Data was entered into a computerized data base; all raw 
data was checked for errors before and after entering the data. 
 
Procedure for Protection of Human Subjects 
The study was reviewed and approved by The Human Protection Committee of 
Allegheny General Hospital – Allegheny Singer Research Institute and Duquesne 
University.  Health care professionals who had knowledge of the study, primarily critical 
care physicians and nurses, and had a direct clinical relationship with potential subjects, 
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obtained initial verbal consent that permitted the PI to introduce the study to potential 
subjects.  Upon an affirmative verbal consent the health care professional notified the PI, 
who explained the study in detail and answered any questions asked by the subject or 
surrogate decision maker before any review of the medical record is undertaken.  
Subjects or surrogates were only approached with dignity by the PI and only if deemed to 
be an acceptable and appropriate time by the bedside nurse and physician.  The utmost 
care and respect was given to subjects and surrogates who were experiencing a life 
threatening and traumatic event.  Following the initial explanatory process by the PI, one 
of the physician co-investigators obtained a signed written informed consent from the 
subject and /or appropriate surrogate decision maker.  Consenting subjects’ medical 
records were then screened according to the Screening, Enrollment, and Randomization 
Log (Appendix A) for study eligibility.  If study criteria are met subjects were enrolled 
and a study identification number was assigned and randomization to a study group was 
done.    
A copy of the informed consent was reviewed with the subjects or surrogate 
decisions makers.  They were informed that the risk of participating in the study was 
minimal.  There was a very small risk of developing urinary tract infection (UTI) because 
it is necessary to open the urinary catheter drainage system for a brief moment to attach 
the AbViser™.  To minimize this risk, the PI attached the AbViser™ using sterile 
technique under strict sterile conditions.  Subjects would have been treated with 
appropriate antibiotics had a UTI occurred.  Subjects were informed that there may be a 
temporary physical discomfort with repositioning.  Every precaution was taken to avoid 
discomfort and subjects were medicated for pain by the bedside nurse if necessary or 
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were immediately repositioned to a more comfortable position.  The positions used for 
the study are commonly used positions by nurses when performing routine care for 
critically ill individuals.  However, if the discomfort was too great the subject had the 
freedom to choose not to continue in the study.  Subjects were informed of the very-low 
risk of equipment dislodgment with changes in position.  Every precaution to prevent 
equipment dislodgement was taken.   
Subjects were fully informed that their medical records will be reviewed to extract 
only pertinent information for the study and a separate record was created for the keeping 
of this data.  A paper copy of the extracted data was recorded on the Screening, 
Enrollment and Randomization Log and Data Collection Form (Appendix A and B) and 
an electronic version as part of a database was created to record the data and facilitate 
statistical analysis.   
There was a small risk of breech of confidentiality with these records.  To 
minimize the risk of breech in confidentiality, measures were taken to collect only the 
least amount of information required for the study.  The information was stored in a safe 
and secure manner.  The PI was the sole possessor of this information.  Collected data 
was only shared with limited personnel and only if necessary and no subject identifiers 
were shared.  The paper copy of the Screening, Enrollment and Randomization Log that 
contains the study identification number, relevant study data, and subject identifiers will 
be destroyed at the PIs earliest convenience (see below).  The electronic versions will be 
destroyed as soon as possible after academic requirements have been fulfilled and 
research findings have been disseminated via presentations or publications or two years 
following completion of the study.   
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To further minimize the risk of breech of confidentiality several precautions were 
taken.  First a limited amount of information that contains subject’s unique identifiers 
was obtained.  The data set was limited to the subject’s initials, date of birth (to calculate 
age) and medical record number.  No other unique subject identifiers such as address, 
phone number, social security number, insurance information, etc. were collected.  
Second, the limited data set was only collected on the Screening, Enrollment and 
Randomization Log which was kept in a locked file at all times in the PIs office and was 
accessible only to the PI.  In the privacy of the PIs office the information was entered into 
the secure electronic database.  The paper copy of the Screening, Enrollment and 
Randomization Log was destroyed.  The electronic copy will be maintained until the data 
has been verified as correct, academic requirements have been fulfilled and publication 
and presentations disseminating the research findings are complete or two years after the 
study has been published.  The paper copy of the Data Collection Form (Appendix B) 
will be shredded once data analysis is complete.  Once a study number is assigned to the 
electronic data, only that study number will identify subjects.  Third, access to the data 
sets without subject’s identifiers was restricted to personnel only involved in the study 
(such as the PI, co-investigators, and statistician), regulatory personnel (AGH and 
Duquesne University IRB) and the dissertation committee.  Fourth, subjects were notified 
that the data collected could be subpoenaed by a court order.  Fifth, all data entered into a 
secure electronic database was protected by encryption and a password known only to the 
PI.  The secure electronic data containing subject identifiers will be deleted two years 
after the study is published and presented. 
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No matter how high the UBP measurement was, no intervention was planned as 
part of the study.  However, the results of the UBP measurements were available to the 
health care professionals caring for the subject and a printed progress note (Appendix C) 
was placed in the progress note section of the subject’s medical record.  Health care 
professionals responsible for the care of the subject decided if any intervention was 
needed.  However, a disclaimer was displayed with the values of the UBP obtained 
during the study to explain that the values were obtained under non-standardized 
conditions and that the results should be considered together with other clinical data in 
making a decision to intervene.  
The risk of participation in the study was minimal.  Participation in this study did 
not impose risks to the subjects other than those associated with his/her illness and 
routine CCU care.  The study did not include the use of investigational drugs or devices.  
All the methods and procedures used in the study were within the standards of care for 
critically ill patients.  Urinary bladder pressure measurement is painless and quick (two-
five minutes per set of UBP measurements).  There was no financial risk to patient.  
There was no discomfort for patients while moving from one position to another.  In 
addition, no equipment was dislodged during body position changes during the study.  
Position changes necessary for the study were customary positions performed daily by 
CCNs.  To minimize the risk of equipment dislodgement, subjects were repositioned 
gently and special precautions were taken to ensure that no equipment is dislodged or 
malfunctions occurred during and after the maneuver.  
The major risks to the subjects were development of UTI and breech of 
confidentiality.  To minimize the risk of UTI, only subjects who required urinary 
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drainage catheters, as part of their routine care were selected, and the AbViser™ valve 
was connected under sterile conditions.  Because the AbViser™ is a closed valve once it 
is in place there is no added risk for UTI and or septicemia associated with its use.  To 
reduce the risk of UTI even further once the AbViser™ valve was placed, it was left in 
place and was not removed until the urinary catheter was discontinued. 
Although the information obtained may be of benefit to other patients in similar 
conditions in the future, there was no immediate direct benefit to the subjects who 
participated in this study.  However, participants may have benefited indirectly because 
they were monitored more intensively. 
 
Sample Size Calculation 
Sample size was calculated using PASS (Number Cruncher Statistical Software 
(NCSS) and PASS, 2004, Kaysville, UT).  First a power analysis for a multiple linear 
regression analysis was performed for sample sizes ranging from five to 10 subjects per 
each of the 12 groups for position and volume.  For this analysis it was assumed that the 
controlled variables of instill volume and position explain 50% of the variability and six 
other independent variables account for an additional 10 % of UBP variability.  Level of 
significance (alpha) was set at 0.05 or 0.01.  The result of the analysis is shown below. 
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Table 6  
Power Calculation for the Study 
N per group N Total  = 0.05  = 0.01 
5 60 70 %  
6 72 80%  
7 84 88% 57% 
8 96 93% 79% 
9 108 96% 86% 
10 120 97% 91% 
Assuming R
2
 for controlled variables is 0.5 and R
2
 for 6 
independent variables is 0.01. 
  
A sample size of 96 (8 per group) will have a 93-79 % power for an alpha of 0.01- 
0.05, respectfully.  Based on these considerations a sample size of 120 (10 subjects per 
group) was chosen to allow for drop outs and/or incomplete data collection. 
In addition, PASS was used to calculate the sample size needed for the inter- and 
intra-observer reliability phase of the study.  A sample size of 10 subjects achieves a 97% 
power to detect a difference of 0.8 between the null hypothesis correlation of 0.9 and the 
alternative hypothesis correlation of 0.01 using a two-sided hypothesis test with a 
significance level of 0.05.  The total sample size for the study was 120 subjects for the 
multiple linear regression analysis and 20 subjects were measured an additional time for 
the inter- and intra-observer reliability study.  
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Procedure for Data Analysis 
Data were analyzed using SPSS statistical software (Graduate pack 14.0, 2005, 
SPSS, Inc. Chicago, IL) and figures were created using GraphPad Prism 4 (GraphPad 
Software Inc. 2005, San Diego, CA).  Demographic data was analyzed with frequencies, 
means, standard deviations, and ranges and is presented in graphic and tabular form in 
Chapter 4.  Mean, standard deviation ranges, and other descriptive statistics of UBP were 
also calculated.   
Statistical analysis included both parametric and non-parametric techniques as the 
data were not always normally distributed.  These procedures included the Pearson 
correlation, Kruskal-Wallis with post analysis Dunns, Wilcoxon Signed-Rank test, and 
one and two way ANOVA with Neuman-Kuels post hoc analysis.  The main statistical 
method performed was multiple linear regression analysis.  Urinary bladder pressure was 
the dependent variable and bladder instill volumes and subject positions were considered 
the controlled independent variables.  Additional independent variables that were 
examined in a stepwise analysis includes age, BMI (kg/m
2
), net fluid balance (ml/day), 
positive airway pressure (cm H20), and dose of paralyzing agents (mcg/Kg/min) as these 
are known to influence IAP.  The limits of agreement as described by Bland Altman 
method was used to analyze the inter-and intra-observer reliability data (Bland & Altman, 
1986) 
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Chapter 4  
 
 
Results 
 
Population Description 
Two hundred and eighty (280) patients identified by their nurse or physician as 
potential subjects were screened by the principal investigator (PI) to determine eligibility 
to participate in the study.  One hundred and sixty patients (57%) were excluded from the 
study.  Sixty-two (22%) of the total pool of potential subjects declined to participate after 
a detailed explanation of the study was given.  Fifty-nine subjects (21%) did not meet 
inclusion criteria, such as ¸18 years of age, anuria, hematuria, or neurogenic bladder and 
were ineligible to participate.  Eighteen patients (6%) were unable to participate for other 
reasons, such as the urinary bladder catheter had been removed or orders for transfer 
from the critical care unit (CCU) were written and adequate time to compete the study 
could not be guaranteed.   Seventeen patients (6%) were unable to give informed consent 
because of sedation and their surrogate decision maker was not available to give consent.   
Finally, three patients’ families (1%) declined participation, and one patient (0.4%) was 
not enrolled for an unknown reason. 
The remaining 120 subjects (43%) agreed to participate in the study and were 
enrolled after a detailed explanation of the study was provided by the PI and a signed 
written informed consent was obtained.  Table 7 shows the age, gender, ethnicity; body 
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mass index (BMI) and length of stay (LOS) of subjects categorized by instill volume and 
position as determined by the randomization group.  
Table 7  
Select Characteristics of the Study Population:  Randomization Group, Randomized 
Instill Volume, Randomized Position, Age, Gender, Ethnicity, Body Mass Index ( BMI), 
and Length of Stay (LOS). 
Random-
ization  
Group 
Instill 
volume 
Randomized 
Position 
Age (years) 
Mean ± SD 
Range 
Gender 
(% male) 
Ethnicity 
(% Caucasian) 
BMI 
(kg/m2) 
Mean ± SD 
Range  
LOS     
(days) 
Mean ± SD 
Range  
1 25 ml 
Supine-0° 
HOBE 
73.8 ± 5.4 
66-79 
60% 100% 
27.6 ± 3.2 
22.8-37.2 
4.0 ± 2.8 
1-9 
2 25 ml 
Supine-30° 
HOBE 
75.8 ± 6.8 
63-86 
60% 100% 
28.2 ± 6.4 
20-37 
3.3 ± 2.3 
1-8 
3 25 ml 
RL-30° 
HOBE 
64.7 ± 19 
29-82 
50% 100% 
26.3 ± 3.5 
21-32 
4.2 ± 2.1 
1-21 
4 25 ml 
LL-30° 
HOBE 
66.3 ± 13 
46-84 
50% 80% 
30.4 ± 9.2  
18-51 
4.2 ± 2.1 
1-8 
5 50 ml 
Supine-0° 
HOBE 
51.8 ± 16 
23-70 
70% 100% 
29.2 ± 8  
15.8-38 
4.0 ± 3.8 
1-12 
6 50 ml 
Supine-30° 
HOBE 
55.0 ± 19 
22-77 
60% 100% 
26.6 ± 7 
22-51 
5.8 ± 6.4 
1-29 
7 50 ml 
RL-30° 
HOBE 
64.2 ± 12 
49-83 
60% 100% 
35.6 ± 9 
22-51 
5.1 ± 6.6 
1-23 
8 50 ml 
LL-30° 
HOBE 
59.1 ± 22 
20-87 
70% 100% 
30.0 ± 10 
20-54 
7.7 ± 13 
1-44 
9 200 ml 
Supine-0° 
HOBE 
53.5 ± 24 
18-78 
60% 100% 
25.7 ± 16 
16-43 
4.3 ± 3.1 
1-12 
10 200 ml 
Supine-30° 
HOBE 
72.7 ± 12 
54-93 
30% 100% 
32.1 ± 7 
22-40 
3.2 ± 3.2 
1-12 
11 200 ml 
RL-30° 
HOBE 
58.2 ± 19 
20-91 
50% 80% 
23.8 ± 3.2 
20-30 
2.5 ± 1.6 
1-6 
12 200 ml 
LL-30° 
HOBE 
66.5 ± 12 
46-79 
60% 80% 
33.1 ± 6.0 
23-40 
7.7 ± 15 
1-50 
All 
Groups 
  
63.5 ± 17.1 
18-93 
55% 97% 
29.0 ± 7.3 
15.8-54 
4.7 ± 6.8 
1-50 
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The subjects’ ranged in age from 18 to 93 years with an average of 63.5 ± 17.1 
years.  Sixty-six (55%) of the subjects were male.  One-hundred eleven (97 %) of study 
subjects were Caucasian.  The BMI ranged from 15.8 to 54 kg/m
2
 with an average of 29.0 
± 7.3 kg/m
2
.  The LOS in the CCU prior to UBP measurement ranged from one to 50 
days with an average of 4.7 ± 6.8 days.  Eight subjects (6.7 %) were mechanically 
ventilated and five others (4.2 %) had some form of positive airway pressure for a total of 
13 subjects (10.8%) collectively with positive airway pressure.  Twenty-five subjects 
(20.8 %) were in negative fluid balance, ranging from -7661 to -73 ml, and 95 subjects 
(79.2 %) were in positive fluid balance, ranging from 1 to 35,497 ml.  None of the 
subjects were receiving paralytic agents.   
Using a one way ANOVA no statistical significant difference was observed 
among the 12 groups for length of stay (LOS), but significant differences were observed 
for age (F = 2.5, R
2
 0.2, p = 0.0069) and BMI (F = 2.5, R
2
 0.2, p = 0.0074).  For age, 
group 2 (supine-30° HOBE position with a 25 ml instill volume) differed from group 5 
(supine-0° HOBE position with a 50 ml instill volume) (p = 0.048) and for BMI group 7 
(RL-30° HOBE position with a 50 ml instill volume) differed from group 11 (RL-30° 
HOBE position with a 200 ml instill volume) (p = 0.014).  Subjects randomized to the 
supine-30° HOBE position with 25 ml instill volume (group 2) were on average 75.8 ± 
6.8 years old and differed in age from the subjects randomized to the supine-0° HOBE 
position with 50 ml instill volume (group 1) (51.8 ± 15.5 years).  Subjects randomized to 
the RL-30° HOBE position with a 50 ml instill volume (group 7) had a mean BMI of 
35.5 ± 9.3  kg/m
2
 and differed from subjects randomized to the LL-30° HOBE position 
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with 200 ml instill volume (group 11) who had a mean BMI of 23.8 ± 3.2 3  kg/m
2
.  All 
other paired comparisons were not significant. 
Eight subjects (6.7 %) were receiving enteral feedings at the time of UBP 
measurement, and 67 (55.8%) had some form of abdominal pathology, i.e., abdominal 
trauma, surgery, ascites, or pancreatitis.  Seventeen subjects (14.2 %) had a UBP ≥12 
mmHg for all four measurements, thus meeting the criteria for the diagnosis of IAH.  
Three subjects (2.5 %) had ACS, which is a sustained IAP ≥ 20 mmHg with or without 
an abdominal perfusion pressure (APP) <60 mmHg that is associated with new organ 
dysfunction or failure.  Only three subjects (2.5 %) had an APP < 60 mmHg in all four 
measurements.     
Subjects were recruited from six adult critical care units.  Forty-eight (40 %) 
subjects were recruited from the trauma unit, 25 (20.8 %) were from the two 
neurosurgical intensive care units (NICU), 18 (15%) were from the medical intensive 
care unit (MICU), 15 (12.5%) were from the coronary care unit (CCU) and 14 (11.7%) 
were from the surgical intensive care unit (SICU).   
 
Initial Urinary Bladder Pressure Measurement 
All 120 subjects had one pair of UBP measurements recorded in the initial study 
position of supine-30º HOBE.  The first UBP measurement was obtained after the subject 
was properly positioned and the monitoring equipment correctly assembled, calibrated, 
and leveled but before any instill volume (0 ml) was injected into the bladder.  The 
second measurement was obtained after 25 ml of NSS was instilled into the bladder.  The 
supine-30º HOBE position represents the most common position subjects assumed at the 
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time of enrollment and in general is the most common position assumed by patients in 
CCUs.  Therefore, UBP measured in the supine-30º HOBE position represents a neutral 
and undisturbed value since subjects were untouched and the bladder was not altered by 
changes in positions or saline instillation.  The individual UBP measurements obtained 
for each subject with 0 and 25 ml instill volumes for all patients are shown in Figure 6.  
All 240 UBP measurements were taken by the PI.  The average time elapsed between the 
first and second UBP measurements with 0 ml and 25 ml instill volumes, respectively, 
was 2.88 ± 2 minutes, ranging from one to 15 minutes.  
 
 
Urinary bladder pressures in the supine-30º HOBE position with 0 ml instill 
volume ranged from -6 to 20 mmHg.  Seven subjects (5.8 %) had UBP < 0 mmHg and 29 
subjects (24.2 %) had UBP ≥ 12 mmHg.  The negative UBP values when UBP was 
measured with 0 ml instill volume persisted despite flushing of the monitoring system 
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Figure 6.  Individual UBP measurements of all subjects (n=120) measured in the supine-
30° HOBE position with 0 ml and 25 ml instill volumes by the PI. 
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and after re-leveling and re-calibrating the monitoring equipment.  According to the study 
procedure for UBP measurement the urinary catheter and the drainage collection tubing 
remained on the bed in the same plane as the subjects lower extremities. 
 Urinary bladder pressures in the supine-30º HOBE with a 25 ml instill volume 
yielded values that ranged from 1 to 44 mmHg.  None of the subjects had UBPs < 0 
mmHg and 53 (44.2 %) had values ≥ 12 mmHg. Of the UBPs measured with 25 ml instill 
volume 112 (93.3 %) were greater than or equal to the UBP measured with a 0 ml instill 
volume.  The eight UBP values that were lower in the second measurement as compared 
to the first differed by 1 mmHg in five subjects, 2 mmHg in two subjects, and 4 mmHg in 
one subject.  As a result there was a statistically significance increase from the UBP 
measured with 0 ml to that measured with 25 ml instill volumes (7.0 ± 5.9 vs. 11.6 ± 5.9, 
respectively, p <0.0001) by the Wilcoxon Signed-Rank test (Figure 7).    
0 ml 25 ml
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Figure 7. Mean ± SD of urinary bladder pressure measured with 0 ml and 25 ml instill 
volumes for all subjects (n = 120 for each group). 
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Linear regression analysis was employed to develop an equation to predict UBP 
measured in the supine-30° HOBE with 25 ml instill volume (S30-25) based on UBP 
measured in the supine-30° HOBE with 0 ml volume (S30-0).  Two subjects who had 
unusually high UBPs when measured with the 25 ml instill volume (34 mmHg and 44 
mmHg) were omitted from the analysis (Figure 6).  Omission of this data does not 
radically alter the coefficient estimates but increased the explained variability of the 
equation from 20 to 30%.  The predictive equation that results after fitting the remaining 
118 pairs is:      
UBP(S30-25) = 0.4499*UBP(S30-0) + 8.168. 
Multiple linear regression analysis was employed to explore the relationship of 
UBP (S30-25) with pertinent other variables.  For this analysis the UBP (S30-25) was 
considered to be the dependent variable and BMI (kg/m
2
), age (y), gender (male or 
female), LOS (days), net fluid balance (ml), positive airway pressure (yes or no), 
abdominal pathology (yes or no) and enteral nutrition (yes or no), were considered to be 
the independent variables.  For the reasons described above, the two outliers were also 
omitted from the analysis.  This was necessary to satisfy model assumptions.  Fitting the 
data from the remaining 118 subjects reveals that only BMI, enteral nutrition (EN), and 
net fluid balance (NFB) are significant predictors of UBP (S30-25).  The estimated 
regression equation that best explains the relationship is:   
UBP(S30-25) = 0.3460*BMI – 6.5061*EN + 0.000197*NFB + 1.3060.   
This model roughly explains 31% of the variability of UBP (S30-25).  Similar 
analysis was carried out using UBP(S30-0) as the dependent variable and the results were 
similar except that NFB was no longer a significant predictor of UBP. 
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Linear regression was used to identify relationships between UBP and the other 
independent variables of age, gender, BMI, ethnicity, NFB, and mechanical ventilation.   
Age 
Figure 8 is the regression lines for subjects’ UBP values measured in the supine-
30° HOBE position with a 25 ml instill volume as a function of age.  There was no 
significant correlation between UBP and age (r = -0.026). Linear regression analysis 
showed that the slope of the best fit curve was not significant from zero (F = 0.08502, 
DFn = 1.00, DFd = 117, p = 0.77) 
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Figure 8. Urinary bladder pressure measurements in all subjects measured in the supine-
30° HOBE position with a 25 ml instill volume by age. 
 
Body Mass Index 
Figure 9 is a plot of the in the subjects’ individual UBP values measured in the 
supine-30° HOBE position with a 25 ml instill volume as a function of subject BMI.  
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There was a highly significant correlation between UBP and BMI (r = 0.47, p<0.0001).  
Urinary bladder pressure was found to be higher in subjects with higher BMIs.  Linear 
regression analysis showed that the slope of the curve was significant from zero 
(F=33.82, DFn=1.0, DFd=118, p, 0.001). 
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Figure 9. Urinary bladder pressure measurements in subjects positioned in the supine-30° 
HOBE position with a 25 ml instill volume by BMI. 
 
Gender 
To determine if subjects’ gender influenced UBP, the mean ± SD of UBP’s of 
males and females in the supine-30° HOBE position with a instill volume of 25 ml were 
compared using unpaired-t test.  Males had slightly higher UBP than females (12.17 ± 
6.89 vs. 11.0 ± 4.3) but did not reach statistical significance (t = 1.078, df = 118) (Figure 
10). 
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Figure 10. Urinary bladder pressure measurements in subjects in the supine-30° HOBE 
position with a 25 ml instill volume by gender. 
 
Ethnicity 
Of the subjects recruited into the study three were African American, one was 
Latino and 116 were Caucasian.  To determine if UBP vary by ethnicity, the UBPs of 
Caucasians was compared with non-Caucasian by unpaired t test (Figure 11).   
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Figure 11. Urinary bladder pressure measurements in the supine-30° HOBE position with 
a 25 ml instill volume by ethnicity. 
 
There were no significant differences in UBP measurements between Caucasian 
and non-Caucasian (11.6 ± 5.9 vs. 12.2 ± 4, t = 0. 2088, df = 118).   
 
Fluid Balance 
Figure 12 is a plot of the in subject’s individual UBP values when measured in the 
supine-30° HOBE position with an instill volume of 25 ml as a function of subjects’ net 
fluid balance at the time of the study.  There was a highly significant correlation between 
UBP and fluid balance (r = 0.2244, p<0.0001).  Urinary bladder pressure was higher in 
subjects with greater fluid balance.  A linear regression analysis showed that the slope of 
the curve was significant from zero (F = 6.20, DFn = 1.0, DFd = 118, p, 0.0141). 
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Figure 12. Urinary bladder pressure measurements in subjects measured in the supine-30° 
HOBE position with a 25 ml instill volume by net fluid balance. 
 
Effect of Ventilation 
To determine if positive airway pressure influenced UBP, the mean ± SD of UBP 
measurement taken in subjects requiring mechanical ventilation were compared to the 
UBP measurements taken in subjects not receiving mechanical ventilation using 
unpaired-t test.  Subjects receiving mechanical ventilation had slightly higher UBP 
measurements than those subjects not receiving mechanical ventilation (13.0 ± 10.6 vs. 
11.5 ± 5.4) but did not reach statistical significance (t = 0.6722, df = 118, p = 0.5028) 
(Figure 13).   
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Figure 13. Urinary bladder pressure measurements in subjects in the supine-30° HOBE 
position with a 25 ml instill volume by use of mechanical ventilation. 
 
Urinary Bladder Pressure Measurements after Randomization 
A second pair of UBP measurements was obtained after subjects were 
repositioned either supine-0º HOBE, supine-30º HOBE, RL-30º HOBE or LL-30º HOBE 
as per the randomization assignment.  The first measurement was obtained before any 
volume was instilled into the bladder (0 ml) and the second measurement was obtained 
after instillation of 25 ml, 50 ml or 200 ml, as per the randomization assignment.  One 
subject randomized to group 9 (supine-0º HOBE position with a 200 ml instill volume) 
was unable to assume the supine-0º HOBE position due to respiratory and ventilatory 
issues.  Figures 8, 9 and 10 show the individual values of the remaining 119 pairs of UBP 
measurements obtained in their respective randomized position and volume.  All 119 
pairs or 238 measurements were taken by the PI. 
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Figure 14. Summary of the second pair of urinary bladder pressure measurements in the 
four randomized positions with 0 ml and 25 ml instill volumes.  n = 10 per each group. 
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Figure 15. Summary of the second pair of urinary bladder pressure measurements in all 
four of the randomized positions with 0 ml and 50 ml instill volumes.  n = 10 per group. 
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Figure 16. Summary of the second pair of urinary bladder pressure measurements in all 
four of the randomized positions with 0 ml and 200 ml instill volumes.  n = 9 for the 
supine-0 ° HOBE group and n = 10 for the other groups. 
 
Thirteen of 119 subjects (10.9 %) had UBP values < 0 mmHg when measured in 
the randomized position with 0 ml instill volumes.  Again, the negative values persisted 
even when the urinary catheter and drainage collection tubing were at the level of the 
subject’s lower extremities and after the monitoring system was flushed, and the 
equipment was recalibrated and re-leveled.  Five minutes on average elapsed between the 
 109 
 
 
subject’s position change and the UBP measurement.  Of these subjects, seven were 
randomized to the supine position, three to the LL-30º HOBE, two to the supine-30º 
HOBE position, and one to the RL-30º HOBE position.  When randomized volume was 
considered in these thirteen subjects with negative UBPs, eight were randomized to a 25 
ml instill volume and five were randomized to the 200 ml instill volume groups.  None of 
the subjects randomized to any of the four positions with a 50 ml instill volume had 
negative UBPs when measured with 0 ml instill volume.  Likewise, no negative UBPs 
were detected when the UBPs were measured using any of the three randomized 
volumes.  For all groups, the UBP value was higher in the randomized position and the 
randomized volume when compared to the randomized position and 0 ml instill volume.  
The greatest changes were observed between the pairs of UBP values obtained in the 
groups randomized to the 200 ml instill volume (Figure 16). 
Overall, 20 of the 240 UBP measurements taken with a 0 ml instill volume 
yielded a negative UBP (8.3%).  Nine were measured in the supine-30° HOBE position 
(6.0 %), seven in the supine-0° HOBE position (23.3 %), three in the LL-30° HOBE 
position (10 %) and one in the RL-30° HOBE position (3.3 %).  These 20 negative UBP 
measurements were taken in 15 subjects.  Almost half of the subjects (7) had a UBP < 0 
mmHg in the initial study position and five of these subjects continued to have a negative 
UBP value when placed in the randomized position with 0 ml instill volume.  The other 
eight subjects had initial UBP measurements that ranged between 0 and 11 mmHg (mean 
± SD = 4.9 ± 5 mmHg) and half were ≤ 4 mmHg, but when positioned in the randomized 
positions the UBP measurements became negative.  Values ranged between -1 and -7 
mmHg (mean ± SD = -3.8 ± 2 mmHg).  Four of these subjects were randomized to the 
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supine-0° HOBE position, two to the LL-30° HOBE position, and one each to the supine-
30° HOBE and the RL-30° HOBE positions. 
Effect of Instill Volume on Urinary Bladder Pressure Measurement 
To asses the effects of instill volume on UBP measurements, each of the pairs of 
UBP measurements obtained after randomization was first tested for significance using 
the Wilcoxon Signed-Rank test.  In each position the UBP was higher when measured 
with the randomized instill volume as compared to the 0 ml instill volume.  All paired 
comparisons were statistically significant except the supine-30° HOBE group.  Statistical 
significance ranged from 0.02 to 0.002 (Table 8).   
 
Table 8  
Results of Wilcoxon Signed-Rank Test  
Comparison Body Position 
 
Supine-0º 
HOBE 
Supine-30º 
HOBE 
RL-30º HOBE LL-30º HOBE 
0 ml vs 25 ml p = 0.0273 p = 0.1505. p = 0.0039 p = 0.0078 
0 ml vs 50 ml p = 0.0039 p = 0.0273 p = 0.0020 p = 0.0078 
0 ml vs 200 ml p = 0.0078 p = 0.0020 p = 0.0020 p = 0.0020 
  
Next, UBP measurements were stratified based on randomized instill volume.  
Since subjects were not randomized to a 0 ml instill volume, the aggregate of the UBP 
values obtained with a 0 ml instill volume for the respective positions was used for this 
comparison.  Figure 17 shows the UBPs at 0 ml and the randomized instill volume for 
each position and for all positions grouped together. 
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Figure 17. Urinary bladder pressure as a function of instill volume for each position and 
all positions grouped together.  For each position n = 30 for 0 ml volume except for 
supine n = 29, n = 10 for the randomized volume groups (25 ml, 50 ml), and n = 9 for the 
200 ml 
 
For all positions, UBP measured with 0 ml (Figure 11) and 200 ml instill volumes 
yielded the lowest and highest values, respectively.  For the supine-0º HOBE position and 
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the RL-30º HOBE position, UBP progressively increased as instill volume increased.  
However, for the supine-30º HOBE position UBP was higher when measured with an 
instill volume of 25 ml as opposed to the 50 ml instill volume, while for the for the LL-
30º HOBE position the UBP value measured with a 50 ml and 25 ml instill volume were 
similar (Figure 18). 
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Figure 18. Observed mean urinary bladder pressures for each of the 12 randomized 
positions-volume combinations.  Note the interaction of position and volume for the 25 
ml and the 50 ml volume groups. 
 
Lastly, a Kruskal-Wallis test of UBP measurements by instill volume was carried 
out.  There were statistically significant effects of volume on UBP in every position, as 
well as when all positions are considered together (Table 9). 
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Table 9  
Kruskal-Wallis Test of Urinary Bladder Pressures for Effect of Instill 
Volume
 Position 
Volume 
Supine-0º 
HOBE 
Supine- 
30 º HOBE 
RL- 
30º HOBE  
LL- 
30º HOBE 
All 
25 ml 5.8 ± 2.2 12.7 ± 2.7 11.0 ± 3.7 12.2 ± 5.8 10.4 ± 4.6 
50 ml 11.6 ± 4.8 9.8 ± 5.1 15.1 ± 4.9 11.8 ± 4.7 12.4 ± 5.2 
200 ml 26.19 ± 29.7 23.2 ± 12.8 42.2 ± 45.5 31.8 ± 28.5 31.8 ± 31.2 
Kruskal-
Wallis  
p = 0.0022 p = 0.0025 p = 0.0275 p = 0.0358 p < 0.0001 
  
 
Post hoc analysis using the Dunns comparison test showed that there were no 
statistically significant differences in UBPs measured with a 25 ml or 50 ml instill 
volume regardless of the position.  (Table 10).   
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Table 10  
Dunns Post Hoc Comparison for the Effect of Volume on Urinary Bladder Pressure by 
Position 
 
Randomized Position 
 
Comparison 
 
Supine-0° 
HOBE 
 
 
Supine-30° 
HOBE 
 
 
RL-30° 
HOBE 
 
 
LL-30° 
HOBE 
 
All 
25 vs 50 ml p>0.05 p>0.05 p>0.05 p>0.05 p>0.05 
  
 
Effect of Position on Urinary Bladder Pressure Measurement 
To assess the effect of position upon UBP the data was stratified by body 
position.  Figure 19 shows the UBP measurements for each instill volume and each 
randomized position and the aggregate.   
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Figure 19. Urinary bladder pressure as a function of position for each volume and for all 
volumes grouped together, n = 10 for each of the randomized volume groups except the 
group in the supine position with a 200 ml instill volume, n = 9. 
Note. For the all volumes graph n = 29 for supine-0º HOBE position and n = 30 for the 
supine-30º HOBE, RL-30º HOBE, and the LL-30º HOBE positions. 
 
One way ANOVA demonstrated a significant effect of position on UBP (Table 
11) in the 25 ml and 50 ml instill volume groups but not with the 200 ml group and not 
when all instill volumes are considered together in aggregate.  The large variability 
within the 200 ml instill volume group was too great to appreciate any significance 
related to position effect at this volume, therefore no statistically significant difference in 
 116 
 
 
any position or when all positions are considered together is found when an instill volume 
of 200 ml is used for UBP measurement. 
   
Table 11  
Analysis of Variance of Urinary Bladder Pressure for Effect of Position 
 
 
Volume  
Position 25 ml 50 ml 200 ml 
 
All 
 
Supine-0° 
HOBE 
 
5.8 ± 2.2 11.6 ± 4.8 28.0 ± 30.4 14.7 ±19.0 
Supine-30° 
HOBE 
 
12.7 ± 2.7 9.8 ± 5.1 23.2 ± 12.8 15.23 ± 9.7 
RL-30° HOBE 
 
11.0 ± 3.7 16.2 ± 4.9 42.20 ± 45.9 23.3 ± 29.32 
LL-30 ° HOBE 
 
12.2 ± 5.84 11.8 ± 4.7 31.8 ± 28.5 18.6 ± 18.9 
ANOVA F = 6.711 
 
R
2 
= 0.3587 
 
p = 0.0010 
F = 3.18 
 
R
2 
= 0.2095 
 
p = 0.0355 
F = 0.64 
 
R
2 
= 0.05 
 
p = 0.5912 
F = 1.072 
 
R
2 
= 0.027 
 
 p = 0.3638 
  
 
The post hoc Neuman-Keuls multiple comparison test is shown in Table 12.  In 
the groups randomized to 25 ml instill volume the UBPs measured in the supine position 
were significantly lower than when measured in the supine-30º HOBE, RL-30º HOBE 
and LL-30º HOBE positions.  In the groups randomized to the 50 ml instill volume the 
only significant difference was between the supine-30º HOBE and the RL-30º HOBE 
positions. 
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Table 12  
Neuman-Keuls Post Hoc Comparison for the Effect of Position on Urinary Bladder 
Pressure by Instill Volume 
Comparison Randomized Volume 
All 
Volumes 
 25 ml 50 ml 200 ml  
Supine-0° HOBE vs Supine-30º HOBE p<0.01 p>0.05 p>0.05 p>0.05 
Supine-0° HOBE vs RL-30º HOBE p<0.01 p>0.05 p>0.05 p>0.05 
Supine-0° HOBE vs LL-30º HOBE p<0.01 p>0.05 p>0.05 p>0.05 
Supine-30º HOBE vs RL-30º HOBE p>0.05 p<0.05 p>0.05 p>0.05 
Supine-30º HOBE vs LL-30º HOBE p>0.05 p>0.05 p>0.05 p>0.05 
RL-30º HOBE vs LL-30º HOBE p>0.05 p>0.05 p>0.05 p>0.05 
  
To further assess if body position was a significant contributor to UBP a multiple 
linear regression analysis was performed.  For this analysis the dependent variable was 
UBP measured in subjects when positioned in the randomized position with 0 ml instill 
volume, thus examining the position effect without the influence of instill volume.  The 
independent variables were BMI, age (years), gender (male or female), EN (yes or no), 
NFB (ml), positive airway pressure (PAP) (yes or no), LOS (days), and abdominal 
pathology (yes or no), in addition to position.  This model meets criteria for linearity, 
normality, independence and homoskedasticity.  The only significant predictors of UBP 
in this model were BMI and position.  The estimated regression equation is:   
UBP(S30-0) = 0.2052*BMI + 3.34588*S30 + 3.1557*RL + 3.460*LL – 2.2786. 
In this equation the supine-0° HOBE position is represented by the intercept  
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(-2.2786) and S30, RL, LL are indicator variables for the positions of supine-30° HOBE,                  
RL-30° HOBE, and LL-30° HOBE, respectively.  For each position the numeric variable 
is 1 if the measurement was taken in that position and otherwise is 0.  Thus, the supine-0° 
HOBE position results in a lower UBP than the other three positions.  For the average 
subject’s BMI in this study (29 Kg/m2) the supine-0° HOBE position results in a UBP 
3.67 mmHg lower than any other position.  No significant distinctions can be made 
among the other three positions.  These results are in agreement with the ANOVA using 
instill volumes of 25 ml (Tables 12 and 13) where the mean UBP in the supine-30° 
HOBE position is significantly lower than in the other three positions.  Furthermore, 
there were no other significant paired comparisons among the other three positions.   
A two-way ANOVA was carried out to further investigate the effects of position, 
volume, and position-volume interaction.  Urinary bladder pressure measurements with a 
200 ml instill volume exhibited massive variability relative to the UBP measurements 
obtained with 25 ml or 50 ml instill volumes.  Inclusion of this data did not meet model 
criteria and were not included.  The eight other groups (80 subjects) were found to have 
similar variability using a Brown-Forsythe test and therefore were included in the 
analysis.  The results are shown in Table 13. 
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Table 13  
Two-way ANOVA for Effect of Position, Volume, and Position-Volume Interaction 
Effect Df Mean square F P 
Main effects 
Position 3 83.412 4.369 0.007 
Volume 1 74.113 3.882 0.053 
Interaction 
Position-volume 3 90.71 4.752 0.004 
  
A statistically significant position effect was found.  Post hoc comparison shows 
that the only significant difference was between the supine-0° HOBE and the RL-30° 
HOBE (p = 0.04).  The volume effect was significant at the 5% level (p = 0.0526).  The 
interaction between volume and position was also highly significant (p = 0.004). 
To assess if position and volume are significant predictors of UBP in the presence 
of other explanatory variables further statistical analysis of the data was performed.  
Multiple linear regression was used to examine the effect of volume and position as a 
predictor of UBP for eight of the 12 randomized groups selected above.  In this model the 
dependent variable is UBP measured in any of the four positions with 25 ml or 50 ml 
instill volumes and the independent variables were BMI (kg/m
2
), age (years), gender 
(male or female), EN (yes or no), NFB (ml), PAP (yes or no), LOS (days), and abdominal 
pathology (yes or no), in addition to position.  The results indicate that position is 
significant in predicting mean UBP (p = 0.0041), but no significant difference was found 
in the mean UBP between 25 ml and 50 ml instill volumes overall (p = 0.0731).  
Interestingly, within each position, the effect of increasing instill volumes from 25 ml to 
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50 ml on UBP was significantly different (p = 0.0162).  The LOS and BMI were 
significant in predicting the UBP in the randomized position and volume as well (p = 
0.0292 and <0.0001 respectively). The model for predicting mean UBP in any of the 
randomized positions at volumes 25 ml and 50 ml is: 
UBP = 0.27*(BMI) + (Position/Volume effect) - 0.15*(LOS) + 4.74. 
For the above equation the position-volume effect values are obtained from Table 
14.  
  
Table 14  
Position/Volume Effect Values 
 Supine-0° HOBE Supine-30° HOBE RL-30° HOBE LL-30° HOBE 
25ml -0.593 0.76 -0.24 -0.17 
50ml -0.53 -1.33 2.51 0 
  
To further assess the effect of body position on UBP the differences in UBP 
measured by the PI in the supine-30° HOBE position with a 25 ml instill volume and the 
UBP measured in each of the three other randomized positions were calculated.  For this 
analysis the instill volume was kept constant at 25 ml (Figure 20). 
 121 
 
 
Supine S30 RL LL
-6
-5
-4
-3
-2
-1
0
1
2
Randomized Position
C
h
an
g
e 
(m
m
 H
g
)
 
Figure 20. Differences in urinary bladder pressure when subjects were moved from the 
supine-30° HOBE to the respective randomized position. 
 
Note. Instill volume was 25 ml for all paired UBP differences (n = 10 for each group).  
Supine = supine-0º HOBE, S30 = supine-30º HOBE, RL = Right Lateral-30º HOBE, LL 
= Left Lateral-30º HOBE. 
 
When subjects changed from the supine-30º HOBE position to the supine-0º 
HOBE position the UBP decreased by 5.2 ± 1.7 mmHg.  However only small changes 
occurred when the subjects remained in the supine-30º HOBE position (0.6 ± 1.6 
mmHg), or when repositioned in the RL-30 º HOBE position (0.1 ± 3.4 mmHg ) or the 
LL-30º HOBE position (0.0 ± 3.3 mmHg ).  One way ANOVA showed significant 
differences between the four groups (F = 10.43, R
2
 = 0.46, p<0.0001).  Post hoc analysis 
using the Newman-Keuls multiple comparison test showed that the supine-0º HOBE 
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position was significantly different from the other three positions.  Furthermore, no 
significant differences were found among these other three positions. 
 
Current Recommendations for Urinary Bladder Pressure Measurement  
To further explore how body position and instill volume affects UBP 
measurement, subjects randomized to the two groups that follow the current 
recommendations for UBP measurement according to the American Association of 
Critical Care Nurses (AACN) and the World Society of Abdominal Compartment 
Syndrome (WSACS) were compared to the initial standardized position of the study 
(supine-30° HOBE position with a 25 ml instill volume).  Following the 
recommendations of the AACN a change in both position (from supine-30º HOBE to 
supine-0º HOBE) and an instill volume (from 25 ml to 50 ml) is required and using the 
WSACS recommendations only a change in position (from the supine-30º HOBE to the 
supine-0º HOBE) is required.  
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Figure 21. Changes in UBP in subjects when moved from the supine-30° HOBE with a 
25 ml instill volume to the randomized body position. 
Note. Instill volumes recommended by AACN (supine-0° HOBE with an instill volume 
of 50 ml) and WSACS (supine-0° HOBE with a 25 ml instill volume), n = 10 for both 
groups. 
 
When comparing the UBP measured using the WSACS recommendations for 
UBP measurement against the initial study position the UBP decreased significantly 
when subjects moved from a supine-30º HOBE position to a supine 0º HOBE position.  
Urinary bladder pressure fell by -5.2 ± 1.7 mmHg.  However, when the initial study 
position was compared to the AACN recommendations the UBP only decreased by -1.8 ± 
8.1 mmHg and when the patient remained in the initial study position the UBP increased 
by 0.6 ± 1.6 mmHg.  A one way ANOVA showed there was a significant difference 
between these groups (F = 3.6, R
2
 = 0.21, p = 0.04).  The post hoc analysis using the 
Newman-Keuls multiple comparison test found only a statistically significant difference 
between the net difference in UBP measured in the initial study position and that of the 
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WSACS position recommendation for UBP measurement (p < 0.05).  There was no 
statistically significant difference between the net difference in UBP from the initial 
study position and that of the AACN position recommendation for UBP measurement (p 
>0.05). 
 
Inter-Observer Reliability 
In clinical practice, UBP may be measured by one or more nurses and it is 
important to establish if the results are reliable when two different nurses obtain the 
results.  To establish the inter-observer reliability of UBP measurements, another 
experienced CCU nurse who agreed to be a co-investigator obtained a third pair of UBP 
measurements in subjects who were randomized to the supine-30º HOBE position with 
an instill volume of 25 ml.  A pair of UBP measurements consisted of one measurement 
taken after the equipment was assembled, the transducer was calibrated and leveled at the 
symphysis pubis with 0 ml instill volume and the other measurement was obtained after 
instilling 25 ml NSS into the bladder.  The results were compared with the second pair of 
measurements obtained by the PI in the same group.  Figure 22 shows the individual 
values for these measurements with an instill volume of 0 ml. 
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Figure 22. Urinary bladder pressure measurements obtained in subjects in the supine-30º 
HOBE position with a 0 ml instill volume by the principal investigator and a nurse co-
investigator (n = 10). 
 
When the UBP measurements taken with 0 ml instill volumes are considered, the 
nurse co-investigator obtained UBP values that were the same as the PI in two subjects, 
lower in four, and higher in four.  Except for one subject, UBP measurements taken by 
the PI and the nurse co-investigator were comparable.  The subject with the lower UBP 
values obtained by the PI also had the lowest UBP values of their group when measured 
by the nurse co-investigator.  The PI and nurse co-investigator obtained UBP values that 
ranged from -4 to 14 mmHg and -3 to 16 mmHg, respectively.  The mean ± SD of the 
measurements taken by the PI and co-investigator were 7.9 ± 6.1 mmHg and 6.9 ± 7.1 
mmHg, respectively.  The mean difference between the two measurements was 1.0 
mmHg.  When comparing the mean UBP measurements using a paired t-test, significance 
was not demonstrated (95 % CI -2.2 to 4.2, t = 0.7, df = 9, p = 0.5).  The Pearson 
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correlation between the paired measurements taken by the PI and the nurse co-
investigator was very high (r = 0.7791, p<0.0039).   
The agreement between the two UBP measurements obtained by the PI and co-
investigator was performed by the method of Bland and Altman (1986).  This is another 
method to assess agreement between two different observers and is a graphical and 
analytical method for comparisons was used to assess inter-observer reliability.  The 
Bland-Altman plot graphs the difference between the two measurements as a function of 
the average of the two measurements for each subject, which is considered to be the best 
estimate of the true value.  Bias is the difference between one measurement and the other.  
If one measurement is sometimes higher and, sometimes the second measurement is 
higher, then the average of the difference should be close to zero.  If the bias is not close 
to zero, this indicates that the two measurements are not similar.  The Bland-Altman plot 
for the measurements taken by the PI and the nurse co-investigator with 0 ml instill 
volume is shown in Figure 23.  The bias of the measurement was 1.0 and the limits of 
agreement were between -7.76 and 9.76. 
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Figure 23. Bland Altman plot of the UBP measurements taken by the principal 
investigator and the nurse co-investigator in subjects in the supine-30º HOBE position 
with a 0 ml instill volume. The solid lines represent the bias and the dotted lines the limits 
of agreement. 
 
The individual values of the measurements taken by the PI and the nurse co-
investigator when 25 ml instill volumes were used to measure UBP is shown in Figure 
24.  All values taken by the nurse co-investigator were higher than 0 mmHg and in five 
subjects the UBP was higher than the PIs measurement, lower in four subjects and the 
same in one subject.  The mean ± SD of the UBP measurements taken by the PI and the 
nurse co-investigator were 12.7 ± 2.7 mmHg and 13.4 ± 4.1 mmHg, respectively with 
ranges of 10 to 18 mmHg and 8 to 20 mmHg, respectively.  No significant differences 
were found comparing the mean UBP measurements using a paired t-test.  The mean 
difference between the two measurements was -0.700 (95 % CI -2.454 to 1.054, t = 0.9, 
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df = 9, p = 0.4).  The Pearson correlation of the two samples was high (r = 0.8, p = 
0.0018). 
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Figure 24. Urinary bladder pressure measurements obtained in subjects in the supine-30º 
HOBE position with a 25 ml instill volume by the principal investigator and the nurse-co 
investigator (n = 10). 
 
 The Bland- Altman plot of the measurements taken by the PI and the nurse co-
investigator with 25 ml instill volumes is shown in Figure 25.  The bias of the 
measurement was -0.7 and the limits of agreement were between -5.5 to 4.0. 
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Figure 25. Bland Altman plot of the urinary bladder pressure measurements taken by the 
principal investigator and the nurse co-investigator in subjects in the supine-30º HOBE 
position with a 25 ml instill volume. The solid line represents the bias and the dotted lines 
the limits of agreement          (n = 10). 
 
Intra-Observer Reliability 
To assess the intra-observer reliability of UBP measurements the 10 subjects who 
were randomized to the supine-30º HOBE with a 25 ml instill volume remained in this 
position for a second pair of UBP measurements (one measurement with 0 ml and 
another with a 25 ml instill volume).  The two pairs of UBP measurements were taken 
within 30 minutes of each other by the PI.  Figure 26 shows each pair of the UBP 
measurements obtained with 0 ml instill volumes. 
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Figure 26. Urinary bladder pressure measurements taken by the principal investigator in 
subjects randomized to the supine-30º HOBE position with a 0 ml instill volume (n = 10). 
 
The PI obtained the first UBP measurement of the first set.  Urinary bladder 
pressure ranged from -5 to 12 mmHg with a mean ± SD of 6.1 ± 5.9 mmHg.  Eight 
subjects had a positive UBP measurement taken, one subject had UBP of 0 mmHg, and 
another had a value of -5 mmHg.  Comparing the first UBP measurement of the first set 
to the first UBP measurement of the second set six subjects had relatively higher values 
and four subjects had lower values.  The subject with the negative value for the first UBP 
measurement of the first set remained negative for the first measurement of the second set 
taken with a 0 ml instill volume.  The four subjects who had lower UBP values in the first 
measurement of the second set of measurements as compared to the first UBP 
measurement differed by 1, 2, 3, and 4 mmHg.  The first UBP measurement of the second 
set of measurements taken by the PI with a 0 ml instill volume were quite similar with 
range from -4 to 14 mmHg with a mean ± SD of 7.9 ± 6.1 mmHg.  The mean difference 
between the two measurements was -1.8 mmHg (95 % CI -4.9 to 1.3, R
2 
= 0.2).  There 
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were no statistically significant differences between the pairs of UBP measurements 
taken at the 0 ml volume in the supine-30° HOBE position (paired t test, t = 1.3, df = 9, p 
= 0.22).  There was a very high correlation between the first UBP measurements of both 
sets taken by the PI (Pearson correlation r = 0.74, p = 0.0073).   
The Bland-Altman plot for the two UBP measurements taken by the PI in subjects 
in the supine 30°- HOBE position with 0 ml instill volume is presented in Figure 27. 
 
-5 0 5 10 15
-15
-10
-5
0
5
10
15
Average
D
if
fe
re
n
ce
 
Figure 27. Bland Altman plot for the two UBP measurements taken by the principal 
investigator with subjects in the supine-30° HOBE position with a 0 ml instill volume. 
The solid line represents the bias and the dotted lines the limits of agreement (n = 10).  
 
When the two measurements taken by the PI with 0 ml instill volumes were 
analyzed the bias was estimated to be -1.8.  The limits of agreement or the expected 
difference between measurements of future samples was between -10.3 to 6.7 mmHg.  
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Figure 28 shows the pairs of urinary bladder pressure measurements obtained by 
the principal investigator in subjects in the supine-30° HOBE position with a 25 ml instill 
volume. 
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Figure 28. Urinary bladder pressure measurements taken by the principal investigator 
with subjects in the supine-30° HOBE position with a 25 ml instill volume (n = 10). 
 
When the PI measured subjects in the supine-30° HOBE position with a 25 ml 
instill volume the second measurement of the first set ranged from 7 to 16 mmHg.  The 
second measurement of the second set ranged from 10 to 18 mmHg.  The second UBP 
measurements of the second set taken by the PI were higher than the second measurement 
of the first set on five occasions, lower on three and the same on two occasions.  The 
averages of the second measurement of the first set and the second measurement of the 
second set were 12.1 ± 2.7 mmHg and 12.7 ± 2.7 mmHg, respectively.  The average 
difference of the two samples was -0.6 mmHg.  Using a paired t-test to compare the 
means no statistically significant differences were observed (95 % CI -1.78 to 0.6, R
2
 0.1, 
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paired t-test, t = 1.2, df = 9, p = 0.3).  The two samples were highly correlated (Pearson 
correlation = 0.8, p = 0.002).   
The Bland-Altman plot for the two UBP measurements obtained by the PI with 
subjects in the supine-30° HOBE with a 25 ml instill volume is presented in Figure 29.  
The bias of the measurements was close to 0 at -0.6 mmHg and the limits of agreement 
were between -3.82 to 2.62, which were both lower than the set of UBP measurements 
obtained with a 0 ml instill volume. 
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Figure 29. Bland Altman plot of the two measurements taken by the principal investigator 
in subjects randomized to the supine-30º HOBE position with a 25 ml instill volume. 
The solid line represents the bias and the dotted lines the limits of agreement (n = 10). 
 
Abdominal Perfusion Pressure 
Intra-abdominal hypertension (IAH) is associated with multiple organ failure 
syndrome (MOFS).  The main mechanism contributing to MOFS with IAH is the 
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reduction of blood flow to the abdominal organs as reflected by the abdominal perfusion 
pressure (APP).  Abdominal perfusion pressure has also been recognized as a better 
indicator of fluid resuscitation when treating the critically ill.  To investigate if APP is 
affected by the body position or the bladder instill volume, the APP of all 120 patients 
was calculated and stratified by the 4 body positions and by instill volumes.  Figure 30 
shows the APP for each of the four randomized positions.  The APP in the supine-0º 
HOBE, supine-30º HOBE, RL-30º HOBE and LL-30º HOBE positions was 72 ± 10 
mmHg, 70 ± 17 mmHg, 69 ± 15 mmHg, and 67 ± 20 mmHg, respectively.  Analysis of 
variance showed no significant statistically differences in APP among the four body 
positions studied (F = 0.6, R
2
 = 0.02, p = 0.6). 
 
  
 
 
 
However, statistically significant differences were found among the groups in 
regards to the APP when a one way ANOVA examined the effect of the bladder instill 
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Figure 30.  Abdominal perfusion pressure of all subjects stratified by randomized position.  
S30 = supine-30º HOBE, RL = right lateral 30º HOBE, LL = left lateral 30º HOBE.  (n = 
30 in each group). 
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volume used to measure UBP (F = 10.18, R
2
 = 0.12, dF = 3, p<0.001) ( Figure 31).  Post 
hoc Neuman-Keuls multiple comparison test demonstrated that the 200 ml instill bladder 
volume produced a significantly lower APP (56 ± 36 mmHg) as compared to 0 ml (75 ± 
15 mmHg), 25 ml (71 ± 13 mmHg), and 50 ml (70 ± 14 mmHg) bladder instill volumes.  
There were no statistically significance differences in APP between 0 ml and 25 ml.  
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Figure 31.  Abdominal perfusion pressures stratified by bladder instill volumes.  n = 120 
for 0 ml.  n = 40 for 25 and 50 ml.  n = 39 for the 200 ml instill volume. 
  
Intra-Abdominal Hypertension 
Elevated intra-abdominal pressures (IAP) are associated with abdominal organ 
dysfunctions leading to the development of abdominal compartment syndrome (ACS).  
The level of IAP that causes organ dysfunction and ACS varies among individuals and 
depends not only on IAP but also on other clinical variables such as previous organ 
dysfunction, abdominal perfusion pressure, and BMI, to name a few.  Although there is 
no consensus among researchers on the level of IAP that most accurately predicts organ 
dysfunction or the need for clinical interventions, the WSACS has defined a UBP > 12 
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mmHg (when measured in the supine position) as IAH and is an indication for more 
frequent measurement of UBP.  The prevalence of IAH (UBP>12 mmHg) was calculated 
for the supine-30º HOBE position at 0 ml and 25 ml instill volumes.  The prevalence of 
IAH was 1.8 fold higher when a 25 ml instill volume was used as compared to a 0 ml 
instill volume (53 vs. 29).   
 In summary, the data collected during this prospective observational study 
was accomplished according to the design.  Descriptive statistics of the study population 
and further analysis including correlation, Bland-Altman, ANOVA, linear regression and 
multiple linear regression were able to be completed and satisfactorily answered the 
research questions.  
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Chapter 5  
 
 
Discussion 
 
Introduction 
Urinary bladder pressure (UBP) measurement accurately reflects intra-abdominal 
pressure (IAP) (Fusco et al., 2001) and is considered to be the gold standard for 
estimating IAP at the bedside (Malbrain, 2004).  Currently, UBP is measured using one 
of several variations of the method initially described by Kron and colleagues (1984).  
This technique of UBP measurement utilizes hydrostatic pressure principles which are 
frequently used by critical care nurses (CCNs) for bedside hemodynamic monitoring.  
Therefore, most CCNs possess the basic knowledge and skills required for UBP 
measurement.   
An elevated IAP that is > 12 mmHg is considered intra-abdominal hypertension 
(IAH) and can evolve into abdominal compartment syndrome (ACS) when one or more 
organ systems are negatively affected (Balogh, McKinley, Holcomb et al., 2003).  The 
gastrointestinal (GI) system is one of the many organ systems that is compromised with 
IAH and that contributes to the development of multiple organ failure syndrome (MOFS) 
(Balogh, McKinley, Cox et al., 2003).  Given the anatomic location of the intestines 
within the abdominal compartment, it is reasonable to speculate that increased IAH may 
directly or indirectly contribute to altered GI function.   
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Dysfunction of the GI system has implications for nursing because enteral feeding 
is the preferred route for nourishing critically ill patients, and if GI function is 
compromised enteral feeding can be challenging.  Recognition of GI system dysfunction 
is difficult by physical examination alone but clinically important.  Use of objective data 
to assess and evaluate GI dysfunction and/or enteral feeding tolerance by bedside nurses 
has been limited.  Traditionally nurses have relied on data such as bowel sounds, residual 
volumes, and diarrhea, but all of these depend on subjective interpretation and are prone 
to errors.    Having an objective tool available at the bedside to assess when patients are 
intolerant to enteral nutrition (EN) would theoretically improve patient care as predicted 
by Benner’s theory of nursing (Benner, 1982).   
Benner’s theory, from novice to expert, (1982) utilizing critical thinking as 
applied to nursing by Martin (2002) explains the educational and experiential 
development of nurses as a process that occurs over several years.  If an objective 
measure could provide clinically meaningful data to determine enteral feeding tolerance, 
the novice nurse’s level of practice could be escalated to place the nurse’s practice at a 
higher level of function in a shorter period of time.  Having more data available at the 
bedside to guide patient care, it is theorized, would improve bedside nursing care at all 
levels from novice to expert which in turn would improve patient outcomes (Benner, 
1982).  A goal of nursing research would be to identify such tools and was the impetus 
for this nursing study. 
During the initial stages of study design, the original hypothesis was to determine 
if UBP could become an objective predictor of enteral feeding tolerance.  If UBP 
measurement could in some way be linked to enteral feeding tolerance, the nursing 
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process of enteral nutrition administration and monitoring for the critically ill would be 
greatly enhanced.  Unfortunately, that hypothesis was unable to be tested because after an 
extensive review of the medical and nursing literature, it became apparent that UBP 
measurement at the bedside of critically ill patients had not been standardized.   
Over the years, the process of bedside UBP measurement has evolved from a 
single measurement of IAP during surgical procedures to frequent intermittent 
measurements in the CCUs to diagnose and monitor for IAH and ACS.  Initially, UBP in 
CCUs was measured exclusively by physicians and the procedure was copied from the 
procedures used in the surgical suite or laboratory (Iberti et al., 1987; Iberti et al., 1989; 
Kron et al., 1984).  With time, the responsibility of UBP measurement in CCU was 
transitioned from the physician to the critical care nurse (CCN) but the procedure was not 
changed and did not take into account the nursing needs or the recent recommendations 
to improve patients care in the CCU.  For example, the current recommendation is to only 
measure UBP when patients are positioned supine-0º HOBE.  This position is not 
recommended in CCU due to the higher risk for aspiration pneumonia (Heyland et al., 
2003).  In addition, the supine-0º HOBE is inconvenient for patients and nurses; no 
nursing research has been carried out to determine if UBP can be measured in other 
positions.  Likewise, UBP measurements require instillation of NSS into the bladder and 
physicians have used volumes ranging from 10 ml to 250 ml in the past.  Nursing 
research had not been carried out to investigate the most appropriate volume for UBP 
measurement and instead nurses arbitrarily chosen instill volumes based on what 
physicians have found in the laboratory (Iberti et al., 1989; Kron et al., 1984).  
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Furthermore, no research had been carried out by nurses to assess the inter- and intra-
observer reliability of UBP measurement to ascertain the utility of this technique in CCU. 
Because of the lack of standardization regarding position and instill volume and 
the void of data regarding the reliability of UBP measurement by nurses, the initial 
hypothesis could not be tested.   The experimental design to test the hypothesis requires 
subjects to be in the recommended supine-30º HOBE as well as multiple UBP 
measurements taken over time by the same or different nurses.  Thus, the PI took a step 
back and critically reflected on the UBP measurement process as currently practiced by 
CCNs.  After a thorough review of the literature it was apparent that the three elements 
with the greatest potential to influence UBP measurement are bladder instill volume, 
subject position, and inter- and intra-rater reliability. 
The purpose then of this research was to critically evaluate the process of UBP 
measurement employed by professional nurses at the bedside of critically ill patients.  
The ultimate aim of the research was to develop an evidence based nursing protocol for 
bedside UBP measurement using hydrostatic pressure principles that can be used for 
clinical and research purposes. 
 
General Observations 
The study was designed to recruit a large number subjects who would have a wide 
range of bladder pressures, clinical conditions and demographics.  Although the sample 
size and many important goals were achieved, other goals were not.  For example, few 
mechanically ventilated subjects, no subjects requiring paralyzing agents, and few non-
Caucasian subjects were recruited into the study.  One reason for failing to enroll certain 
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segments of the CCU population was the boundaries imposed by ethical and federal 
regulations, i.e. The Health Insurance Portability and Accountability Act (HIPAA), 
making clinical research in CCUs difficult (Ciroldi et al., 2007).   
Specifically, recruitment of subjects for participation in a research study is 
challenging because current federal guidelines do not allow direct contact of potential 
subjects by the investigator for the screening.  Therefore, subjects for this study had to be 
recruited by health professionals who had a previous relationship with the subject.  The 
nurse or physician directly caring for the subject had to introduce the study to the 
potential subject first and if acceptable the PI could provide a full explanation of the 
study followed by a signed informed consent if agreement to participate was acceptable.  
In this study, nurses and or physicians blocked access to some of the most critically ill 
patients and on other occasions the surrogate felt that the risk of the study was too high 
and did not sign the informed consent.  These limitations have not been present or 
acknowledged in many of the other studies investigating UBP because many of the PIs 
were physicians directly involved in the care of the subject and because UBP 
measurements were considered the standard of care and an informed consent was not 
required by the IRB of the institution (Malbrain & Deeren, 2006).  This situation is not 
unique to this study since others have also found difficulty in obtaining informed consent 
for research studies in critically ill patients (Ciroldi et al., 2007).   
The current study involved subjects who were critically ill but in a stable state.  
While most of the previous studies have investigated UBP in subjects who where 
critically ill, sedated and at risk for intra-abdominal hypertension (IAH) and abdominal 
compartment syndrome (ACS), this study investigated a range of subjects who were not 
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sedated and at a lower risk for IAH and ACS.  Because this study is laying the ground 
work for additional research examining the relationship of EN and UBP in a critically ill 
population, it was important to study a variety of patients who would range in risk of IAH 
and ACS from high to low.  The UBP data gathered from this diverse population is 
actually more relevant to the ultimate goal of establishing UBP as a predictor of enteral 
feeding tolerance since UBP is intended not to be a diagnostic tool for IAH and ACS.      
The values for UBP obtained in this research study reflect the UBP values 
reported by other investigators.  For instance, Sanchez et al. (2001) measured UBP in 
hospitalized, non-critically ill patients in the supine position with a 50 ml instill volume 
using a manometric technique and reported UBP values ranging from 0.2 to 16.2 mmHg 
with a mean of 6.5 mmHg.  Values were measured in cm H20 and reported by the authors 
in mmHg.  Malbrain et al. (2004) using a technique similar to the one used in this study 
measured UBP in critically ill patients in the supine position with a 50 ml bladder instill 
volume and reported mean values of 9.8 ± 4.7 mmHg.  Many if not all of these subjects 
were sedated and receiving mechanical ventilation at the time of the study.  Kimball and 
colleagues (2007) reported mean values of three different UBP measurements taken by 
89 nurses in 18 subjects that ranged between 12.2 ± 4.7 to 12.8 ± 4.9 mmHg.  In 
comparison, the UBP values obtained in this study in the supine-30º HOBE with 0 ml and 
25 ml instill volumes were 7.1 ± 5.9 mmHg and 11.6 ± 5.9, respectively.  When only the 
values of the 10 subjects randomized to the supine-0º HOBE position with a 50 ml instill 
volume are considered the UBP values ranged from 3 to 23 mmHg with a mean of 12.5 ± 
6.3 mmHg, nearly identical to the findings of Kimball and colleagues (2007).  The 
slightly higher values found in this study as compared to Sanchez et al. (2001) and 
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Malbrain et al. (2004) may be due to differences in subject position, and/or technical 
differences of UBP measurement or subject factors, such as the effect of sedation which 
would decrease UBP.  Since none of the subjects were sedated in this study it could be 
predicted that higher UBP may be observed.   
A novel and unexpected finding of this study is the sub-atmospheric UBP values 
obtained by the PI under certain conditions.  When all 478 UBP measurements taken in 
this study are considered, 20 were < 0 mmHg (4.2 %).  Sub-atmospheric UBP values 
were only observed in subjects with a 0 ml bladder instill volume but occurred in all 
positions.  Sub-atmospheric UBP values most frequently occurred in the supine-0° 
HOBE position (23.3 %) followed by the LL-30° HOBE position (10 %), the supine-30° 
HOBE (6.0 %), and the RL-30° HOBE (3.3 %).  Five of the seven subjects who had 
negative UBP values in the initial position remained negative when positioned in the 
randomized position and these values became more negative in subjects who were 
randomized to the supine-0º HOBE position.   
These negative values were not likely due to errors in the investigator’s 
procedural execution or technical skills as these findings occurred late in the study after 
the investigator had become proficient in all aspects of UBP measurement.  In addition, 
during the early stages of data collection when the first negative value was observed the 
engineers at Wolfe-Tory Medical, Inc., manufacturers of the AbViser™, were contacted.  
The only explanation that was offered that could conceivably clarify negative values was 
related to the position of the urinary catheter and drainage collection system in reference 
to the transducer and the urinary bladder and perhaps the presence of fluid in the drainage 
tubing.  However, these recommendations were already addressed by the PI. 
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One possible explanation of these findings is that in some subjects IAP was truly 
sub-atmospheric.  Intra-abdominal pressure may be highly variable among individuals 
secondary to subject characteristics (fluid administration or sedation) or the conditions of 
measurement (transducer location, zeroing and leveling procedures) and the knowledge 
and expertise of nurses.  Because the abdominal cavity is considered to be a closed box 
that contains both partially rigid (ribs, spinal cord, and pelvis) and flexible boundaries 
(diaphragm and abdominal muscles) as well as compressible visceral organs, at any 
single moment IAP may vary as influenced by the character of respiration, abdominal 
wall muscle tone, position of the individual and relative position of the abdominal organs, 
and posture.  All of these variables impact IAP and UBP measurement.   
Wagoner (1926) measured intra-abdominal pressure using a water manometer in 
animals after introducing a needle or catheter into the abdominal cavity.  He 
demonstrated that when precautions were taken to ensure a closed-air system the IAP in 
animals was between -2 to -55 mm H2O (-0.15 to -4 mmHg).  Negative IAP was also 
observed in recently deceased human subjects or cadavers.  Forty-one of 50 cadavers 
with no evidence of abdominal disease, had negative IAPs ranging from -2 to -106 mm 
water (-0.15 to -6.6 mmHg).  However, cadavers with abdominal disease such as tumors, 
obesity, ascites, and pneumonia with edematous intestines showed positive IAP ranging 4 
to 150 mm water (0.3 to 11.5 mmHg).  Further studies in animals by Overholt (1931) and 
Salkin (1934) showed sub-atmospheric IAP when the animals were horizontal and when 
the cannulae were positioned in the upper part of the abdomen.  Twardowski et al.  
(1986) measured IAP in patients undergoing peritoneal dialysis with an intra-abdominal 
pressure transducer and showed zero or sub-atmospheric IAP when the subjects were 
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supine and relaxed but positive IAP when subjects were relaxed and in a sitting or upright 
position.   
A second possible explanation for the sub-atmospheric pressures observed in this 
study is that the transducer was leveled at a position higher than the fluid line of the 
bladder volume.  This is possible since it is difficult to determine the intrinsic bladder 
volume of a critically ill subject at any moment because they are receiving IV fluids, 
diuretics, vasoactive medications, and other treatments that may affect urinary output.  It 
is possible that subjects who had a UBP ≥ 0 mmHg had urinary catheters that did not 
fully empty the bladder while in the subjects with UBP < 0 mmHg had urinary catheters 
that completely emptied the bladder.  
In summary, the supine-0° HOBE position with a 0 ml instill volume produces 
sub-atmospheric UBP about 23.3 % of the time and the supine-30° HOBE position with a 
0 ml instill volume produces sub-atmospheric UBP about 6 % of the time.  As of this 
writing and to the knowledge of the PI, sub-atmospheric pressures have not been 
previously reported in clinical studies.  However, Malbrain and Deeren (2006) have 
recently reported 0 mmHg in one subject. 
 
Research Questions 
Research Question 1:  Does the Amount of Bladder Instill Volume Affect UBP 
Measurement?  
The results of this research study showed that UBP is affected by the amount of 
NSS instilled into the bladder before measurement.  The evidence supporting this 
assertion is three fold:  First, the initial set of paired UBP measurements showed a 
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statistically significant higher UBP value in subjects who were placed in a supine-30º 
HOBE position with a bladder instill volume of 25 ml as compared to a 0 ml instill 
volume (Figure 7).  Second, UBP was higher when measured in any of the randomized 
volumes.  In each position, the UBP was higher when measured with the randomized 
volume as compared to zero volume.  Third, the one way ANOVA showed a significant 
effect of volume and a two way ANOVA also showed a significant effect of volume and 
volume-position interaction on UBP.  
The results of this research study are comparable with recent studies investigating 
the effect of bladder instill volume on UBP measurement (Chiumello et al., 2007; De 
Waele et al., 2006; Malbrain & Deeren, 2006).  All of these studies use the same 
experimental design where UBP is measured in the same subject multiple times using 
serial additions of NSS into the bladder.  This design does not take into account normal 
physiology of the bladder.  Urinary bladder pressure measurement is an indirect 
measurement of IAP only if the bladder detrusor muscle pressure (DMP) is zero or near 
zero (UBP = IAP + DMP) at the time of measurement (Von Garrelts, 1957) and only if 
biomechanical factors that control bladder function such as compliance and 
accommodation are not activated.  Compliance (C) is defined as the change in volume 
(V) relative to a corresponding change in intra-vesicular pressure (P) (C = ΔV/ ΔP).  
Subjects with poor bladder compliance produce higher changes in UBP for a given instill 
volume. With time, the detrusor muscle and connective tissue re-arrange or accommodate 
in a process that will result in a lower pressure for a given volume.  The time needed for 
full accommodation of the bladder after a given instill volume is not known but it is 
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likely to be > one minute, which is the time between instillations used in the above 
studies.   
Evidence for the effect of compliance and accommodation in the measurement of 
UBP comes from the study of Malbrain and Deeren (2006) and Chiumello and others 
(2007).  Malbrain and Deeren (2006) showed marked differences in UBP measurements 
among subjects with different degrees of bladder compliance and (Chiumello et al., 2007) 
showed the effect of bladder accommodation by observing lower UBP measurements five 
minutes after saline instillation as compared to the UBP when measured five to ten 
seconds after saline instillation.  Kimball et al. (2007) also recognized the concept of 
bladder accommodation when they observed higher UBP variability when successive 
UBP measurements were taken less than eight minutes apart. 
In addition to the experimental design, the present study differs from the 
previously discussed studies in several ways.  First, the sample size of the present study 
(n = 120) is significantly larger than the previously discussed studies thus increasing the 
power and validity.  Second, the majority of subjects in the present study was not at risk 
for IAH and ACS, nor was they sedated and mechanically ventilated.  (All of the subjects 
in the previous studies were at risk for IAH and ACS and were sedated and mechanically 
ventilated at the time of measurement.)  Both sedation (De Waele et al., 2003) and LOS 
(Biancofiore et al., 2003; De Waele & De Laet, 2007) have been shown to affect UBP 
and may have altered the results.  Third, in this study the effect of volume was tested in 
positions that have not been previously reported.  Findings of this study demonstrate that 
there is a significant volume-position interaction.  Higher UBP measurements were 
always obtained with any instill volume as compared to 0 ml instill volumes regardless of 
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position.  In the positions of supine-0º HOBE and RL-30º HOBE UBP measurements 
increased sequentially when measured with the increasing study volumes, thus higher 
instill volumes produced higher UBP measurements.  However in subjects positioned in 
the supine-30º HOBE or LL-30º HOBE higher UBP measurements were obtained with a 
25 ml instill volume as compared to a 50 ml instill volume demonstrating a volume 
position interaction (Figure 18 and Table 9).  In all groups the lowest UBP values were 
measured with 0 ml instill volumes and the highest were measured with the 200 ml instill 
volumes.   
In summary, the results of this study and other studies (Chiumello et al., 2007; De 
Waele et al., 2006; Malbrain & Deeren, 2006) demonstrate that the amount of NSS 
instilled into the bladder at the time of UBP measurement affects the UBP results.  A 
unique and original contribution of this study is the discovery of a significant volume-
position interaction when measuring UBP.  A bladder instill volume of 0 ml gives a lower 
UBP value but also increases the probability of obtaining a negative UBP value as well as 
greater variability for both inter- and intra-observer reliability (see research questions 3 
and 4).  A bladder instill volume of 200 ml was also associated with more variability and 
produced higher UBP values while the 25 ml and 50 ml instill volumes produced 
comparable results in all positions.   
 
Research Question 2:  Does the Subject’s Body Position Affect UBP Measurement?   
The second research question explored the effect of body position on UBP 
measurement.  The findings of this study demonstrate that body position affects UBP.  
This conclusion is supported by the ANOVA and the multiple regression analyses.  
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Urinary bladder pressure is lower when measured in the supine-0° HOBE position than 
when measured in any of the other three positions studied which were all with a 30º 
HOBE (Figure 18).  However, the differences in UBP with changes in body position only 
reached statistical significance when 25 ml and 50 ml bladder instill volumes were used 
again indicating significant volume-position interaction (Table 11 and Figure 18).   
This study has the largest data base of UBP measurements taken in critically ill 
subjects in the supine-30º HOBE position.  The study of the supine-30º HOBE position is 
of clinical interest because it represents the most common position assumed by critically 
ill patients and is the recommended position of many critical care experts and reflected in 
consensus standards published by professional organizations to prevent and decrease the 
incidence of ventilator associated pneumonia and aspiration pneumonia frequently found 
in critically ill patients (Chinsky, 2002).  It is also the preferred position for patients who 
cannot assume the supine-0º HOBE position.  Furthermore, this position would be 
necessary for centers that employ the continuous UBP measurement technique of Balogh 
(Balogh et al., 2004).   
The data obtained from the current study found that UBP measured in the supine-
0º HOBE position was 3 - 5 mmHg lower than when compared to the supine-30º HOBE 
position.  This was calculated in two ways:  First by using the equation that predicts 
changes in UBP in the supine-0º HOBE position with zero volume.  For this calculation, 
BMI was considered to be the average for the study (29 Kg/m
2
) and supine-30º HOBE 
value was one (1) and the  RL-30º HOBE and LL-30º HOBE positions were at zero (0).  
This calculation shows that UBP measured in the supine-0º HOBE position will result in 
a value that is 3.67 mmHg lower than when measured in any of the other positions.  
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Second, for the 10 subjects randomized to the supine-0º HOBE position with a 25 ml 
instill volume the difference in the UBP value from the supine-30º HOBE position with a 
25 ml instill bladder volume was calculated (Figure 20).  This calculation yielded a lower 
mean difference of 5 mmHg.  Mc Beth et al. (2007) also found UBP to be 5 mmHg lower 
when measured in the supine-0º HOBE position as compared to the supine-30º HOBE 
position.    
When the present study was designed the supine-30º HOBE position had not been 
previously investigated, but since then two studies have been published showing UBP 
measurement data in this position (McBeth et al., 2007; Vasquez et al., 2007).  Both of 
these studies show that UBP when measured in the supine position with varying degrees 
of HOBE  (10º, 15º or 30º) is higher than when measured in the supine-0º HOBE 
position.  The major difference between the present study and the studies of Vasquez et 
al. (2007) and McBeth et al. (2007) is the position and leveling of the pressure transducer.  
In both of the previous studies the pressure transducers were not changed after each 
position change, while in the present study, the pressure transducer was re-leveled and re-
calibrated after each position change.  This is important because changes in body position 
may change the relationship of the transducer to the anatomic landmark that is calibrated 
at zero pressure. 
Results of the present study add to the knowledge regarding UBP measurement 
because it uses two lateral positions that have not been investigated before.  These lateral 
positions were chosen because after the supine-30º HOBE they represent the most 
common positions assumed by critically ill patients in CCU and are positions 
recommended to prevent the complications of immobility such as impaired skin integrity 
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(Baas, 2003).  These lateral positions are more common than the supine-0º HOBE and the 
supine-10 º, 20 º, or 45 º HOBE positions studied by Vasquez, and colleagues (2007) and 
McBeth et al. (2007).  The results of the present study demonstrate no significant 
difference in UBP between the supine-30º HOBE position and the RL- and LL-30º 
HOBE positions (Table 12).  This was unexpected because positioning subjects in the 
LL-30º HOBE position should result in a shift of weight of the abdominal viscera that 
could have increased the UBP secondary to the gravitational effect of the organs on the 
bladder resulting in higher UBP values (Hebbard et al., 1995).   
The results of this study have direct clinical relevance.  Specifically, they show 
that the absolute UBP value is higher when it is measured in the supine-30º HOBE as 
compared to the UBP measured in the supine-0º HOBE position.  These slightly higher 
UBP values are to be expected in the supine-30º HOBE position because of the tension in 
abdominal wall musculature and the gravitational effects of the abdominal viscera 
contents on the bladder with HOBE (Grillner et al., 1978; Hebbard et al., 1995).  
Supporting these findings are the results of McBeth and colleagues (2007) who reported 
similar increases in UBP measurements with a 30º HOBE position.  Therefore, it will be 
acceptable to measure UBP in the supine-30º HOBE position.  This position can be used 
as an alternative position to the supine-0º HOBE position for all subjects who are able to 
assume this position, providing that the relatively higher values in this position are 
recognized.  Accepting this alternative UBP measuring position, ongoing research will be 
required to obtain more data under different circumstances.  Finally, it will also require 
revised definitions of IAH and ACS. 
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Research Question 3:  What is the Inter-Observer Reliability of UBP Measurement?  
The third research question assessed the inter-observer reliability of UBP 
measurements.  The reliability of UBP measurements is a function of the process of UBP 
measurement that includes the accuracy of equipment, the technique of the nurse or 
observer, and other patient related clinical factors.  Previous studies have shown that 
when properly calibrated the bedside monitoring equipment is sensitive and produces a 
reliable transduction of hydrostatic pressures (Ahrens, 1999; Ahrens et al., 1995).  Some 
of the most pertinent clinical factors related to subjects that may affect UBP variability 
from one measurement to another are body weight, use of sedatives, breathing and 
ventilatory status with positive airway pressure, net fluid balance, and activity.  
Influencing factors that can contribute to UBP measurement variability related to the 
nurse’s technique includes the accuracy of positioning the subject, proper assembly of the 
equipment, i.e. assuring that there are no air bubbles in the line, proper placement and 
leveling of the transducer, zeroing of the pressure transducer, proper identification of the 
wave form, and reading the monitor at end expiration.   
Because subjects in CCUs are very ill and receiving multiple therapies, subject 
clinical factors are very difficult to standardize and it would be expected to contribute 
significantly to the variability of paired UBP measurements.  Of the three areas cited as 
potential factors of variability, the nursing process of UBP measurement may be the most 
influential and is one of the foci to limit variability during UBP measurement.  Therefore, 
it is possible to reduce variability of UBP measurement if the nurse’s technique is 
standardized.  In order to account for this potential variability, the present study was 
designed to simulate the necessary steps a CCN must take to obtain reliable UBP 
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measurements.  To that end, after the initial measurement, the transducer was misaligned 
by the PI and the nurse co-investigator was required to recheck the subject position and to 
re-level and to re-zero the pressure transducer and to perform a square wave test before 
the second set of UBP measurements were taken.  When all factors are considered the 
results show that UBP can be measured with low variability, and therefore high inter-
observer reliability.  Furthermore, the bias and coefficient of agreement between the two 
measurements as calculated by the Bland-Altman analysis were both smaller when 
measured with a 25 ml instill volume as compared to a 0 ml bladder instill volume 
(Figure 23 and Figure 24).   Davis and associates (2005) also showed more variability in 
UBP measurements when a 0 ml instill volume was used.   
One experimental and one clinical study previously assessed inter-observer 
reliability of UBP measurement.  Wolfe and Kimball (2005b) built a laboratory model of 
the abdomen by using a 210 liter container with a urinary catheter exiting from its base.  
The proximal end of the urinary catheter tip was sealed with a 100 ml bag and was placed 
at the base of the container simulating a urinary bladder and the distal end was connected 
to the AbViser™ Kit that in turn was connected to a transducer and a monitor.  The 
transducer was leveled at the level of the simulated bladder at the bottom of the container.  
A column of fluid was placed within the container to simulate IAP of 5, 10, 15, 20, 25, 30 
and 40 mmHg.  Eleven (11) observers each took five measurements for each of the seven 
simulated IAPs.  These investigators found very little inter-observer variability of the 
measurements and the standard deviations of the measurements were very small (0.1 to 
0.5).  This study assessed variability of the monitoring system but did not address the 
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more important questions such as variability introduced by subjects or by nurse’s 
technique. 
The inter-observer reliability of UBP found in the present study is in agreement 
with the study of Kimball et al. (2007) which is the only other study that has assessed 
inter-observer reliability of UBP measurement with a technique and clinical setting 
similar to the present study.  For example, the mean UBP measurements from the two 
nurses in the study of  Kimball et al. were 12.37 ± 4 mmHg and 12.37 ± 4.84 mmHg, 
when measured in the supine-0º HOBE with a 50 ml instill volume and in this study were 
12.7 ± 6.6 mmHg and 13.4 ± 4.11 mmHg, when measured in the supine-30º HOBE and 
25 ml instill volume. Both pairs of UBP measurements in both the study of Kimball and 
this study were not statistically significant by paired t-test.  The paired samples in the 
study of Kimball et al. (2007) had a slightly higher Pearson correlation than in the present 
study (0.95 vs. 0.82, respectively) and a lower mean difference between them (0.0 vs. -
0.7), respectively.  Therefore, both studies showed low variability and high inter-observer 
reliability.   
The slightly higher inter-observer correlation in the study of Kimball et al. (2007) 
as compared to the present study may be explained by three important differences in the 
experimental design.  First, in the study of Kimball et al. (2007) UBP was measured with 
subjects positioned supine-0º HOBE with a 50 ml bladder instill volume, while in the 
present study subjects were positioned in the supine-30º HOBE with a bladder instill 
volume of 25 ml.  This is important because of the volume-position interaction affects 
UBP as demonstrated in this study.  Second, but equally important, is related to the 
position of the pressure transducer, which remained fixed at the symphysis pubis and was 
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not re-leveled or re-zeroed between UBP measurements in the study of Kimball and 
colleagues (2007) while in the present study the pressure transducer was re-leveled and 
re-zeroed, and the entire monitoring system was re-checked and a square wave test was 
performed between UBP measurements.  Thus, the paired sample data obtained in the 
present study not only reflects the administration of NSS, and the variability of reading 
the monitor as in the study of Kimball and colleagues (2007) but also includes the 
variability added to the measurement due to differences in transducer positioning, 
leveling, and square wave testing between nurses.   
Lastly, the study of Kimball et al. (2007) had a larger study population (18 vs. 10) 
as compared to the present study as well as a larger sample size (181 vs. 10 paired 
samples).  However, in the study of Kimball et al. subjects contributed anywhere from 1 
to 39 paired samples for analysis and some of the paired samples were excluded from the 
analysis because they exceeded the collection time.  Omitting data from the analysis and 
having a few subjects contribute a large number of the sample data points will bias the 
data towards a lower variability and higher correlation.  In contrast, the present study had 
10 subjects who each contributed one data set and no data set was omitted from the 
analysis. 
The high inter-observer reliability of UBP measurement found in this study has 
several major clinical relevancies.  First, it demonstrates that it is possible for different 
observers to obtain highly reproducible UBP measurements with subjects in the supine-
30º HOBE position if a standardized protocol is followed.  This is important in clinical 
practice where patients are cared for by more than one nurse in a day and UBP 
measurements are taken more than once per day, and this would be the position assumed 
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by patients when receiving enteral nutrition.  Second, it adds to the current literature that 
confirms and validates the previous results of Kimball et al. (2007) obtained on subjects 
in the supine-0º HOBE.  Finally, it contributes new nursing knowledge for performing 
bedside UBP measurement that is evidenced based.   
Research Question 4:  What is the Intra-Observer Reliability of UBP Measurements?   
Intra-observer reliability of UBP measurement was determined in the present 
study by comparing the two pairs of UBP measurements taken by the PI in the 10 
subjects randomized to the supine-30º HOBE.  The results demonstrated a very high 
Pearson correlation between the two pairs of measurements obtained with bladder instill 
volumes of 0 ml and 25 ml.  In addition, there was no difference in mean values of the 
paired measurements by paired t-test.  The bias and the limits of agreement between the 
measurements were calculated with the Bland-Altman analysis and both were lower 
when the measurements were taken with a bladder instill volume of 25 ml than as 
opposed to being measured with a bladder instill volume of 0 ml.  This data indicates that 
a bladder instill volume of 25 ml reduces the variability of repeated measurements and 
therefore increases the intra-observer reliability of UBP measurements.  The intra-
observer reliability of UBP measurement from this study is in agreement with the study 
of Kimball et al. (2007) despite the differences in methodology and design as described 
above. 
The clinical importance of these findings is that this is the first study to show that 
intra-observer reliability of UBP measurement in the supine 30º-HOBE is very high and 
similar to what others have measured in the supine-0º HOBE. 
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Research Question 5:  What Other Factors Influence UBP Measurements?   
The purpose of the fifth question was to assess the effect of select clinical 
variables on UBP.  The variables selected for the analysis a priori were age, gender, Body 
Mass Index (BMI), net fluid balance (NFB), positive airway pressure (PAP) by 
evaluating respiratory or ventilatory status, and paralytic agents.  Additionally, length of 
stay (LOS), the use of enteral nutrition (EN) via an enteral feeding tube, and the presence 
of abdominal pathology were added to the analysis post data collection.  The question 
was explored by investigating the relationship of the above listed variables when the UBP 
was measured in the supine-30º HOBE position with an instill volume of 0 ml or 25 ml 
using multiple linear regression analysis.  Very few subjects who were enrolled into the 
study were treated with mechanical ventilation or paralytic agents.  Therefore, the 
influences of PAP and paralytic agents could not be adequately tested.  The multiple 
regression analysis found that the most influential variables on UBP were BMI, EN, 
LOS, and NFB. 
Of these variables, BMI appears to be the most important because it was a 
significant factor in all three predictive equations and accounted for a relatively large 
portion of the variability of UBP measurements.  The effect of BMI on UBP is likely due 
to its direct relationship with intra-abdominal fat (Lambert, Marceau, & Forse, 2005).  
The intra-abdominal fat acts as another solid organ that may greatly affect intra-
abdominal volume and may also exert a significant gravitational effect on UBP 
measurement.  Other investigators have also found a direct link between BMI and UBP 
(Sanchez et al., 2001; Sugerman et al., 1998; Sugerman et al., 1997; Vasquez et al., 
2007). 
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In a series of studies during the early 90’s Dr. Harvey Sugerman and associates 
(1998; 1997) from the Medical College of Virginia were the first to show that UBP and 
BMI were positively related.  In this series of experiments, these investigators found that 
morbidly obese individuals have elevated UBP which decreases with weight loss.  In 
these studies, the first UBP measurements were taken while the subjects were 
anesthetized and sedated before open gastric bypass and the second UBP measurement 
was taken one year later after the subjects lost an average of 50 kg.  Urinary bladder 
pressure was measured using a manometric technique and a100 ml bladder instill volume.  
The UBP measurement before surgery was approximately 18 cm H2O (13.5 mmHg) and 
fell to approximately 10 cm H2O (7.4 mmHg) after weight loss a year later.  Sanchez et 
al. (2001) also showed higher UBP values in obese subjects.  Using data collected in 97 
subject who participated in a multicenter-epidemiological study of the prevalence of IAH 
in CCUs throughout Europe, Malbrain et al. (2004) also found that obese subjects (BMI 
> 30 kg/m
2
)  were associated  with IAH (UBP > 12 mmHg).  More recently, Vasquez and 
associates (2007) measured UBP in 45 subjects in the supine position with different 
degrees of HOBE and found that at all positions studied, obese subjects (BMI >30 kg/m
2
) 
had significantly higher UBP measurements than subjects who were overweight (BMI 
25-29.99 kg/m
2
) and normal weight (BMI 18.5- 24.99 kg/m
2
).   
The current study also found a positive relationship between UBP and net fluid 
balance.  This is consistent with a recent report of Daugherty and colleagues (2007) who 
found IAH and ACS in medical subjects who had a NFB > five liters.  The present 
findings are also consistent with other studies that have also reported a positive 
relationship between UBP and the amount or rate of fluid resuscitation (Balogh, 
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McKinley, Holcomb et al., 2003).  Aggressive crystalloid administration is common in 
patients admitted to CCUs because frequently hypotension due to sepsis or bleeding 
occurs prior to admission.  These patients are aggressively resuscitated early and 
vigorously with intravenous crystalloid fluid administration and blood products such as 
packed RBC transfusions as well as vasoactive agents.  This strategy has been found to 
decrease mortality with improvements in other clinical outcomes (Rivers et al., 2001) but 
it is also associated with fluid overload (O'Mara et al., 2005) and the development of 
ACS (Balogh, McKinley, Cocanour et al., 2003).    
The multiple linear regression analysis discovered UBP to be inversely related to 
LOS and EN.  These results were unexpected and were not part of the a priori analysis, 
but were detected in the post hoc analysis of the data.  The LOS in this study ranged from 
one to 50 days with an average of 4.8 ± 6.9 days.  There are two possible explanations for 
these findings.  First, patients who require admission to CCUs frequently receive 
aggressive fluid resuscitation that can lead to ascites and intestinal edema putting them at 
higher risk for increased IAP (Balogh, McKinley, Cox et al., 2003).  Likewise, patients 
undergoing abdominal surgery or who have experienced abdominal trauma are at risk of 
developing ACS and also develop IAH during the first 24 hours after admission to CCUs 
which progressively decreases over time (Biancofiore et al., 2003).    Therefore, longer 
LOS may be a marker of less severity.  Second, LOS may be a marker for longer duration 
of urinary bladder catheterization.  De Waele (2006) observed that prolonged urinary 
bladder catheterization was associated with higher UBP.  A possible explanation for this 
observation is that continuous drainage decreases bladder compliance thus resulting in 
higher UBP.  Hypocompliance of the urinary bladder has been observed in other patients 
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requiring prolong catheterization such as patients with spinal cord injury (Hackler, Hall, 
& Zampieri, 1989). 
The inverse relationship of UBP and EN found in this study is compatible with 
the original hypothesis of the PI that UBP may be used as a predictor of enteral feeding 
tolerance.  It indicates that the use of EN in the critically ill is linked to lower UBP.  
From this finding it can be inferred that high UBP values will be linked to enteral feeding 
intolerance.  However, the study was not designed to enterally feed all subjects and it was 
not powered for this factor.  Therefore, it is not possible to reach any conclusion 
regarding EN and UBP.     
 It should be pointed out that the predicative equations that that resulted 
from this study explained no more than 30% of the variability of UBP.  Other factors that 
may contribute to UBP variability remain to be identified.  The results of this study 
demonstrate that age, sex and ethnicity did not contribute to the variability of UBP.  The 
lack of a relationship with age and gender with UBP has been observed by other 
investigators as well (Frezza, Shebani, Robertson, & Wachtel, 2007; Sanchez et al., 2001; 
Sugerman et al., 1997).  Clinical factors that have been previously identified as potential 
contributors to UBP, such as mechanical ventilation and sedation were part of the a priori 
analysis of this study.  Unfortunately, they could not be evaluated because very few 
subjects were recruited with these conditions.  Other clinical indices that are measures of 
severity of illness, such as the APACHE or SOFA score may also be useful to explain 
some of the variability.  In addition, the position of the transducer and other nursing 
factors related to the performance of UBP measurement, such as years of experience, 
knowledge and expertise in hydrostatic pressure measurements may also contribute to 
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variability.  Lastly, other factors such as the length, material and compliance of the 
urinary catheter may contribute to some variability of UBP measurement. 
Research Question 6:  What are the Elements of an Evidenced based Protocol Necessary 
for CCNs to Reliably Perform Bedside UBP Measurement?  
The sixth and final research question aimed to identify the elements of an 
evidenced based protocol necessary for CCNs to reliably perform bedside UBP 
measurement based on the results of the study.  The observations and recommendations 
made below are based on the experience of the PI obtained during the study who 
performed 498 UBP measurements in 120 subjects who were in one of four different 
body positions and one of three bladder instill volumes.  This is the largest data set for 
UBP measurement for a single individual reported thus far.  Vasquez and colleagues 
(2007) reported 675 measurements on 45 subjects but each subject was measured 3 times 
in five different positions to obtain an average UBP measurement for each position.  
Therefore, statistically the data set is 225 UBP measurements.  In addition, it is not clear 
from their report if the data was obtained by the same person or if it was obtained by a 
nurse, a physician or a technician.  There were two other reports by Malbrain and 
colleagues with 97 subjects (2004) and 265 subjects (2005), respectively.  Both of these 
studies were multi center studies and UBP was measured by different observers and it 
was not clear if a standardized procedure was used. 
UBP is a relatively simple technique that is within the scope of practice of most 
CCNs.  However, like other technical skills, nurses will need to acquire procedural 
knowledge and technical skills to obtain reliable results.  Several aspects of the bedside 
process of UBP measurement include:  subject position, bladder instill volume, pressure 
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transducer position, equipment, education and training, and patient related variables.  
Each one of these will be discussed.   
Subject position 
The results of the present and other studies found that subject’s position is one of 
the factors that affect UBP measurement.  The WSACS recommends that UBP be 
measured in the supine-0°HOBE position only but a rationale for the exclusive use of this 
position is not given.  Of all the body positions pertinent to the care of the critically ill 
patients that have been studied to date, the supine-0° HOBE position gives the lowest 
estimate of UBP and it is in principle a body position that is easy to standardize.    In 
addition, this is a position that is used in laboratory studies by physicians but is not a 
position that is commonly used in critically ill patients.  The supine-0° HOBE position is 
not common in CCU and changing patients to the supine position only for the purpose of 
measuring UBP is time consuming, and places patients at high risk for developing 
aspiration pneumonia and equipment dislodgment.  Furthermore, there are patients who 
cannot assume this position because of pulmonary compromise.  Therefore, it is 
important that an alternative body position be available for these patients.  In this study 
UBP was assessed in four of the most common positions used in critical care.  Based on 
the results of this study, the position that is best suited for UBP measurement is the 
supine-30º HOBE.  The arguments in favor of this position are: 
a. The supine-30° HOBE is the standardized position favored in CCUs to 
reduce aspiration and ventilator associated pneumonia. 
b. The supine-30° HOBE allows patients to have UBP measurements taken 
in the most frequently used CCU position and will result in less UBP 
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variability due to patient factors that may be caused by changes in 
position.  As a matter of fact, once patients have UBP measurements taken 
in the supine-0º HOBE position they are returned to the more common and 
usual supine-30° HOBE position which will result in a relatively higher 
UBP. 
c. The supine-30º HOBE position has intra- and inter-observer reliability 
comparable with the supine-0º HOBE (Figure 24). 
d. The supine-30º HOBE will permit EN administration and there is no need 
to hold EN during the UBP measurement.  Therefore, a higher delivery of 
nutrients will be possible and is a goal in critically ill patients. 
e. The supine-30º HOBE position will promote greater patient comfort. 
f. The supine-30º HOBE position will decrease CCN nurse work load and 
increase efficiency.   
However, it is important to recognize that the supine-30º HOBE position results in 
UBP measurements that are on average three to five mmHg higher than UBP 
measurement taken in the supine-0º HOBE.  This difference is large enough to warrant a 
change in the definition of IAH and ACS.  This means that the definition of IAH and the 
grades of IAH will need to be revised upward if the supine-30º HOBE position is 
accepted as a standard for UBP measurement. 
 
Bladder Instill Volume 
The results of this study demonstrate that the amount of NSS instilled into the 
bladder before UBP measurement affects the absolute value and also the reliability of 
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UBP measurements.  In general, the higher the bladder instill volume the higher the UBP, 
but UBP values are not always linear when position is considered.  It should be pointed 
out that UBP does not increase as volume increases in certain positions, because of the 
volume-position interaction (Figure 18).  Accepting the volume-position interaction, it is 
possible to find that a higher bladder instill volume may produce a lower UBP value.  On 
average, lower UBP values were obtained with  0 ml and 25 ml bladder instill volumes as 
compared to 50 ml and 200 ml bladder instill volumes but each instill volume yielded 
reasonable results in selected subjects.  However, the use of 0 ml bladder instill volumes 
resulted in negative UBP values.  In subjects positioned in the supine-0° HOBE position 
negative UBP values were found 17.5 % of the time, while in subjects positioned in the 
supine-30° HOBE position rarely had negative UBP measurements (1.3 %).  In addition, 
the intra- and inter-observer reliability was lower in the supine-30° HOBE position with a 
0 ml volume as compared to the 25 ml instill volume.  The use of a 200 ml instill volume 
was associated with higher UBP values, lower abdominal perfusion pressure (APP) 
values, and overestimation of IAH in both positions.  Based on these considerations an 
instill volume > 0 and ≤ 25 ml produces UBP measurements with the higher reliability.  
Some investigators (De Waele et al., 2006) have recommended the use of bladder instill 
volumes as low as 10 ml for UBP measurement as this was the smallest volume that 
produced a positive oscillation test which is the generation of a waveform on the bedside 
monitor by manual palpation of the lower abdomen over the urinary bladder.  However, 
this recommendation is not based on important physiological, clinical, or statistical 
principles but rather on a mechanical action and should not be used a criterion for 
selecting the best instill volume to use for UBP measurement.   
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Pressure Transducer Position 
UBP is measured via a fluid filled catheter and is based on hydrostatic pressure 
principles.  When properly assembled this system is capable of transmitting accurate 
pressure waveforms, but for quantitative assessment of pressure the fluid in the chamber 
of interest must be referenced to the fluid filled system.  To accomplish this, the open end 
of the measuring catheter in the fluid filled chamber must be referenced to an external 
anatomic landmark and the system opened to atmospheric pressure to establish a common 
zero pressure reference.  In this technique the only factor that determines the magnitude 
of the pressure of the chamber is the relationship of the transducer to the anatomic 
landmark.  The height of the external transducer to the uppermost fluid level in the 
chamber in which the pressure is being measured determines the pressure.  Therefore, 
UBP may be under- or over-estimated depending on the position of the pressure 
transducer to the level of fluid within the bladder.  The optimal placement of the pressure 
transducer to measure UBPs is still unknown and was not investigated in the present 
study.   
Traditionally the pressure transducer has been placed at the level of the symphysis 
pubis as was done in the present study.  Recently, the WSACS recommended the pressure 
transducer be positioned at the intersection of the mid-axillary line and the iliac crest 
because these are anatomic landmarks that are easily identifiable.   However, the WSACS 
has failed to produce data on how the UBP measurement would differ from the previous 
recommendation to use the symphysis pubis.  It could be predicted that the proposed 
leveling of the transducer at the cross-section of the mid-axillary line at the iliac crest will 
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change as the position of the patient changes.  In the supine-0° HOBE position there may 
not be an error but in the supine-30° HOBE position and or the lateral positions 
differences may be observed.   
The symphysis pubis is also an easily identifiable anatomic landmark and is the 
closest reference point to the bladder.  The only difficulty of leveling the pressure 
transducer to the symphysis pubis found in this study was in the very obese patient with a 
large pannus. Therefore, until further data is forthcoming, the external transducer is to be 
leveled and zeroed at the symphysis pubis, because it is theoretically the external 
landmark most reflective of the urinary bladder.   
 
Standardized Equipment 
The procedure for measuring UBP has undergone several modifications since the 
original description in 1984 by Kron and colleagues (1984).  The latest modification of 
this technique is the use of commercially available kits for UBP measurement.  One of 
the kits available is the AbViser™.  This kit has all the necessary components to connect 
the urinary drainage catheter to the external monitoring system. By using this kit the 
potential for variability is reduced.  Using the home-made “Jerry-rigged” set up for 
measurement of UBP allows for additional errors in measurement.  The only 
disadvantage of using the AbViser™ kit is the cost but considering the cost and time 
expended in assembling a home-made system and the multiple errors in measurement that 
are possible the cost differential is acceptable.  Furthermore, the possibility of infection 
with the home-made kit is greater (Iberti et al., 1989).   
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Education and Training 
Measurement of UBP by hydrostatic principles is similar to the technique of 
hemodynamic pressure measurements commonly performed in CCUs around the world.  
Thus, most experienced CCNs will have a basic understanding of the principles and 
mechanics of hydrostatic UBP measurements.  However, the reliability of hemodynamic 
measurements taken by nurses is low and similar findings are to be expected when nurses 
measure UBP as well if they are not properly trained.  This study showed a high intra- 
and inter-observer reliability between experienced CCNs.  To minimize variability, 
nurses should undergo education, training, and supervision until they are proficient in 
UBP measurements and before independently measuring UBP.  Based on the experience 
of this PI, 10-20 supervised measurements are required before a CCN would be consider 
proficient in UBP measurements. 
 
Clinical Variables  
All subjects were measured in Hill-Rom
®
 total care beds.  Subjects in beds that 
did not have a solid mattress and a mechanism to elevate the HOB at 30° were not 
selected for the study.  Therefore, it was easy to standardize the position.  Any patient 
who required an air or an air-fluid bed was excluded from the study.   
The majority of urinary catheters were latex or silicone urinary drainage catheters 
manufactured by Bard
®
.  Several subjects had catheters that were thermometric.  The 
material of the catheter is important as the compliance of the plastic plays a role in the 
conductivity of the pressure from the bladder to the monitoring equipment, and a stiffer 
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and smaller caliber catheter may produce different results.  The effect of the catheter 
material was not investigated in this study. 
 
Limitations of the Study 
The major limitation of the study was in subject recruitment.  Unfortunately the 
very critically ill subjects who where ventilated and sedated were not accessible to the PI 
secondary to restrictions of patient privacy and access.  Also very few minorities were 
enrolled.  However, evaluating UBP in a critical care setting with subjects not at risk for 
IAH provides data that has not been reported before.   
Another limitation of the study was that only selected bladder instill volumes 
were studied and limited to three volumes 25 ml, 50 ml and 200 ml.  It would have been 
desirable to have subjects randomized to a 0 ml volume group.  In addition, using an 
instill volume of 100 ml as opposed to 200 ml may have produced more interpretable and 
meaningful data.   The 200 ml instill volume clearly produced UBPs that were in excess, 
and exhibited extreme variability. 
 
Future Research 
The findings of this study are important and have many clinical implications for 
the bedside measurement of UBP in the critical care setting and also raise many other 
interesting research questions worthy of investigation by nurses.  
1.)   Prospective research studies are recommended to: 
a. Investigate the optimal position for placement of the pressure transducer. 
b.  Re-define IAH and ACS using the supine-30° HOBE. 
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c. Use UBP as a predictor of enteral nutrition tolerance in critically ill patients. 
d. Evaluate UBP measurement in other types of beds  
e. Evaluate UBP measurement using different urinary bladder catheters to 
evaluate the effect of the catheter in transmitting wave forms.   
2.)  A longitudinal study is recommended to assess the diurnal variation of UBP.  
 
Summary and Conclusion 
UBP measurement is the gold standard technique for estimation of IAP in patients 
admitted to CCUs.  Urinary bladder pressure is measured at the bedside by CCNs based 
on hydrostatic pressure principles using a modification of the technique originally 
described by Kron and colleagues (1984).  Experts recommend that UBP be measured in 
most patients admitted to CCU to monitor the resuscitation efforts and to monitor for 
ACS (Malbrain et al., 2007).  Urinary bladder pressure measurement is a responsibility 
that has been transitioned to the CCN.  Therefore, it was important that the nursing 
process for UBP measurement be subjected to rigorous clinical testing before it becomes 
wide spread and avoids the pitfalls that have been associated with hemodynamic pressure 
monitoring (Dalen & Bone, 1996).  In addition, if UBP is to be investigated as an 
objective measure of enteral feeding tolerance, the procedure and process of the UBP 
measurement technique must be reliable to insure consistent interpretation and clinical 
decisions.  Otherwise, clinical decisions will be fraught with error.    
A review of the literature revealed a lack of consensus for the optimal body 
position patients should assume when measuring UBP as well as the amount of bladder 
instill volume needed for UBP measurement.  The current research was undertaken to 
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answer five questions related to body position, amount of instill volume, intra- and inter-
observer reliability, and other factors that may influence UBP measurement in the CCUs.  
A sixth question was to describe the elements of an evidence based protocol necessary for 
reliable measurement of UBP.  Answers to these questions are necessary if the 
application of UBP measurement as a tool for enteral feeding tolerance is to be 
investigated.   
The findings of this study demonstrate that the effect of volume and position in 
UBP measurement is complex and there are significant interactions of body position and 
bladder instill volume on UBP measurement.  In addition, it demonstrated that when this 
research protocol is followed, UBP measurements have high intra- and inter-reliability 
and are influenced by BMI, NFB, LOS, and EN; but not age or gender. The conclusions 
of this study are strengthened by the experimental design, the large heterogeneous sample 
size and by having all measurements performed by the same nurse observer.  Utilizing 
the technique of UBP measurement investigated in this study, all future research can be 
comparable because the measurement of UBP will be standardized.  The greatest 
contribution of this study is the provision of a common denominator for all future UBP 
research.   
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Appendix A Subject screening, enrollment, and randomization log 
Screening, Enrollment, Randomization Log 
Date:      Time:      
Location:   Trauma NICU  SICU  CCU  MICU 
Initials FML Date of Birth Randomization 
Group 
Medical Record 
Number 
    
 
Preliminary Consent Signed:    NO   YES 
Age: >18      NO   YES 
Presence of Urinary Bladder Catheter:  NO   YES 
 
Bladder perforation     YES   NO 
Bladder tumor      YES   NO 
Hematuria      YES   NO 
Neurogenic bladder     YES   NO 
 
Anuria       YES   NO 
 
Pregnant      YES   NO 
 
Unable to assume body positions    YES   NO 
 
 
Eligible for study:     NO          YES 
 
Study Number:    
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Appendix B Data Collection Form 
Subject Demographics 
 
Study Date   Hospital LOS in 
days 
 
Study ID #  ICU LOS in days  
Age  Hospital ICU  
Gender  Enteral nutrition Type                  Rate 
Race  MAP @ UBP   
 
Randomization  
Study group (1-12)  
Instill volume  25 ml 50 ml 200 ml 
Body position Supine-0º Supine-30º RL-30º LL-30º 
 
UBP Measurements 
Measurement  
Set 1 
PI 
Supine-30° HOBE  0 ml @  
                  AM/PM 
25 ml @  
                  AM/PM 
MAP mmHg mmHg 
Measurement   
Set 2 
PI 
Randomized P & V 0 ml @  
          AM/PM 
25, 50, 200  ml @  
                  AM/PM 
MAP mmHg mmHg 
Measurement  
Set 3 
Nurse Co-
investigator 
Supine-30° HOBE  0 ml @  
            AM/PM 
25 ml @  
                AM/PM 
MAP mmHg mmHg 
 
Other Variables 
Usual 
weight 
 ICU 
weight 
 Height  
Net LOS fluid balance mls   
Respiratory/ 
Ventilatory Status 
None AC SIMV PS 
PEEP BiPAP CPAP 
Paralytic 
agents 
Name and dose: 
 
Medical/ Surgical Diagnoses 
1.   6. Notes: 
2.  7. 
3.  8. 
4.  9. 
5.  10. 
Remarks:  
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Appendix C: Progress Notes 
 
 195 
 
 
Appendix D Informed Consent 
 
Allegheny Singer Research Institute-Allegheny General Hospital 
First informed consent:     November 27, 2006 
  
Duquesne University 
First informed consent     February 2, 2007 
 
Allegheny Singer Research Institute-Allegheny General Hospital 
Second approval following ASRI-AGH annual review September 19, 2007   
 
 
 
Duquesne University 
Review following ASRI-AGH annual review February 2, 2007 date moved 
to lower left corner 
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subject has an equal chance of being placed in any one of the 12 groups.  Each group will have 10 
subjects.  One of the doctors that are taking care of you will ask you to participate in the study.  
These doctors can be your primary care doctor (that is the doctor who took care of you prior to 
your admission to the hospital or the surgeon who did your operation) or one of the doctors who 
are experts in critical care that has been asked by your primary care doctor or surgeon to help take 
care of you while you are critically ill.  Many of these doctors are co-investigators for this study 
along with Dr. Jorge A. Vazquez, medical nutritionist.   
 
If you agree to participate in this study, your primary care doctor, your surgeon or the critical care 
doctors, will continue to provide you with the best care they believe necessary.  In addition, one 
of these doctors will order the urinary bladder pressure measurement be taken according to the 
group you are assigned by the randomization process.  You will have your urinary bladder 
pressure measured in one of the 12 possible and different ways.  Eleven of the 12 groups will 
have 2 sets of bladder pressures measurements taken by Melanie Shuster, RN and 1 of the 12 
groups will have 3 sets of bladder pressure measurements taken.  The first 2 measurement sets by 
Melanie Shuster, RN and the third set by Tammy Haines, RN.  One set of bladder pressure 
measurement consists of two measurements:  one measurement taken before any sterile liquid 
(salt water) is added to the bladder and the other one is taken after a fixed amount of sterile liquid 
(salt water) is added to the bladder.  All bladder pressure measurements will be taken within a 30 
minute period.   
 
To measure the urinary bladder pressure a small valve will be attached using sterile technique to 
your bladder catheter, which is outside your body, and this valve will also be attached to the 
hospital monitoring system.  You will then be positioned in bed lying on your back with the head 
of the bed elevated to 30 degrees.  A bladder pressure measurement will be taken by Melanie 
Shuster, RN when you are comfortable with no added sterile salt water in your bladder and again 
after twenty-five milliliters (about one ounce) of sterile salt water is added to your bladder.  After 
the first set of measurements, Melanie Shuster, RN will reposition you to be either lying on your 
back with the head of the bed flat with a pillow under your head, or lying on your right or left side 
with the head of the bed elevated to 30 degrees with a pillow under your head and one pillow 
between your knees.  Your back will be supported with a foam wedge and your head will be 
supported with a pillow under the right or left side of your face if you are lying on your side.  
These are usual positions patients normally assume while sleeping at home or while in ICU’s.  
See the following pictures of the positions subjects will be placed in for the measurement of 
urinary bladder pressure.   
 
The remainder of the page is left intentionally blank.   
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Table 1.  Study groups for bladder instill volume and subject position 
Group Position Instill Volume Nurse 
1 
 
25 ml Melanie Shuster, RN 
5 See Above 50 ml Melanie Shuster, RN 
9 See Above 200ml Melanie Shuster, RN 
2 
 
25 ml 
Melanie Shuster, RN 
Tammy Haines, RN 
6 See Above 50 ml Melanie Shuster, RN 
10 See Above 200 ml Melanie Shuster, RN 
3 
 
25 ml Melanie Shuster, RN 
7 See Above Right Side Lying 50 ml Melanie Shuster, RN 
11 See Above Right Side Lying 200 ml Melanie Shuster, RN 
4 Same as above Left Side Lying 25 ml Melanie Shuster, RN 
8 Same as above Left Side Lying 50 ml Melanie Shuster, RN 
12 Same as above Left Side Lying 200 ml Melanie Shuster, RN 
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Once you are comfortable and settled in the next position, another set of bladder pressure 
measurements will be taken by Melanie Shuster, RN.  The first measurement will be taken before 
any sterile salt water is added to the bladder and the other measurement will be taken after 
approximately 1, 2, or 6 ounces of sterile salt water is added to your bladder.  You will receive 
only one of the 3 amounts of sterile salt water listed above and you will assume only one of the 4 
positions shown above.  You will only be in this position for just as long as necessary to complete 
the two sets of urinary bladder pressure measurements. 
 
If you are one of the 10 subjects assigned to group 4, (see shaded area in Table 1) you will have 3 
sets of bladder pressure measurements taken.  You will be kept in bed lying on your back with the 
head of bed elevated to 30 degrees for all 3 sets of bladder pressure measurements.  The third set 
of bladder pressure measurements will be taken by Tammy Haines, RN.   
 
Each set of measurements takes two to five minutes and the whole study will be done in 30 
minutes or less.  All the measurements will be taken on the same day and will not be repeated 
again regardless of how long you stay in the ICU.  After all measurements are completed, 
Melanie Shuster, RN or Tammy Haines, RN will reposition you to the most comfortable position 
for you.   
 
Your hospital record will be reviewed and your date of birth, date of hospital admission, reason 
for hospital admission, and the type of treatment you received will be recorded on a separate 
piece of paper. All information taken from your record will be kept confidential and you will not 
be identified on this piece paper. 
 
This is an observational study and no further diagnostic or therapeutic treatment is planned as part 
of the study regardless of the value of the urinary bladder pressure measurement.  However, the 
values of the urinary bladder pressure will be made available to your primary care physician and 
the critical care team physicians.  They will decide if additional testing or treatments are 
necessary which will be outside of the study protocol.   
 
The remainder of this page left intentionally blank.
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Risks:  The risks for participating in this study are minimal.  You will receive routine care as 
necessary for your medical or surgical condition and participating in this study will not delay or 
alter your treatments in any way.  The placement of the urinary bladder catheter is considered a 
standard of care for nearly anyone in the ICU.  Bladder pressure is measured in selective subjects 
admitted to ICU’s at Allegheny General Hospital and is routinely measured in many other 
hospitals in the United States and Europe.  The bladder pressure will be measured using a Federal 
Drug Agency (FDA) approved device called the AbViser™ that is placed very carefully on the 
outside end of the urinary bladder catheter while maintaining a sterile condition.  Thus, there is a 
very small risk of developing a urinary tract or other infection because it is necessary to open the 
urinary catheter drainage system for a brief moment when attaching this device, but the attaching 
the device will be done under sterile conditions.  Urinary bladder pressure measurement is 
painless and quick; each set of measurements takes two-five minutes to complete.  There may be 
a temporary physical discomfort when you are positioned into one of the four positions for 
measurement and a small chance that medical equipment will get disconnected.  However, most 
ICU patients are placed in these positions for routine nursing care at some time during a 24-hour 
period and every precaution will be taken to prevent these problems.  There is no anticipated 
physical, metabolic, social, psychological, legal, or financial risk associated with participation in 
the study. 
 
This is an observational study and no further diagnostic or therapeutic treatment is planned as part 
of the study regardless of the value of the UBP measurement.  However, the values of the urinary 
bladder pressure will be made available to your primary care physician and the critical care team 
physicians.  They will decide if additional testing or treatments are necessary which will be 
outside of the study protocol.    
 
There is a very small but real risk of losing confidentiality.  Your medical record will be reviewed 
to extract only the information needed to complete the study.  A separate piece of paper will be 
created to keep the information that is gathered during the study.  To minimize the risks of losing 
confidentiality the people reviewing your medical record will be limited to the principal 
investigator.  The least amount of information needed for the completion of the study will be 
collected.  A study specific identification number will be assigned to you at the beginning of the 
study and most personal or confidential data such as your social security number, home address, 
telephone number, insurance information that could identify you will not be collected.  
 
Common risks 
(Incidence >10%) 
Less Common Risks 
(Incidence >1%-<10%) 
Rare Risks 
(Incidence < 1%) 
Minor risks: 
 None 
Severe risks: 
 None 
Minor risks: 
 None 
Severe risks: 
 None 
 
Minor risks: 
 Urinary tract 
                           infection 
 
Benefits:  There are no immediate direct benefits to you by participating in this study although 
the information obtained may be of benefit to other patients in similar conditions in the future.  
You may benefit immediately because you will be monitored more intensively than other patients 
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in the ICU.  All information gathered by, the researcher will be available to the primary care 
physician and critical care team.   
 
Alternative procedures:  You may choose not to participate in this study.  
 
Costs and Payments:  The cost of routine medical care provided to you while in the ICU will be 
billed to your medical insurance.  Participating in this study will not increase the cost of your ICU 
care.  Neither you nor your insurance company will be billed for the costs of measuring the 
bladder pressure.  The costs of the AbViser® device used to measure your bladder pressure will 
be paid for by funds provided through a grant or will be provided by the manufacturer.  You will 
not receive payment for participation in this study. 
 
Confidentiality:  Information obtained about you as a result of participation in this study will be 
kept strictly confidential, however as with all medical records, they may be obtained with a court 
order.  The research records that will be created for this study will be kept separately and are not 
part of your hospital medical record.  Your identity, medical records, and data related to this 
study will be kept confidential, except as required by law and except for inspections by the Food 
and Drug Administration (FDA) and the Institutional Review Board of Allegheny General 
Hospital (the committee that oversees research).  Results of the research may be published or 
presented to scientific groups, however, your identity will not be revealed.  
 
Compensation:  You have been informed and acknowledge that in the event of your voluntary 
participation in this research protocol results in the need for you to receive medical care, that no 
money or free medical care will be made available to you by Allegheny General Hospital or 
Allegheny-Singer Research Institute. 
 
Research Study Authorization of Protected Health Information & HIPAA Authorization: 
 
In 1996 the government passed a law known as The Health Insurance Portability and 
Accountability Act (HIPAA), Public Law 104-191. This law, among other things will improve 
how your health care information is protected and kept confidential when it is shared with others. 
This includes your medical records and insurance information as well as other personal health 
information. It also assures that everyone who shares this information will have to follow this 
law. This consent form describes to you how information about you may be used or shared if you 
are in a research study. It is important that you read this carefully. 
 
In order to participate in this research study, you must permit (allow) certain research records to 
be made about you in addition to the usual records the hospital and doctors create about your 
medical treatment.  These research records will contain private medical and other information, 
which is protected by law.  The researchers will only create the minimum amount of research 
records necessary to carry out the research.   
 
Type(s) of research records that may be shared is (are): 
 Tissue Samples: 
X    Medical Records:  Medical and surgical history, medication history 
 Lab Results: 
 Other: 
 
In addition to using these research records to carry out the research and, perhaps, to treat you, the 
researchers will share portions of these research records to third parties involved in the research 
study. The third parties, who receive research information, may further share the information 
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about you in accordance with their policies, practices and what the law requires.  However, some 
third parties (such as the Sponsor) may not need to follow the HIPAA law. To the best of our 
knowledge, a complete and accurate description of who the third parties are and how they will 
use or share the information are as follows: 
 
                  THIRD PARTY      PURPOSE 
 
Allegheny General Hospital  
Allegheny-Singer Research Institute 
 
 
 
May share this signed consent form and records that 
identify you to meet regulatory requirements or for 
purposes related to this research. 
 
 
The release of information described above will be the minimum necessary to abide by the law 
complete the research, and, perhaps, publish the research.   
 
Unlike your medical records, you will not have access to research records made about you. 
Although every effort will be made to keep research records about you private, complete 
confidentiality cannot be guaranteed.  Such research records may be subject to subpoena or court 
order.  The researcher has set up safeguards to keep private information about you confidential.   
 
There is no expiration for this Authorization unless you revoke (cancel) it. You may revoke this 
Authorization by writing to the Principal Investigator.  If you revoke your Authorization, you will 
also be removed from the study. Revoking your Authorization only affects the use and sharing of 
your information after the written request is received.  Any information obtained prior to 
receiving the written request, may be used to maintain integrity of the study. 
Principal Investigator Address: Melanie Shuster, RN 
 Allegheny Center for Digestive Health 
 1307 Federal Street, Suite 301 
 Pittsburgh, PA 15212 
  
If you choose to not sign this Authorization, you will not be permitted to participate in this 
research study.  In order to participate in this study, you must agree to share your information 
with the groups above.  Upon completion of the study, or if you withdraw from the study at any 
time, the research records about you will be kept by the researcher (s) and all of the information 
provided above will continue to apply to your research records. 
 
You give permission that your research records can be used and disclosed as described. 
 
Voluntary Participation/Right to Withdraw:  Participation is voluntary, and refusal to 
participate will involve no penalty or loss of benefits to which you are otherwise entitled.   You 
are free to refuse to participate in this study.  If you agree to participate, you are also free to 
withdraw from the study at any time.  Your decision to refuse to      participate or to withdraw 
from the study will not adversely affect your care at this hospital. 
 
Inquires:  If you should you have any questions regarding your rights as a research participant, 
you may contact the Institutional Review Board of Allegheny General Hospital at 412.359.3156.  
Any questions about the research have been answered or will be answered to your satisfaction by 
Melanie Shuster, RN, at (412) 359-8958.  If you have any additional questions about the research 
you may contact the Investigators or the IRB Office (412) 359-3156.  In the event of a research-
related injury, you should -contact Melanie Shuster, RN at (412) 359-8958. 
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Recruitment:  The investigator is committed to comply with the basic principles of the NIH 
guidelines on inclusion of women and minorities in research and will make every effort to enroll 
subjects into the study from all minority groups. You will receive a signed copy of this consent 
form. 
 
Subject’s Name    _______________________________________ Date    
(Please Print) 
 
Subject’s Signature _____________________________    ________ Date    
Surrogate Decision 
Maker’s Signature                Date    
(If Applicable) 
 
Witness’ Signature        _______________________________________ Date    
 
Investigator’s Signature __________________________________ ____ Date    
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subject has an equal chance of being placed in any one of the 12 groups.  Each group will have 10 
subjects.  One of the doctors that are taking care of you will ask you to participate in the study.  
These doctors can be your primary care doctor (that is the doctor who took care of you prior to 
your admission to the hospital or the surgeon who did your operation) or one of the doctors who 
are experts in critical care that has been asked by your primary care doctor or surgeon to help take 
care of you while you are critically ill.  Many of these doctors are co-investigators for this study 
along with Dr. Jorge A. Vazquez, medical nutritionist.   
 
If you agree to participate in this study, your primary care doctor, your surgeon or the critical care 
doctors, will continue to provide you with the best care they believe necessary.  In addition, one 
of these doctors will order the urinary bladder pressure measurement be taken according to the 
group you are assigned by the randomization process.  You will have your urinary bladder 
pressure measured in one of the 12 possible and different ways.  Eleven of the 12 groups will 
have 2 sets of bladder pressures measurements taken by Melanie Shuster, RN and 1 of the 12 
groups will have 3 sets of bladder pressure measurements taken.  The first 2 measurement sets by 
Melanie Shuster, RN and the third set by Tammy Haines, RN.  One set of bladder pressure 
measurement consists of two measurements:  one measurement taken before any sterile liquid 
(salt water) is added to the bladder and the other one is taken after a fixed amount of sterile liquid 
(salt water) is added to the bladder.  All bladder pressure measurements will be taken within a 30 
minute period.   
 
To measure the urinary bladder pressure a small valve will be attached using sterile 
technique to your bladder catheter, which is outside your body, and this valve will also be 
attached to the hospital monitoring system.  You will then be positioned in bed lying on your 
back with the head of the bed elevated to 30 degrees.  A bladder pressure measurement will be 
taken by Melanie Shuster, RN when you are comfortable with no added sterile salt water in your 
bladder and again after twenty-five milliliters (about one ounce) of sterile salt water is added to 
your bladder.  After the first set of measurements, Melanie Shuster, RN will reposition you to be 
either lying on your back with the head of the bed flat with a pillow under your head, or lying on 
your right or left side with the head of the bed elevated to 30 degrees with a pillow under your 
head and one pillow between your knees.  Your back will be supported with a foam wedge and 
your head will be supported with a pillow under the right or left side of your face if you are lying 
on your side.  These are usual positions patients normally assume while sleeping at home or while 
in ICU’s.  See the following pictures of the positions subjects will be placed in for the 
measurement of urinary bladder pressure.   
 
The remainder of the page is left intentionally blank.   
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Table 1.  Study groups for bladder instill volume and subject position 
Group Position Instill Volume Nurse 
1 
 
25 ml Melanie Shuster, RN 
5 See Above 50 ml Melanie Shuster, RN 
9 See Above 200ml Melanie Shuster, RN 
2 
 
2ml 
Melanie Shuster, RN 
Tammy Haines, RN 
6 See Above 50 ml Melanie Shuster, RN 
10 See Above 200 ml Melanie Shuster, RN 
3 
 
25 ml Melanie Shuster, RN 
7 See Above Right Side Lying 50 ml Melanie Shuster, RN 
11 See Above Right Side Lying 200 ml Melanie Shuster, RN 
4 Same as above Left Side Lying 25 ml Melanie Shuster, RN 
8 Same as above Left Side Lying 50 ml Melanie Shuster, RN 
12 Same as above Left Side Lying 200 ml Melanie Shuster, RN 
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Once you are comfortable and settled in the next position, another set of bladder pressure 
measurements will be taken by Melanie Shuster, RN.  The first measurement will be taken before 
any sterile salt water is added to the bladder and the other measurement will be taken after 
approximately 1, 2, or 6 ounces of sterile salt water is added to your bladder.  You will receive 
only one of the 3 amounts of sterile salt water listed above and you will assume only one of the 4 
positions shown above.  You will only be in this position for just as long as necessary to complete 
the two sets of urinary bladder pressure measurements. 
 
If you are one of the 10 subjects assigned to group 4, (see shaded area in Table 1) you will have 3 
sets of bladder pressure measurements taken.  You will be kept in bed lying on your back with the 
head of bed elevated to 30 degrees for all 3 sets of bladder pressure measurements.  The third set 
of bladder pressure measurements will be taken by Tammy Haines, RN.   
 
Each set of measurements takes two to five minutes and the whole study will be done in 30 
minutes or less.  All the measurements will be taken on the same day and will not be repeated 
again regardless of how long you stay in the ICU.  After all measurements are completed, 
Melanie Shuster, RN or Tammy Haines, RN will reposition you to the most comfortable position 
for you.   
 
Your hospital record will be reviewed and your date of birth, date of hospital admission, reason 
for hospital admission, and the type of treatment you received will be recorded on a separate 
piece of paper. All information taken from your record will be kept confidential and you will not 
be identified on this piece paper. 
 
This is an observational study and no further diagnostic or therapeutic treatment is planned as part 
of the study regardless of the value of the urinary bladder pressure measurement.  However, the 
values of the urinary bladder pressure will be made available to your primary care physician and 
the critical care team physicians.  They will decide if additional testing or treatments are 
necessary which will be outside of the study protocol.   
 
The remainder of this page left intentionally blank.
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Risks:  The risks for participating in this study are minimal.  You will receive routine care as 
necessary for your medical or surgical condition and participating in this study will not delay or 
alter your treatments in any way.  The placement of the urinary bladder catheter is considered a 
standard of care for nearly anyone in the ICU.  Bladder pressure is measured in selective subjects 
admitted to ICU’s at Allegheny General Hospital and is routinely measured in many other 
hospitals in the United States and Europe.  The bladder pressure will be measured using a Federal 
Drug Agency (FDA) approved device called the AbViser™ that is placed very carefully on the 
outside end of the urinary bladder catheter while maintaining a sterile condition.  Thus, there is a 
very small risk of developing a urinary tract or other infection because it is necessary to open the 
urinary catheter drainage system for a brief moment when attaching this device, but the attaching 
the device will be done under sterile conditions.  Urinary bladder pressure measurement is 
painless and quick; each set of measurements takes two-five minutes to complete.  There may be 
a temporary physical discomfort when you are positioned into one of the four positions for 
measurement and a small chance that medical equipment will get disconnected.  However, most 
ICU patients are placed in these positions for routine nursing care at some time during a 24-hour 
period and every precaution will be taken to prevent these problems.  There is no anticipated 
physical, metabolic, social, psychological, legal, or financial risk associated with participation in 
the study. 
 
This is an observational study and no further diagnostic or therapeutic treatment is planned as part 
of the study regardless of the value of the UBP measurement.  However, the values of the urinary 
bladder pressure will be made available to your primary care physician and the critical care team 
physicians.  They will decide if additional testing or treatments are necessary which will be 
outside of the study protocol.    
 
There is a very small but real risk of losing confidentiality.  Your medical record will be reviewed 
to extract only the information needed to complete the study.  A separate piece of paper will be 
created to keep the information that is gathered during the study.  To minimize the risks of losing 
confidentiality the people reviewing your medical record will be limited to the principal 
investigator.  The least amount of information needed for the completion of the study will be 
collected.  A study specific identification number will be assigned to you at the beginning of the 
study and most personal or confidential data such as your social security number, home address, 
telephone number, insurance information that could identify you will not be collected.  
 
Common risks 
(Incidence >10%) 
Less Common Risks 
(Incidence >1%-<10%) 
Rare Risks 
(Incidence < 1%) 
Minor risks: 
 None 
Severe risks: 
 None 
Minor risks: 
 None 
Severe risks: 
 None 
 
Minor risks: 
 Urinary tract    
                           infection 
 
Benefits:  There are no immediate direct benefits to you by participating in this study although 
the information obtained may be of benefit to other patients in similar conditions in the future.  
You may benefit immediately because you will be monitored more intensively than other patients 
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in the ICU.  All information gathered by, the researcher will be available to the primary care 
physician and critical care team.   
 
Alternative procedures:  You may choose not to participate in this study.  
 
Costs and Payments:  The cost of routine medical care provided to you while in the ICU will be 
billed to your medical insurance.  Participating in this study will not increase the cost of your ICU 
care.  Neither you nor your insurance company will be billed for the costs of measuring the 
bladder pressure.  The costs of the AbViser® device used to measure your bladder pressure will 
be paid for by funds provided through a grant or will be provided by the manufacturer.  You will 
not receive payment for participation in this study. 
 
Confidentiality:  Information obtained about you as a result of participation in this study will be 
kept strictly confidential, however as with all medical records, they may be obtained with a court 
order.  The research records that will be created for this study will be kept separately and are not 
part of your hospital medical record.  Your identity, medical records, and data related to this 
study will be kept confidential, except as required by law and except for inspections by the Food 
and Drug Administration (FDA) and the Institutional Review Board of Allegheny General 
Hospital (the committee that oversees research).  Results of the research may be published or 
presented to scientific groups, however, your identity will not be revealed.  
 
Compensation:  You have been informed and acknowledge that in the event of your voluntary 
participation in this research protocol results in the need for you to receive medical care, that no 
money or free medical care will be made available to you by Allegheny General Hospital or 
Allegheny-Singer Research Institute. 
 
Research Study Authorization of Protected Health Information & HIPAA Authorization: 
 
In 1996 the government passed a law known as The Health Insurance Portability and 
Accountability Act (HIPAA), Public Law 104-191. This law, among other things will improve 
how your health care information is protected and kept confidential when it is shared with others. 
This includes your medical records and insurance information as well as other personal health 
information. It also assures that everyone who shares this information will have to follow this 
law. This consent form describes to you how information about you may be used or shared if you 
are in a research study. It is important that you read this carefully. 
 
In order to participate in this research study, you must permit (allow) certain research records to 
be made about you in addition to the usual records the hospital and doctors create about your 
medical treatment.  These research records will contain private medical and other information, 
which is protected by law.  The researchers will only create the minimum amount of research 
records necessary to carry out the research.   
 
Type(s) of research records that may be shared is (are): 
 Tissue Samples: 
X    Medical Records:  Medical and surgical history, medication history 
 Lab Results: 
 Other: 
 
In addition to using these research records to carry out the research and, perhaps, to treat you, the 
researchers will share portions of these research records to third parties involved in the research 
study. The third parties, who receive research information, may further share the information 
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about you in accordance with their policies, practices and what the law requires.  However, some 
third parties (such as the Sponsor) may not need to follow the HIPAA law. To the best of our 
knowledge, a complete and accurate description of who the third parties are and how they will 
use or share the information are as follows: 
 
                  THIRD PARTY      PURPOSE 
 
Allegheny General Hospital  
Allegheny-Singer Research Institute 
 
 
 
May share this signed consent form and records 
that identify you to meet regulatory requirements or 
for purposes related to this research. 
 
 
The release of information described above will be the minimum necessary to abide by the law 
complete the research, and, perhaps, publish the research.   
 
Unlike your medical records, you will not have access to research records made about you. 
Although every effort will be made to keep research records about you private, complete 
confidentiality cannot be guaranteed.  Such research records may be subject to subpoena or court 
order.  The researcher has set up safeguards to keep private information about you confidential.   
 
There is no expiration for this Authorization unless you revoke (cancel) it. You may revoke this 
Authorization by writing to the Principal Investigator.  If you revoke your Authorization, you will 
also be removed from the study. Revoking your Authorization only affects the use and sharing of 
your information after the written request is received.  Any information obtained prior to 
receiving the written request, may be used to maintain integrity of the study. 
Principal Investigator Address: Melanie Shuster, RN 
 Allegheny Center for Digestive Health 
 1307 Federal Street, Suite 301 
 Pittsburgh, PA 15212 
  
If you choose to not sign this Authorization, you will not be permitted to participate in this 
research study.  In order to participate in this study, you must agree to share your information 
with the groups above.  Upon completion of the study, or if you withdraw from the study at any 
time, the research records about you will be kept by the researcher (s) and all of the information 
provided above will continue to apply to your research records. 
 
You give permission that your research records can be used and disclosed as described. 
 
Voluntary Participation/Right to Withdraw:  Participation is voluntary, and refusal to 
participate will involve no penalty or loss of benefits to which you are otherwise entitled.   You 
are free to refuse to participate in this study.  If you agree to participate, you are also free to 
withdraw from the study at any time.  Your decision to refuse to      participate or to withdraw 
from the study will not adversely affect your care at this hospital. 
 
Inquires:  If you should you have any questions regarding your rights as a research participant, 
you may contact the Institutional Review Board of Allegheny General Hospital at 412.359.3156.  
Any questions about the research have been answered or will be answered to your satisfaction by 
Melanie Shuster, RN, at (412) 359-8958.  If you have any additional questions about the research 
you may contact the Investigators or the IRB Office (412) 359-3156.  In the event of a research-
related injury, you should -contact Melanie Shuster, RN at (412) 359-8958. 
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Recruitment:  The investigator is committed to comply with the basic principles of the NIH 
guidelines on inclusion of women and minorities in research and will make every effort to enroll 
subjects into the study from all minority groups. You will receive a signed copy of this consent 
form. 
 
Subject’s Name    _______________________________________ Date    
(Please Print) 
 
Subject’s Signature _____________________________    ________ Date    
Surrogate Decision 
Maker’s Signature                Date    
(If Applicable) 
 
Witness’ Signature        _______________________________________ Date    
 
Investigator’s Signature __________________________________ ____ Date    
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subject has an equal chance of being placed in any one of the 12 groups.  Each group will have 10 
subjects.  One of the doctors that are taking care of you will ask you to participate in the study.  
These doctors can be your primary care doctor (that is the doctor who took care of you prior to 
your admission to the hospital or the surgeon who did your operation) or one of the doctors who 
are experts in critical care that has been asked by your primary care doctor or surgeon to help take 
care of you while you are critically ill.  Many of these doctors are co-investigators for this study 
along with Dr. Jorge A. Vazquez, medical nutritionist.   
 
If you agree to participate in this study, your primary care doctor, your surgeon or the critical care 
doctors, will continue to provide you with the best care they believe necessary.  In addition, one 
of these doctors will order the urinary bladder pressure measurement be taken according to the 
group you are assigned by the randomization process.  You will have your urinary bladder 
pressure measured in one of the 12 possible and different ways.  Eleven of the 12 groups will 
have 2 sets of bladder pressures measurements taken by Melanie Shuster, RN and 1 of the 12 
groups will have 3 sets of bladder pressure measurements taken.  The first 2 measurement sets by 
Melanie Shuster, RN and the third set by Tammy Haines, RN.  One set of bladder pressure 
measurement consists of two measurements:  one measurement taken before any sterile liquid 
(salt water) is added to the bladder and the other one is taken after a fixed amount of sterile liquid 
(salt water) is added to the bladder.  All bladder pressure measurements will be taken within a 30 
minute period.   
 
To measure the urinary bladder pressure a small valve will be attached using sterile technique to 
your bladder catheter, which is outside your body, and this valve will also be attached to the 
hospital monitoring system.  You will then be positioned in bed lying on your back with the head 
of the bed elevated to 30 degrees.  A bladder pressure measurement will be taken by Melanie 
Shuster, RN when you are comfortable with no added sterile salt water in your bladder and again 
after twenty-five milliliters (about one ounce) of sterile salt water is added to your bladder.  After 
the first set of measurements, Melanie Shuster, RN will reposition you to be either lying on your 
back with the head of the bed flat with a pillow under your head, or lying on your right or left side 
with the head of the bed elevated to 30 degrees with a pillow under your head and one pillow 
between your knees.  Your back will be supported with a foam wedge and your head will be 
supported with a pillow under the right or left side of your face if you are lying on your side.  
These are usual positions patients normally assume while sleeping at home or while in ICU’s.  
See the following pictures of the positions subjects will be placed in for the measurement of 
urinary bladder pressure.   
 
The remainder of the page is left intentionally blank.   
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Table 1.  Study groups for bladder instill volume and subject position 
Group Position Instill Volume Nurse 
1 
 
25 ml Melanie Shuster, RN 
5 See Above 50 ml Melanie Shuster, RN 
9 See Above 200ml Melanie Shuster, RN 
2 
 
25 ml 
Melanie Shuster, RN 
Tammy Haines, RN 
6 See Above 50 ml Melanie Shuster, RN 
10 See Above 200 ml Melanie Shuster, RN 
3 
 
25 ml Melanie Shuster, RN 
7 See Above Right Side Lying 50 ml Melanie Shuster, RN 
11 See Above Right Side Lying 200 ml Melanie Shuster, RN 
4 Same as above Left Side Lying 25 ml Melanie Shuster, RN 
8 Same as above Left Side Lying 50 ml Melanie Shuster, RN 
12 Same as above Left Side Lying 200 ml Melanie Shuster, RN 
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Once you are comfortable and settled in the next position, another set of bladder pressure 
measurements will be taken by Melanie Shuster, RN.  The first measurement will be taken before 
any sterile salt water is added to the bladder and the other measurement will be taken after 
approximately 1, 2, or 6 ounces of sterile salt water is added to your bladder.  You will receive 
only one of the 3 amounts of sterile salt water listed above and you will assume only one of the 4 
positions shown above.  You will only be in this position for just as long as necessary to complete 
the two sets of urinary bladder pressure measurements. 
 
If you are one of the 10 subjects assigned to group 4, (see shaded area in Table 1) you will have 3 
sets of bladder pressure measurements taken.  You will be kept in bed lying on your back with the 
head of bed elevated to 30 degrees for all 3 sets of bladder pressure measurements.  The third set 
of bladder pressure measurements will be taken by Tammy Haines, RN.   
 
Each set of measurements takes two to five minutes and the whole study will be done in 30 
minutes or less.  All the measurements will be taken on the same day and will not be repeated 
again regardless of how long you stay in the ICU.  After all measurements are completed, 
Melanie Shuster, RN or Tammy Haines, RN will reposition you to the most comfortable position 
for you.   
 
Your hospital record will be reviewed and your date of birth, date of hospital admission, reason 
for hospital admission, and the type of treatment you received will be recorded on a separate 
piece of paper. All information taken from your record will be kept confidential and you will not 
be identified on this piece paper. 
 
This is an observational study and no further diagnostic or therapeutic treatment is planned as part 
of the study regardless of the value of the urinary bladder pressure measurement.  However, the 
values of the urinary bladder pressure will be made available to your primary care physician and 
the critical care team physicians.  They will decide if additional testing or treatments are 
necessary which will be outside of the study protocol.   
 
The remainder of this page left intentionally blank.
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Risks:  The risks for participating in this study are minimal.  You will receive routine care as 
necessary for your medical or surgical condition and participating in this study will not delay or 
alter your treatments in any way.  The placement of the urinary bladder catheter is considered a 
standard of care for nearly anyone in the ICU.  Bladder pressure is measured in selective subjects 
admitted to ICU’s at Allegheny General Hospital and is routinely measured in many other 
hospitals in the United States and Europe.  The bladder pressure will be measured using a Federal 
Drug Agency (FDA) approved device called the AbViser™ that is placed very carefully on the 
outside end of the urinary bladder catheter while maintaining a sterile condition.  Thus, there is a 
very small risk of developing a urinary tract or other infection because it is necessary to open the 
urinary catheter drainage system for a brief moment when attaching this device, but the attaching 
the device will be done under sterile conditions.  Urinary bladder pressure measurement is 
painless and quick; each set of measurements takes two-five minutes to complete.  There may be 
a temporary physical discomfort when you are positioned into one of the four positions for 
measurement and a small chance that medical equipment will get disconnected.  However, most 
ICU patients are placed in these positions for routine nursing care at some time during a 24-hour 
period and every precaution will be taken to prevent these problems.  There is no anticipated 
physical, metabolic, social, psychological, legal, or financial risk associated with participation in 
the study. 
 
This is an observational study and no further diagnostic or therapeutic treatment is planned as part 
of the study regardless of the value of the UBP measurement.  However, the values of the urinary 
bladder pressure will be made available to your primary care physician and the critical care team 
physicians.  They will decide if additional testing or treatments are necessary which will be 
outside of the study protocol.    
 
There is a very small but real risk of losing confidentiality.  Your medical record will be reviewed 
to extract only the information needed to complete the study.  A separate piece of paper will be 
created to keep the information that is gathered during the study.  To minimize the risks of losing 
confidentiality the people reviewing your medical record will be limited to the principal 
investigator.  The least amount of information needed for the completion of the study will be 
collected.  A study specific identification number will be assigned to you at the beginning of the 
study and most personal or confidential data such as your social security number, home address, 
telephone number, insurance information that could identify you will not be collected.  
 
Benefits:  There are no immediate direct benefits to you by participating in this study although 
the information obtained may be of benefit to other patients in similar conditions in the future.  
You may benefit immediately because you will be monitored more intensively than other patients 
in the ICU.  All information gathered by, the researcher will be available to the primary care 
physician and critical care team.   
 
Alternative procedures:  You may choose not to participate in this study.  
 
Costs and Payments:  The cost of routine medical care provided to you while in the ICU will be 
billed to your medical insurance.  Participating in this study will not increase the cost of your ICU 
care.  Neither you nor your insurance company will be billed for the costs of measuring the 
bladder pressure.  The costs of the AbViser® device used to measure your bladder pressure will 
be paid for by funds provided through a grant or will be provided by the manufacturer.  You will 
not receive payment for participation in this study. 
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Confidentiality:  Information obtained about you as a result of participation in this study will be 
kept strictly confidential, however as with all medical records, they may be obtained with a court 
order.  The research records that will be created for this study will be kept separately and are not 
part of your hospital medical record.  Your identity, medical records, and data related to this 
study will be kept confidential, except as required by law and except for inspections by the Food 
and Drug Administration (FDA) and the Institutional Review Board of Allegheny General 
Hospital (the committee that oversees research).  Results of the research may be published or 
presented to scientific groups, however, your identity will not be revealed.  
 
Compensation:  You have been informed and acknowledge that in the event of your voluntary 
participation in this research protocol results in the need for you to receive medical care, that no 
money or free medical care will be made available to you by Allegheny General Hospital or 
Allegheny-Singer Research Institute. 
 
Research Study Authorization of Protected Health Information & HIPAA Authorization: 
 
In 1996 the government passed a law known as The Health Insurance Portability and 
Accountability Act (HIPAA), Public Law 104-191. This law, among other things will improve 
how your health care information is protected and kept confidential when it is shared with others. 
This includes your medical records and insurance information as well as other personal health 
information. It also assures that everyone who shares this information will have to follow this 
law. This consent form describes to you how information about you may be used or shared if you 
are in a research study. It is important that you read this carefully. 
 
In order to participate in this research study, you must permit (allow) certain research records to 
be made about you in addition to the usual records the hospital and doctors create about your 
medical treatment.  These research records will contain private medical and other information, 
which is protected by law.  The researchers will only create the minimum amount of research 
records necessary to carry out the research.   
 
Type(s) of research records that may be shared is (are): 
 Tissue Samples: 
X    Medical Records:  Medical and surgical history, medication history 
 Lab Results: 
 Other: 
 
In addition to using these research records to carry out the research and, perhaps, to 
treat you, the researchers will share portions of these research records to third parties involved in 
the research study. The third parties, who receive research information, may further share the 
information about you in accordance with their policies, practices and what the law requires.  
However, some third parties (such as the Sponsor) may not need to follow the HIPAA law. To the 
best of our knowledge, a complete and accurate description of who the third parties are and how 
they will use or share the information are as follows: 
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Third Party Purpose 
Allegheny General Hospital 
Allegheny-Singer Research Institute 
WPAHS Compliance Office 
 
Wolfe-Tory Medical, Inc. 
May share this signed consent form and records 
that identify you to meet regulatory requirements or 
for purposes related to this research. 
 
Vendor of equipment used for the measurement of 
urinary bladder pressure and may need to verify the 
proper use of the device. 
 
The release of information described above will be the minimum necessary to abide by the law 
complete the research, and, perhaps, publish the research.   
 
Unlike your medical records, you will not have access to research records made about you. 
Although every effort will be made to keep research records about you private, complete 
confidentiality cannot be guaranteed.  Such research records may be subject to subpoena or court 
order.  The researcher has set up safeguards to keep private information about you confidential.   
 
There is no expiration for this Authorization unless you revoke (cancel) it. You may revoke this 
Authorization by writing to the Principal Investigator.  If you revoke your Authorization, you will 
also be removed from the study. Revoking your Authorization only affects the use and sharing of 
your information after the written request is received.  Any information obtained prior to 
receiving the written request, may be used to maintain integrity of the study. 
Principal Investigator Address: Melanie Shuster, RN 
 Allegheny Center for Digestive Health 
 1307 Federal Street, Suite 301 
 Pittsburgh, PA 15212 
  
If you choose to not sign this Authorization, you will not be permitted to participate in this 
research study.  In order to participate in this study, you must agree to share your information 
with the groups above.  Upon completion of the study, or if you withdraw from the study at any 
time, the research records about you will be kept by the researcher (s) and all of the information 
provided above will continue to apply to your research records. 
 
You give permission that your research records can be used and disclosed as described. 
 
Voluntary Participation/Right to Withdraw:  Participation is voluntary, and refusal to 
participate will involve no penalty or loss of benefits to which you are otherwise entitled.   You 
are free to refuse to participate in this study.  If you agree to participate, you are also free to 
withdraw from the study at any time.  Your decision to refuse to participate or to withdraw from 
the study will not adversely affect your care at this hospital. 
 
Inquires:  If you should you have any questions regarding your rights as a research participant, 
you may contact the Institutional Review Board of Allegheny General Hospital at 412.359.3156.  
Any questions about the research have been answered or will be answered to your satisfaction by 
Melanie Shuster, RN, at (412) 359-8958.  If you have any additional questions about the research 
you may contact the Investigators or the IRB Office (412) 359-3156.  In the event of a research-
related injury, you should contact Melanie Shuster, RN at (412) 359-8958. 
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Recruitment:  The investigator is committed to comply with the basic principles of the NIH 
guidelines on inclusion of women and minorities in research and will make every effort to enroll 
subjects into the study from all minority groups. You will receive a signed copy of this consent 
form. 
 
Subject’s Name    _______________________________________ Date    
(Please Print) 
 
Subject’s Signature _____________________________    ________ Date    
Surrogate Decision 
Maker’s Signature                Date    
(If Applicable) 
 
Witness’ Signature        _______________________________________ Date    
 
Investigator’s Signature __________________________________ ____ Date    
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Appendix E Institutional Review Board Approval Letters 
 
Allegheny Singer Research Institute-Allegheny General Hospital            November 27, 
2006 
 
Duquesne University               February 2, 2007 
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